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The Brain - is wider than the Sky - 
For - put them side by side - 
The one the other will contain 
With ease - and You - beside
Emily Dickinson, 1896
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Introduction
Brain activity and behaviour are related to each other. Psychoactive drugs can influence both 
brain activity and behaviour. This thesis will concern the complex interplay between brain 
activity as measured by the electroencephalogram (EEG), behaviour, and psychoactive drugs in 
rats. Therefore, these three subjects [EEG (§1.1), behaviour (§1.3), psychoactive drugs (§1.4)] 
and their interactions will be introduced [EEG - behaviour (§1.2), behaviour - psychoactive 
drugs (§1.4), psychoactive drugs - EEG (§1.5)]. This will lead to the introduction of the 
interactions between EEG, behaviour, and psychoactive drugs (§1.6).
1.1 The electroencephalogram (EEG)
All living beings show electrical phenomena linked to their vital activities. Neurons in the brain 
generate electrical activity that can be measured, recorded, and analysed. This can be done at the 
level of a single neuron or at multiple neurons, or the collective firing of groups of neurons can 
be examined with electrodes to record the electroencephalogram (EEG). The function of the 
brain, for example in movement control, depends on neuronal ensembles rather than the actions 
of any single neuron. Thus, the EEG constitutes an important tool for neuroscientists. In humans 
the EEG is usually recorded with electrodes from the scalp. In animal studies, brain activity can 
be recorded directly from the cortex (ECoG, electrocorticogram) or subcortical structures such 
as the hippocampus. Although most recordings in animals are an ECoG, they are commonly 
referred to as EEG (and so will be throughout this thesis).
1.1.1 Physiological basis of the EEG
The EEG signal originates in the changes of postsynaptic potentials at neuronal cell bodies and 
dendrites of pyramidal cells. The EEG is recorded extracellularly. The extracellular currents 
generated by synaptic potentials are small, but the sum of activities of a large number of 
neurones can generate potentials that are adequately large for detection by recording electrodes. 
This is only possible if there is a certain amount of synchronisation of the neuronal activity. If 
the post-synaptic potentials appear at different times, the signal can be too small or the 
extracellular currents can cancel each other out. Pyramidal cells of the neocortex, hippocampus 
and septum have the capacity to display synchronized activity. In the neocortex and 
hippocampus, the axons of pyramidal cells send collaterals that excite interneurons. Many of 
these interneurons have inhibitory effects mediated by gamma-aminobutyric acid (GABA). They 
affect many pyramidal cells including the one that evoked their excitation. This inhibitory effect 
produces hyperpolarizations of all the neighbouring pyramidal cells. When the activity of the 
inhibitory interneuron seizes, the cycle can start again. This alternation of depolarisation and 
hyperpolarization of a large number of pyramidal cells gives rise to a rhythm of waves. The cell
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bodies of the pyramidal cells are abundant in layers 3 and 5 of the cerebral cortex, and in the 
septum and hippocampus. They have large apical dendrites that receive afferents from the 
thalamus and ascending reticular activating system. The thalamic cells act as pacemakers for the 
rhythmical potentials of the cerebral cortex.
1.1.2 Analysis of the EEG
The electrical signal obtained from EEG measurements is usually analysed with spectral analysis 
methods, although in recent years many new analysis methods have been developed. In spectral 
analysis, the EEG signal is seen as the sum of multiple sine waves each with its own frequency 
and amplitude. Through the Fast Fourier Transform (FFT) the EEG signal is decomposed into 
multiple sign waves of different frequencies and the amplitude of each frequency can be 
expressed as power (^V2). Assuming stationarity of the EEG signal, the information is so 
converted from the time domain into the frequency domain. The frequency resolution (AF) of 
the power spectrum is determined by the sampling rate (Fs) and the number of sampling points 
(N) (size of the signal window or epoch), with AF = Fs / N (see Jobert 2002). The number of 
sampling points is a function of the time window; N = Fs * t. Therefore, the frequency resolution 
is inversely related to the time window (AF = 1 / t). Accordingly, the frequency resolution 
declines with a shorter time window. For example, for a time window of 4.0 seconds the 
frequency resolution is 0.25 Hz, while 1 Hz when using a window of 1.0 second.
Table 1 Frequency band definitions
Frequency range (Hz)
A) Herrmann et al. (1980) B) Adjustment to integer frequencies*
(rat studies in this thesis)
Delta 1.5-6.0 1.0-5.0
Theta 6.0-8.5 6.0-8.0
Alpha-1 8.5-10.5 9.0-10.0
Alpha-2 10.5-12.5 11.0-12.0
Beta-1 12.5-18.0 13.0-17.0
Beta-2 18.0-21.0 18.0-20.0
Beta-3 21.0-30.0 21.0-30.0
Fast activity (gamma) 31.0-100.0
*  Due to shorter time epochs and consequently lower frequency resolution in our rat experiments, definitions have been 
adjusted to integer frequencies.
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The frequency spectrum can be subdivided into frequency bands and power in these bands is 
calculated. There is no universal standard for the subdivision into bands and many subdivisions 
can be found throughout the literature. The international pharmaco-EEG group (IPEG) has 
chosen the division made by Herrmann et al. (1980) (Table 1 [A]) as the standard for both 
human and animal EEG studies. His division was based on factorial analysis of the human EEG. 
Although perhaps not best suitable for animal studies, the use of one standard for both human 
and animal studies has been preferred. Throughout this thesis, in which studies are described in 
rats, band definitions according to Herrmann et al. (1980) will be used. Due to shorter time 
epochs and consequently lower frequency resolution in our experiments, his definitions have 
been adjusted to integer frequencies (Table 1 [B]). Additionally, spectral parameters of clear 
rhythms in the original EEG spectrum can be computed, such as peak frequency and amplitude 
of the hippocampal theta rhythm.
1.2 The relation between the EEG and animal behaviour
The EEG can 'easily' be recorded in both humans and animals, but what information does the 
EEG convey? Can the activity of groups of neurons provide information on behaviour and 
mental processes? As in this thesis, animals have been used to interpret the EEG. Can rhythms in 
the EEG or certain band activities be related to the activities of the behaving animal? Although 
the brain is responsible for the planning, coordination, and execution of behaviour, only a few 
patterns in EEG recordings have been directly related to ongoing behaviour so far.
1.2.1 Hippocampal RSA
The strongest relation between brain activity and the behaviour of an animal has been 
demonstrated for hippocampal rhythmical slow activity (RSA) in amongst others rats, rabbits, 
and dogs. In rats, this rhythm has a frequency of 6-10 Hz and is also referred to as theta rhythm. 
Both the terms hippocampal RSA and theta are used interchangeably in the literature and will be 
throughout this thesis. This rhythmic activity is predominant in the EEG of the rat hippocampus. 
The hippocampus is a fairly large brain structure in rats and is involved in aspects of memory 
and learning (Jarrard 1995). The hippocampal theta rhythm is the largest and one of the most 
distinctive electrophysiological signals in the rat brain.
Relation to animal behaviour
Hippocampal RSA has already been described in 1939 by Jung and Kornmuller. In the search of 
its behavioural correlates, RSA has been related to psychological concepts such as memory and 
learning (Elazar & Adey 1967, Buzsaki 1989), arousal and attention (Green & Arduini 1954,
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Kemp & Kaada 1975), the orienting response (Grastyan et al. 1959), ‘type I ’ motor movement 
(Vanderwolf 1969, Coenen 1975), and sensory (-motor) activity (Komisaruk 1970, Sainsbury 
1998). Vanderwolf and coworkers and Coenen (1975) demonstrated a clear relation with 
behaviour. Vanderwolf took a behaviouristic or ethological approach, which states that direct 
measures of brain activity can be correlated with behaviour itself without the necessity of 
hypothesizing a psychological concept. He argued that the hippocampal theta rhythm is related 
to motor activity and should not be interpreted as inferred mentalistic concepts (Vanderwolf 
1969, Vanderwolf & Robinson 1981). This was the core of a long lasting debate: does 
hippocampal RSA reflect mere motor activity or do psychological processes contribute to it?
Whether psychological processes contribute to the hippocampal RSA or not, a clear 
relationship to motor activity has been amply demonstrated. Based on these correlates with theta 
activity, behaviour has been divided into ‘type 1 behaviour’ (or ‘voluntary movement’), and 
‘type 2 behaviour’ (‘automatic movement’ and awake immobility) (Coenen 1975, Vanderwolf 
1969, 1992). Type 1 behaviour is correlated with theta and includes behaviour such as walking, 
running, rearing, swimming, and changes in body posture; type 2 behaviour is accompanied by 
large amplitude irregular activity and includes behaviour such as body grooming, face washing, 
and awake immobility. For Type 1 behaviour, more vigorous movements are accompanied by 
higher amplitude RSA (Whishaw & Vanderwolf 1973). Active exploratory sniffing is also 
highly correlated with theta activity (Forbes & Macrides 1984, Komisaruk 1970, Chang 1992), 
although it is not generally included in type 1 behaviour.
However, problems with a simple motor movement hypothesis have been reported 
repeatedly. Species other than the rat show obvious hippocampal theta during motionless 
vigilance states, as well as during movement. Rabbits, for example, display trains of theta during 
immobility (Klemm 1971). Theta can be recorded from animals anaesthetized with ether 
(MacLean 1959) and theta appears in immobile rats just before a jump avoidance response 
(Vanderwolf 1969). Therefore, the old controversy had never really been settled.
Physiology and pharmacology of the theta rhythm
Part of the solution to the problems with the motor hypothesis came with the finding that two 
types of RSA could be pharmacologically dissociated (see Vanderwolf 1988 for review). The 
first type (type 1 RSA) is usually recorded during type I behaviour, e.g. walking, rearing, 
jumping and head movement. Since this type of RSA is relatively unaffected by a large dose of 
atropine, it has been termed atropine-resistant RSA. It is claimed to be dependent on ascending 
serotonergic projections to the hippocampus. The second type (type 2 RSA) occurs in response 
to electrical stimulation of the midbrain reticular formation or to sensory stimulation, and is 
present during ether, pentobarbital or urethane anaesthesia. Since it is abolished by systemic 
administration of atropine, it has been termed atropine-sensitive RSA and is considered to be 
produced by cholinergic inputs to the hippocampus. This type of theta can occur under certain 
circumstances during the 'non-theta' type 2 behaviours.
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There are at least two generators of theta in the hippocampal formation. One is located 
in the stratum oriens of the CA1 pyramidal cell region and the other in the stratum moleculare of 
the dentate gyrus (Bland 1986). The medial septum is the primary extrinsic regulator of the 
hippocampal theta rhythm (Gray 1971, Sainsbury & Bland 1981). The fimbria-fornix connects 
the medial septum to the hippocampus. The atropine-sensitive component of the theta rhythm is 
presumably initiated by the cholinergic cells in the medial septum (Bland 1986), which receive 
inputs from the brainstem including the supra-mammillary area (Kocsis & Vertes 1994). These 
cholinergic cells may rhythmically drive the hippocampal interneurons (Leung 1984). The 
atropine-resistant component of the theta rhythm may depend on a serotonergic input from the 
medial raphe nucleus (Vertes 1982, Moore & Halaris 1975). Furthermore, electrical stimulation 
of the posterior hypothalamic nucleus not only elicits hippocampal theta rhythm, but can also 
induce type 1 locomotor activity (Bland & Vanderwolf 1972). Additionally, the driving of the 
theta rhythm may depend on other neurotransmitters; glutamate and GABA in the hippocampus 
have been implicated (Lopes da Silva et al. 1990). In particular the GABA pathway from the 
medial septal area to the hippocampus appears to be as large as the cholinergic pathway, and it 
may mediate rhythmic driving of the hippocampus, possibly through interneurons (Leung 1998).
1.2.2 Cortical beta/gamma activity
In contrast to the EEG of the hippocampus, the cortex is dominated by an EEG pattern of low 
voltage high frequency activity during behavioural activity. This activity lies in the beta (13-30 
Hz) and gamma frequency bands (30- >70 Hz). Although this activity does not show the precise 
relation to concurrent motor activity as hippocampal theta does (Vanderwolf 1990), cortical high 
frequency activity has been associated with general levels of arousal (Coull 1998, Steriade
1995). The type of EEG pattern of higher frequencies and low amplitude appeared to be 
associated with the waking state. The change from large amplitude slow activity (present during 
sleep) to these high frequencies is commonly referred to as 'activation' of the EEG.
Physiology and pharmacology of the cortical beta/gamma activity 
In analogy to hippocampal theta activity, it is suggested that cortical EEG activation is 
maintained by parallel cholinergic and serotonergic inputs to the cortex (Dringenberg & 
Vanderwolf 1998). As with theta activity, there is a cholinergic input critically involved in 
maintaining cortical EEG activation during certain (Type 2) behaviours. Neocortical activation 
during other (Type 1) behaviours is resistant to a blockade of the cholinergic input. 
Consequently, a non-cholinergic input to the cortex is sufficient to produce cortical EEG 
activation independently of the cholinergic system. Based on a long-series of pharmacological 
experiments to identify the non-cholinergic activating system, this input is suggested to be 
serotonergic (for review see Dringenberg & Vanderwolf 1998). The serotonergic innervation of
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the neocortex arises mainly in the raphe nuclei of the midbrain (Tork 1990). Acetylcholine and 
serotonin appear to constitute direct activating systems, so they do not depend critically on other 
systems to mediate these activating influences (Dringenberg & Vanderwolf 1998). A number of 
additional anatomical (e.g. locus coeruleus, amygdala, superior colliculus) or neurochemical 
(noradrenaline, dopamine, histamine) systems have been shown to modulate neocortical EEG 
activity and have been proposed to function as indirect neocortical activators (Baust & Niemczk 
1964, Kropf et al. 1989, Monnier et al. 1970). The cholinergic and serotonergic systems can be 
regarded as a final common pathway in the induction of cerebral activation. They mediate the 
activating influences of all other brain systems involved in modulation of the EEG. It appears 
that serotonergic activation is more closely coupled to concurrent active behaviour or movement 
than cholinergic activation (Dringenberg & Vanderwolf 1998). It is speculated that the relative 
contribution of the various parallel activating pathways to cerebral activation may vary in 
relation to different behavioural states. This introduces a degree of functional specialization 
among central activating systems, rather than integration of all activating impulses to the cortex 
into a unitary, non-specific ascending pathway (Dringenberg & Vanderwolf 1998). In addition to 
excitatory neurotransmitters, the inhibitory neurotransmitter GABA (at the GABAa receptor) 
plays an important role in the generation of fast frequency oscillations (Whittington et al. 2000a, 
Steriade 2000).
1.3 Rat behaviour
To study the relation between rat behaviour and the EEG, it is important to choose appropriate 
conditions to observe rat behaviour. Rats are nocturnal animals and therefore show high activity 
during the dark phase and lower activity during the light phase of the day-night cycle. In a 
standard home cage, the diversity of rat behaviour -within a given time period- is rather limited. 
When introduced into a larger and novel environment, a greater diversity of behavioural 
elements can be induced. The open field, usually a plain and illuminated enclosure larger than 
the home cage, is such a novel environment. The open field test was first designed for the 
evaluation of rat emotional behaviour (Hall 1934), as the bright open space is aversive to the 
animal. Later it was developed to measure other aspects of behaviour, like exploratory behaviour 
(consisting of locomotion, sniffing and rearing) or grooming. Thus, the open-field test can 
measure two conflicting aspects: emotional reaction and exploratory motivation. The spatio­
temporal structure of locomotor behaviour offers a test of activity and of the sequential (spatio­
temporal) structure of behaviour (Drai et al. 2001). When a rat is placed in a novel environment, 
it alternates between progression and stopping. Each time the animal stops it performs scanning 
movements -sniffing, establishing snout contact with a wall or object, and/or looking around. 
Forward progression carries the animal from one location to the next, while stopping and 
scanning involve investigations of particular locations (Drai et al. 2001). These two patterns
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constitute the locomotor behaviour of the rat. Bouts of this exploratory behaviour alternate with 
bouts of inactivity and grooming. Using low illumination or introducing an object into the centre 
of the open field reduces anxiety and increases exploration. In this way, an enriched behavioural 
pattern of rat behaviour can be studied in a standardized fashion and laboratory setting (open 
field) in the dark phase of the day-night cycle.
1.3.1 Definition of behavioural elements
In the experiments described in this thesis, the open field has been used to study rat behaviour. 
In pilot experiments, elements of rat open field behaviour were investigated and described, 
making use of behavioural definitions after Timmermans (1978) and Vossen (1966). These 
behavioural elements were used and scored throughout the experiments in this thesis:
Walking: The rat is moving forward, using all 4 paws. This locomotion pattern seems more ‘goal 
directed’ rather than ‘exploring’, in that the animal walks from point A to point B with no 
abundant sniffing.
Running: Running is quicker than walking, further identical.
Hopping: The rat moves forward in a straight line with little ‘jumps’. This pattern differs from 
walking in that intense sniffing can be observed and two paws are used at the same time 
(‘jump’).
Exploratory walking: The rat is moving backwards and forwards or turning right or left using at 
least 2 paws, with abundant sniffing.
Squatting: The rat stands on the hind paws, very often with an arched back, without intense 
sniffing.
Climbing: The rat touches a wall or the object with two paws, no intense sniffing.
Rearing: The rat supports itself on its bent hind legs and often also on the base of its tail. The 
trunk and back are raised vertically and the head is lifted up. Accompanied by intense sniffing. 
Rearing supported: Same as rearing but the rat touches a wall with one or two paws.
Rearing object: Same as rearing but the rat touches the object with one or two paws.
Sniffing: Movements of the whiskers, of the nose and the head, scored when no obvious paw- 
movement can be observed.
Sniffing object: Intense sniffing directed to the object.
Sniffing up: Intense sniffing directed in the air.
Sniffing down: Intense sniffing directed to the ground.
Sniffing wall: Intense sniffing directed to a wall 
Sniffing food: Intense sniffing directed to the food pellets.
Manipulating food: Handling of the food pellets with either the paws or jaws (without chewing 
on it).
9
Chapter 1
Eating: The rat manipulates a food-pellet and bites/chews it.
Drinking: The rat touches the drinking nipple of the bottle with its tongue.
Face washing: The rat licks the forepaws and moves these together across its head in the 
direction of the nose.
Body grooming: The rat licks its body and chews and combs the fur by fast movements of the 
incisors.
Genital grooming: The rat bends its head between its hind legs and licks and manipulates its 
genitals.
Scratching: The rat scratches its flanks or head with a hind paw.
Sitting: The rat rests with his 4 paws on the ground.
Freezing: The rat shows no signs of movement from either the paws or the rest of the body, 
resting with 4 paws on the ground when startled in response to potential danger.
Orienting: The animal shifts its head in a specific direction like it is looking/listening to 
something and shows no obvious movement or sniffing.
Wet dog shake: The rat shakes its body. The movement starts at the head and runs quickly 
backwards along the body. Sometimes only the head is being shaken.
1.3.2 Categorisation of behavioural elements
The behavioural elements described above have been categorized based on correlations with 
hippocampal RSA made by Vanderwolf (1969) and Coenen (1975) (Table 2).
Table 2 Categorisation o f  behavioural elements
Type 1 Type 2 Immobility Sniffing Miscellaneous
Walking
Running
Hopping
Exploratory walking
Climbing
Rearing
Rearing supported 
Rearing object 
Manipulating food
Face washing 
Body grooming 
Genital grooming 
Scratching 
Wet dog shake 
Eating 
Drinking
Sitting Sniffing object 
Sniffing up 
Sniffing down 
Sniffing wall 
Sniffing food
Squatting
Freezing
Orienting
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1.3.3 Strain differences in rat behaviour
Mainly the brown rat (Rattus norvegicus) has been used as the origin for rats that served as 
subjects for more than a century in all kinds of aspects of biological research. Throughout this 
time, many rat strains have been developed and are currently in use in research. Although strains 
do not differ qualitatively in their behaviour (Boice 1981, Price 1984), quantitatively differences 
are evidently present (Andrews 1996, Schmitt & Hiemke 1998b, Van der Staay & Blokland
1996). Meaning, the definitions of the behavioural elements described above can be used 
throughout rat strains, but the relative contribution of each behavioural element to the behaviour 
of the rat can differ between strains. The most noticeable difference amongst rat strains is 
pigmentation. Pigmented strains typically show higher levels of locomotor activity than albino 
strains (Aulakh et al. 1989, Bauer 1990, Onaivi et al. 1992). Commonly used rat strains are the 
albino Sprague-Dawley rats and hooded Long-Evans rats with partly pigmented coats, both 
originally derived from albino Wistar rats.
1.4 Psychoactive drugs
Next to electrical signalling in the brain as reflected by the EEG, the other main communication 
process is based on neurochemical signalling. Brain neurochemistry and related 
psychopharmacology has been the most successful intervention target for brain diseases so far. 
The occurrence of mental health problems is increasing considerably. According to the World 
Health Organization, one in every four people will suffer from a mental or neurological disorder 
at some point during their life. Therefore, mental disorders are an important target for the 
development of new drugs by pharmaceutical companies. A thorough understanding of the 
biological mechanisms underlying mental disorders will allow the development of new drugs 
acting on these mechanisms. Some major classes of psychoactive drugs include antidepressants, 
anxiolytics, psychostimulants and neuroleptics. Experiments throughout this thesis have been 
restricted to a number of psychoactive drugs developed for the treatment of anxiety and 
depression. Therefore only relevant information for the drugs used in the studies will be given, 
instead of an extensive overview of all available psychoactive drugs.
1.4.1 Drugs acting at the benzodiazepine binding-site; sedative and anxiolytic activity
Under normal conditions, anxiety (fearfulness) is adaptive; it signals potential danger and can 
help to overcome a threatening situation. Excessive anxiety, however is maladaptive either 
because it is too intense, or because it is inappropriately provoked by events that present no real 
danger. The benzodiazepines, such as Valium (diazepam), seemed to be the ideal drug for
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treating anxiety disorders and have been widely used in clinical practice. However, next to 
anxiolysis (fear reduction), the benzodiazepines also cause undesirable adverse effects, such as 
sedation and the development of tolerance and dependency. Benzodiazepines bind to specific 
benzodiazepine receptors in the brain on the gamma-aminobutyric acid (GABA) receptor 
complex. They are allosteric modulators of the GABA receptor; they need the presence of 
GABA to exert their effect. Two types of GABA receptors exist, GABAa and GABAb. 
Furthermore, the GABAa receptor is composed of several subunits and a number of subunit 
combinations are expressed in the central nervous system (Lüddens & Wisden 1991, Fritschy & 
Möhler 1995).
Behavioural pharmacology of benzodiazepine action at the GABAa receptor 
Fast synaptic inhibition in the mammalian brain is largely mediated by the activation of GABAa 
receptors, which are GABA-gated chloride channels. Agonists of the benzodiazepine site 
enhance their opening frequency (allosteric modulation), which is the basis of their therapeutic 
effectiveness but also of their side effects. The classical benzodiazepines such as diazepam 
interact indiscriminately with all benzodiazepine-sensitive GABAa receptor subtypes (al, a2, 
a3, and a5) with comparable affinities. They have a variety of behavioural effects, including 
anxiolysis, muscle relaxation, and sedation. Until recently, precisely which subunits mediate the 
various behavioural effects was difficult to determine with certainty because of lack of subtype- 
selective drugs. Progress has been made with the development of subtype-selective 
benzodiazepine site ligands. Point mutation ('knock-in') mouse lines have also been generated to 
investigate the behavioural effects of specific a subunits. One consistent conclusion is that al- 
containing GABAA receptors are the primary mediator of the sedative effects of 
benzodiazepines. The seizure protective action of the benzodiazepines is also believed to be 
mediated by the al-containing GABAa receptors. The anxiolytic action of the benzodiazepines 
is not mediated by the a l subunit (McKernan et al. 2000) but by the other a subunits (a2, a3, 
a5) (Rudolph et al. 1999). However, the a2 and a3 subunit have also been described to mediate 
hyperlocomotion induced by diazepam when the a1 subunit has been made inactive (Reynolds et 
al. 2001).
Diazepam
Diazepam is the classical benzodiazepine, known as Valium. It binds non-selectively to all 
benzodiazepine-sensitive GABAa receptor subtypes (a1, a2, a3, and a5). As a typical 
benzodiazepine, it has anxiolytic, sedative, muscle-relaxant and anticonvulsive properties.
Zolpidem
The imidazopyridine zolpidem is a non-benzodiazepine compound that binds at the 
benzodiazepine binding-site on the GABAa receptor complex. It binds specifically to ai subunit
12
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containing GABAa receptors with high affinity (Langer et al. 1992). This causes zolpidem to be 
highly sedative. It is therefore clinically used as hypnotic/sedative.
1.4.2 Drugs acting at serotonergic pathways: antidepressant activity
Depression involves disturbances in emotion (excessive sadness), behaviour (loss of interest in 
one's usual activities), cognition (thoughts of hopelessness) and body function (fatigue and loss 
of appetite). Until some ten years ago the view was that depression represented a decreased 
availability of either noradrenaline (norepinephrine) or serotonin or of both amines. This was 
termed the catecholamine hypothesis. Most clinically used antidepressants act on either or both 
of the two systems. Several classes of antidepressants were developed over the years, acting at 
different sites of serotonergic or noradrenergic transmission such as enzymatic synthesis, 
storage, receptor interaction, reuptake, and degradation by monoamine oxidase (MAO). One of 
the most targeted sites was the reuptake of serotonin and noradrenaline. The action of serotonin 
and noradrenaline is terminated by being taken up into the presynaptic terminal. Drugs were 
developed that inhibit the membrane transporters, thus increasing the availability of serotonin 
and/or noradrenaline in the synaptic cleft and inducing a greater postsynaptic effect. Tricyclic 
antidepressants inhibited reuptake of both serotonin and noradrenaline. Another group of 
antidepressants, the selective serotonin reuptake inhibitors (SSRI's), did so selectively for 
serotonin. The reuptake inhibitors do not bind themselves directly at receptors, but rather 
influence the amount of monoamine available in the synaptic cleft. However, the SSRI's are only 
clinically effective in elevating mood after prolonged administration. This has been attributed to 
desensitisation of the 5-HT1A auto-receptor. Other antidepressants were developed that targeted 
serotonergic and noradrenergic receptors directly, thereby trying to shorten the latency to 
clinical efficacy.
Behavioural pharmacology of antidepressants
Antidepressants can diverge in behavioural effects in rat models, and most antidepressants show 
antidepressant properties in some behavioural tests but not all. Most consistently the serotonin 
(5-HT) system has been implied in the action of antidepressants. 5-HT has been implicated in 
the aetiology of other mental disorders, such as anxiety, schizophrenia, and eating disorders. As 
much as 14 serotonin receptor subtypes have been identified up till now. O f most interest for 
antidepressant activity seems to be the 5-HT1A receptor. Evidence exists that SSRI's are 
antidepressant through 5-HT1A receptor activation, and with clinical evidence that 5-HT1A 
agonists may have antidepressant efficacy. 5-HT1A receptors in the raphe nuclei act as 
somatodendritic autoreceptors, which inhibit neuronal firing and 5-HT release onto postsynaptic 
sites. Desensitisation of these 5-HT1A auto-receptors may underlie the ability of chronic SSRI 
administration to raise synaptic cleft 5-HT (for review see Blier & Ward 2003).
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In rats, activation of the postsynaptic 5-HTiA receptor results in a characteristic 5-HT 
syndrome consisting of flat body posture, forepaw treading, headweaving, and hypothermia and 
ACTH release. In addition to 5-HTiA receptors, 5-HTiB, 5-HT2A, and 5-HT2c receptors are likely 
to be involved in the therapeutic effects of SSRI's (Cryan & Lucki 2000a, Clenet et al. 2001). 5- 
HT4 receptors have been shown not to play a role (Cryan & Lucki 2000b). In addition to 5-HT 
receptors, the a2A-adrenergic receptor, that modulates norepinephrine release as well as 
serotonin, has been implied to play some role in depression (Schramm et al. 2001).
Citalopram
Citalopram is a reuptake inhibitor, which is most and highly selective for serotonin per se 
(Hyttel 1982).
Fluoxetine
Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) that mainly increases levels of 5- 
HT, but in addition affects levels of noradrenaline and dopamine (Gobert et al. 1997). Under the 
name of Prozac, it is the best-known antidepressant at the moment.
Imipramine
Imipramine is a classic tricyclic antidepressant that non-selectively inhibits reuptake of serotonin 
and noradrenalin by acting at the transporter complex
Mirtazapine
Mirtazapine has yet another unique mechanism of action. It is a noradrenergic and specific 
serotonergic antidepressant (NaSSA) that has a dual action by increasing noradrenergic and 
serotonergic neurotransmission by binding directly at receptors. The acute increase in 
serotonergic transmission is specifically mediated by 5-HT receptors because mirtazapine 
blocks 5-HT2 and 5-HT3 receptors. Additionally, mirtazapine is an antagonist of the adrenergic 
a2-auto- and a2-heteroreceptor (De Boer 1996). Mirtazapine also has histamine (Hi) antagonist 
properties (De Boer et al. 1988) and increases dopamine levels in the frontal cortex (Millan et al.
2000).
1.5 Pharmaco-EEG
In the development and assessment of new drugs for psychiatric disorders diverse behavioural 
animal models are being used. Especially for mood disorders it is hard to develop appropriate 
animal models that validly model a disorder such as depression. Psychoactive drugs target mood 
disorders by influencing the complex processes in the brain. Therefore, it is essential to consider 
psychoactive drug effects on the level of the functionality of the intact brain. The electrical
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processes in the brain, as measured by the EEG, are very suitable for this purpose. They reflect 
in a very complete -though complex- way the net result of integrative processes in the central 
nervous system. Therefore, in addition to the behavioural models, the EEG has been developed 
to contribute to the development and assessment of psychoactive drugs. EEG studies are being 
used both clinically and pre-clinically. EEG-systems available at a number of pharmaceutical 
companies include for example EEG-based sleep-wake systems and pharmaco-EEG systems. 
The use of EEG systems is based on findings that psychoactive drugs with similar clinical 
efficacy show the same alteration patterns in the EEG or sleep-wake activity (Krijzer et al. 1993, 
Ruigt et al. 1993, Dimpfel 2003). Although each drug can have its own characteristic EEG 
profile, EEG profiles of drugs belonging to the same clinical class can have some characteristics 
in common. The pharmaco-EEG is a useful tool in the preclinical screening of compounds and 
in clinical studies on the effectiveness of psychoactive drugs.
1.5.1 Biomarkers
An important objective of pharmaco-EEG studies is to find so called biomarkers for different 
aspects of the action of psychoactive drugs on the brain. A biological marker (biomarker) is 
defined as a characteristic that is objectively measured and evaluated as an indicator of normal 
physiological processes, pathological processes, or pharmacological responses (Biomarkers 
definitions working group, 2001). In this way, a biomarker can be an early sign in animal 
models of potential clinical efficacy. Pharmaco-EEG profiles or specific parameters from those 
profiles could function as such biomarkers.
1.5.2 Pharmaco-EEG profile of anxiolytics and antidepressants
The generalized effect of the group of anxiolytic drugs on the rat neocortical EEG is an increase 
in 20-50 Hz activity (Krijzer et al. 1993). However, a similar profile was described by Dimpfel 
(2003) for a group of drugs that he classed as sedatives. Therefore, caution should be taken 
towards the properties of drugs that are grouped into a common EEG effect: most clinically 
available anxiolytics show sedative effects because most of them act through GABAa agonism. 
It has been suggested that the amplitude of the EEG beta band (11.5-30 Hz) increase can serve 
as a biomarker for GABAa agonism (i.e. benzodiazepines and neurosteroids) (Visser et al. 
2003a). This beta band increase is dose-dependent (Krijzer et al. 1993, Mandema et al. 1991), 
and differences in potency and intrinsic efficacy of the benzodiazepines at the GABAA receptor 
were reflected in this cortical EEG parameter (Mandema & Danhof 1992).
Despite consistent effects on sleep architecture, for the clinically active antidepressants 
the largest variation in pharmaco-EEG effects is found, and in automatic drug classification
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systems based upon pharmaco-EEG changes the classification error is significantly larger for the 
group of antidepressants than other drug classes (Krijzer et al. 1993). This is not so surprising, 
given the fact that the class of antidepressants is chemically quite heterogeneous. Nonetheless, 
the most characteristic effect of all antidepressants would be a decrease in 7-18 Hz activity in the 
cortical EEG (Krijzer et al. 1993, Dimpfel 2003). This decrease was also found to be dose- 
dependent. Additional to this decrease, antidepressants that also show anxiolytic properties 
would increase 20-50 Hz activity (Krijzer et al. 1993).
1.6 The interactions of psychoactive drugs, EEG, and behaviour
Psychoactive drugs can influence both behaviour and EEG activity. Meanwhile, there is a strong 
relationship between behaviour and the EEG. Acknowledging that the EEG is influenced by 
behavioural patterns and that some drug classes can alter behaviour, the pharmaco-EEG systems 
try to measure the pharmaco-EEG under controlled vigilance conditions. This is done by 
artificially inducing activity, for example by placing the animal on a rotating drum (Krijzer et al. 
1993, Visser et al. 2003a). The influence of behaviour on the EEG effects is not always 
acknowledged (Dimpfel 2003).
Thus, the effects of drugs on behaviour are largely acknowledged in EEG studies. 
However, detailed studies of the effects of psychoactive drugs on combined measurements of 
EEG and behaviour are lacking. Information is missing on the exact interplay between 
behavioural and EEG effects. Mostly behavioural tests and EEG test of psychoactive drugs are 
seen as separate and hence are performed separately. Possibly, the combination of EEG 
recordings and behavioural studies will render new information on how psychoactive drugs act. 
Especially for the psychoactive drugs, such information could give new insights into how 
behaviour is reflected in brain processes, how these brain processes control behaviour, and how 
psychoactive drugs can influence both.
Indications that some information may lie in the relation between drug effect on 
behaviour and drug effect on EEG are given by a phenomenon called 'pharmacological 
dissociation' of the normal relation between EEG and behaviour. Such a dissociation has been 
described for opioid and anticholinergic compounds. This dissociation means that when the 
animals were actively running round under the drug condition they displayed EEG patterns that 
were similar to the sleep state in the drug-free condition (Wikler 1952). A similar 
pharmacological dissociation between the slowing of the EEG and waking behaviour has been 
described in some anti-allergic agents (Kakiuchi et al. 1998).
Another pharmacological dissociation has been described for cortical beta EEG activity 
and the benzodiazepines. In drug-free conditions, an increase in power of high frequency EEG 
activity is associated with an increase in arousal (Coull 1998). Benzodiazepines are sedative, but
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they increase beta activity that normally accompanies waking behaviour (Coenen & Van 
Luijtelaar 1991, Van Rijn & Jongsma 1995).
1.7 Aim and outline of this thesis
Behaviour and electrical brain activity (EEG) are related to each other. Psychoactive drugs can 
influence both of these phenomena. The aim of this thesis is to provide detailed information 
about the relations between (pharmaco-) EEG and behaviour in rats. How is spontaneous and 
pharmacologically induced activity represented in EEG activity and how is behavioural activity 
determined by spontaneous and pharmacologically altered EEG activity (see Figure 1)? More 
specifically, can spontaneous differences in the level of activity influence the representation of 
behaviour in EEG activity? Differences in these spontaneous activity levels can be studied by 
choosing different rat strains that differ in their level of activity, or by comparing a behavioural 
element in a sequence of activity with the same element in a sequence of inactivity within a rat. 
Also, can pharmacological agents influence the representation of behaviour in EEG activity? 
What is the nature of the pharmacological dissociation of the relation between EEG and 
behaviour as described for the benzodiazepines? Do pharmacological effects on the EEG differ 
upon behaviour?
This thesis will start with three largely descriptive experiments. First, the relation 
between EEG and behaviour was studied while behavioural activity differed physiologically by 
comparing two different rat strains (Chapter 2). The aim was to relate strain differences in 
behavioural activity to possible strain differences in EEG activity. This was to address the 
question if spontaneous differences in levels of behavioural activity are reflected in the 
representation of behaviour in the EEG. Hippocampal EEG activity was studied, since the 
clearest relation of behaviour with EEG activity has been demonstrated for hippocampal RSA.
Next, two studies were performed in which behavioural activity was manipulated by 
administration of two types of psychoactive drugs: anxiolytics (Chapter 3) and antidepressants 
(Chapter 4). These studies describe the effects of these psychoactive drugs on behaviour, EEG 
and their interplay. In chapter 3 the question was addressed what the precise nature is of the 
pharmacological dissociation between behaviour and the EEG as described for the 
benzodiazepines. Furthermore, in chapter 3 and 4 the question was asked if the effects of a range 
of psychoactive drugs on the EEG are dependent on behaviour. One strain, the Long-Evans rats, 
was used for these pharmacological studies because compared to albino strains they are more 
active in the open field (Chapter 2) and show the best anxiolytic-like response to a number of 
benzodiazepines (Andrews et al. 1995). As benzodiazepine anxiolytics are known for their 
cortical beta effect, in these studies cortical EEG was included as well.
Consequently, two studies will be presented that go deeper into the EEG rhythms that 
are hypothesised to underlie processes involved in behavioural activation. In chapter five
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hippocampal RSA will be further explored in the context of behavioural sequences, rather than 
moment-to-moment behaviour as isolated and independent events. Do differences in activity 
prior to or after a behavioural element influence the EEG representation of this behavioural 
element? This paradigm provided evidence for a new phenomenon, that we termed 'transition 
effect' (Chapter 5). This effect was further studied in chapter six. The question was addressed if 
such a transition effect could also be demonstrated for cortical beta/gamma activity and if 
psychoactive drugs can affect these phenomena (Chapter 6).
In the general discussion (Chapter 7), the most interesting and striking findings are 
summarized and their implications are discussed. A framework will be given for the most 
important EEG patterns that relate to behaviour, and how psychoactive drugs influence these 
patterns and behaviour.
II Psychoactive Drugs
I Physiology
(strain or behavioural sequences)
Figure 1 Simplified schematic representation o f  the five main research questions (Chapter 1). Behaviour and EEG are 
related to each other. Both can be influenced by physiological (I) or pharmacological (II) manipulations (solid arrows), 
but how  do they interact?
A) Are physiological differences in behavioural activity, as studied by strain differences, reflected in the 
representation o f  behaviour in the EEG? (Chapter 2)
B) Is there an interaction between psychoactive drug effects on the EEG and on behaviour? (Chapters 3 & 4)
C) W hat is the nature o f the dissociation o f the relationship between EEG and behaviour under GABAa receptor 
modulation? (Chapter 3)
D) Are spontaneous differences in behavioural activity, as studied by behavioural transitions, reflected in the 
representation o f  behaviour in the EEG? (Chapter 5)
E) Do psychoactive drugs influence the modulating effect o f  behavioural transitions on the relationship between 
EEG and behaviour? (Chapter 6)
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Abstract
To date, EEG studies towards strain differences have focussed on pharmacologically altered or 
pathological EEG activity, but only few studies have investigated strain differences and normal 
EEG activity. A strong relation between behaviour and EEG activity has been demonstrated, 
especially for hippocampal EEG activity. This relation is known to be similar across species and 
strains, but no direct comparisons between rat strains within one study have been made. This 
study compared two rat strains (Sprague-Dawley and Long-Evans) with regard to open field 
behaviour and concurrent hippocampal EEG recordings. A detailed behavioural analysis was 
made and spectral power calculated for corresponding EEG activity in eight frequency bands. 
The two strains differed in exploratory activity and in spectral power in the 9-10 Hz frequency 
band (high frequency RSA (Rhythmical Slow Activity 6-10 Hz)). Long-Evans rats showed 
higher exploratory activity and higher 9-10 Hz spectral power for voluntary movement and 
sniffing behaviours. Our results demonstrated these behaviour-specific strain differences in RSA 
power, although the relation between EEG and behaviour within each strain was similar. The 
strain differences in EEG were interpreted in relation to strain differences in exploratory 
behaviour, attributing the differences to a main motor component but also to a smaller sensory 
component integrated in exploratory behaviour. This is in accordance with theories on the 
sensory-motor function of the hippocampus and hippocampal theta activity.
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2.1 Introduction
Substantial differences between various rat strains exist in levels of behavioural activity 
(Andrews 1996, Schmitt & Hiemke 1998b, van der Staay & Blokland 1996). Strain differences 
have also been found for EEG activity in a number of studies, mainly addressing pathological 
EEG activity (e.g. seizure activity, de Bruin et al. 2000, Inoue et al. 1990) or pharmacologically 
altered EEG activity (Mayo-Michelson & Young 1993, Sisson et al. 1991). However, only few 
studies have been aimed at strain differences in normal EEG activity (Franken et al. 1998).
Strong correlates have been demonstrated for behaviour and EEG activity, especially 
hippocampal theta activity or Rhythmical Slow Activity (RSA, i.e. 6-10 Hz), which has been 
related to psychological concepts such as memory and learning (Buzsaki 1989, Elazar & Adey 
1967), and arousal and attention (Green & Arduini 1954, Kemp & Kaada 1975), the orienting 
response (Grastyan et al. 1959), voluntary motor movement (Coenen 1975, Vanderwolf 1969, 
1992), and sensory (-motor) activity (Komisaruk 1970, Sainsbury 1998). In studies by 
Vanderwolf (1969, 1992) and Coenen (1975), behaviour is classified as voluntary movement (or 
type 1 behaviour), or automatic movement or awake immobility (type 2 behaviour), based on 
movement correlates with theta activity. Type 1 behaviour highly correlates with high frequency 
RSA, whilst type 2 behaviour does not. Active exploratory sniffing also correlates with theta 
activity (Chang 1992, Forbes & Macrides 1984, Komisaruk 1970), although it is not generally 
included in type 1 behaviour.
Recent literature argues for the hippocampus and hippocampal RSA to be involved in 
sensory-motor mechanisms (Oddie & Bland 1998, Sainsbury 1998, Vanderwolf 2001). Studies 
on the direct link between RSA and behaviour emphasize the motor component (Coenen 1975, 
Vanderwolf 1969). In the open field, an environment that evokes exploration, both sensory and 
motor aspects of behaviour in relation to EEG can be studied when rat behaviour with 
contemporaneous EEG is recorded. Although it is known that the relation between RSA and 
motor behaviour within species and strains is similar (Robinson 1980), no direct comparisons 
between rat strains have been made within one study with regards to normal EEG and behaviour. 
In these experiments two rat strains were chosen that differ in behavioural activity. It was 
expected that these two strains would differ in exploratory activity in the open field situation, so 
that behaviour with contemporaneous EEG could be compared with the inclusion of both motor 
and sensory components.
Two commonly used rat strains were selected: albino Sprague-Dawley and hooded 
Long-Evans rats, based on earlier evidence that pigmented rat strains typically show higher 
levels of locomotor activity than albino strains (Aulakh et al. 1989, Onaivi et al. 1992). To study 
strain differences in the normal EEG in relation to behaviour, a detailed analysis of behaviour 
was made. For each behavioural spectral power was calculated for eight frequency bands 
between 1 and 100 Hz. With concurrent open field testing and EEG recordings, it was studied 
whether these strains differed in hippocampal EEG spectral power correlates of behaviour.
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2.2 Methods
Animals
Experiments were conducted at Organon Laboratories Ltd., Newhouse, Scotland. Permission for 
all procedures was granted from the UK Home Office (Animals Scientific Procedures Act, 
1986). Thirteen Sprague-Dawley and fourteen Long-Evans male rats were obtained from Harlan 
(UK, Ltd.). Animals were housed individually in macrolon cages with ad-libitum access to water 
and food and maintained on a reversed light/dark cycle (12/12 h) with lights on at 19.00 h. The 
animals were handled one time a day for five minutes for one week previous to testing.
Behavioural testing
Rats recovered for at least 2 weeks after surgery, before behavioural testing and EEG recording 
at the age of 16-22 weeks. Animals were habituated to recording conditions the night before the 
experiment in their homecage. Recording took place individually in an enriched open field, 
which was cleaned with ethanol (70 %) between sessions to prevent rats using scent cues left by 
previous rats. The observations lasted 25 minutes per animal and were carried out under red light 
conditions between the 2nd and the 5th hour of the dark period to exclude strong circadian 
influences.
Open field
The open field (black plastic, 1 m x 1 m x 0.4 m) had clear acrylic glass on one side to allow 
camera side view. The open field was enriched with a fixed amount of food, a drinking bottle 
and an object, which could freely be explored, but not displaced by the animal (pyramidal 
shaped, glass object, 6 x 6 x 11.5 cm).
Behavioural scoring
Behavioural epochs were recorded on two cameras placed at side and top view of the animal and 
scored off-line using the Observer Video-Pro (Noldus Information Technology, the Netherlands) 
with a time resolution of 0.04s. Twenty-three behavioural elements were scored based on the 
work of Timmermans (1978) and Vossen (1966) and own pilot observations in both strains. For 
compatibility, elements were presented according to in the categories as defined in EEG- 
behaviour studies of Coenen (1975) and Vanderwolf (1969, 1992) with the addition of a 
‘sniffing’ and a ‘miscellaneous’ category (Table 1).
EEG data acquisition
Bipolar recordings were obtained. Signals were filtered between 1-100 Hz, amplification 
300^V/V, and a sample rate of 1024.
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Table 1 Behavioural elements scored in the Open Field
Voluntary movement Automatic movement Immobility Sniffing Miscellaneous
Walking
Running
Hopping
Exploratory walking
Climbing
Rearing
Rearing supported 
Rearing object 
Manipulating food
Eating 
Drinking 
Face washing 
Body grooming 
Genital grooming 
Scratching
Sitting Sniffing object 
Sniffing up 
Sniffing down 
Sniffing wall 
Sniffing food
Squatting
Headswing
For compatibility, elements are presented in the categories as defined in EEG-behaviour studies o f  Coenen (1975) and 
Vanderwolf (1969, 1992), with the addition o f  a ‘sniffing’ category.
Surgical procedure
Surgery was performed under isoflurane anaesthesia. The rat was placed in a stereotactic 
apparatus (Kopf instruments) with bregma and lambda in the same horizontal plane. Local 
analgesic (Xylocaine spray) was applied to the exposed tissue of the head. Animals were 
injected pre-operatively with an antibiotic (Anhydrous ampicillin Ph. Eur. 100mg/ml, 0.3 ml sc.) 
and post-operatively with an analgesic (Carprofen 1:10, 1ml/kg sc). Rats were instrumented with 
bipolar recording electrode sets bilaterally in three cortical areas and in the dorsal hippocampus 
(only hippocampal data are reported in this article). The two wires of the bipolar electrode sets 
were separated 1 mm vertically for hippocampal electrodes. Coordinates: -4.0 (AP); ±2.0(lateral) 
relative to Bregma; -3/-2 (ventrally from skull). Registration of characteristic hippocampal EEG 
is further guaranteed by using an adequately exposed (approximately 0.4 mm) EEG electrode 
surface area. Data from both the left and right brain hemisphere were used in the analysis. A 
screw was used as ground electrode. Electrodes (stainless steel annealed / triple ML insulation 
wire, diameter 0.004 mm (California Fine Wire Company) connected to a pin (ITT Cannon; 
031-9540-000) with a small insert (track pins; Display Elektronica NL; 04.11.T1559) (Typical 
resistance 7.5 (SE 0.1) kQ), were inserted and fixated with superglue (Cyanolit) and dental 
cement. All electrode pins were fitted into an 18-hole connector (ITT Cannon; CTA3-IS-53). 
The electrodes and connector were embedded in dental cement, and the tissue was sutured. 
Animals showing the characteristic pattern of hippocampal electrical activity were selected for 
further experimentation and analysis.
Analysis behavioural data
Using the Observer, elementary analyses (e.g. frequencies, percentages and duration of specific 
behaviours), time-event plots and tables and a lag sequential analysis were obtained. An event 
lag-sequential analysis was performed (the Observer). Number of transitions between
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behaviours was calculated. To test for differences between strains, Students’ t-tests for 
independent samples were used on all 27 rats. Equality of variances was tested with the 
Levene’s test. (SPSS 10) T-value with degrees of freedom (in brackets) are given and the level 
of significance.
Analysis EEG data
A computer programme segmented the EEG according to the files with behavioural scoring. 
Power spectral density was calculated for segments of 1 second. EEG of behavioural epochs <1s 
was discarded and epochs >1s were divided into the largest number of integer 1s segments. The 
hippocampal EEG power spectrum was calculated for eight frequency bands in the range 
between one and 100 Hz. Seven frequency bands in the 1-30 Hz range, as distinguished for 
human EEG according to Herrmann et al. (1980, adapted to integer frequencies), were applied to 
these animal studies as in accordance with IPEG guidelines as agreed upon in the IPEG meeting 
2000, Vienna (delta (1-5 Hz), theta (6-8 Hz), alpha-1 (9-10 Hz), alpha-2 (11-12 Hz), beta-1 (13­
17 Hz), beta-2 (18-20 Hz), and beta-3 (21-30 Hz)). An additional eighth band covered the higher 
end of the EEG spectrum (31-100 Hz) [18]. To test for influence of behaviour on spectral power 
in each frequency band, One-Way ANOVA’s were used. Strain differences were tested with 
Students’ t-tests for independent samples (SPSS 10). Only animals with a characteristic 
hippocampal EEG were included in the experiments and analyses. This combination of analysis 
and electrode placement protocol was validated by previous experiments (Van Lier et al. 2003a). 
In these studies histological verification showed that by using this protocol, electrodes were 
adequately positioned to register a consistent, characteristic hippocampal EEG, provided that the 
tips of the electrodes are appropriately stripped. Data from both the left and right brain 
hemisphere were used in the analysis.
2.3 Results
2.3.1 Open field behaviour
Percentage of time of the 25 minutes spent in the Open Field was highest on sniffing in Sprague- 
Dawley and on voluntary movement in Long-Evans (Figure 1). Percentage of time spent on 
voluntary movement [t (25)=-3.460, p<0.05] and on sniffing [t (25)=4.358, p<0.001] differed 
between strains. Specifically, Long-Evans spent overall more time on walking, squatting, rearing 
and rearing supported compared to Sprague-Dawley; Sprague-Dawley spent more time on 
sniffing up, sniffing down and body grooming (table 2). Sprague-Dawley spent more time 
sitting, 10-15 minutes after placement in the open field than Long-Evans [t (18)=2.462, p<0.05]. 
The average number of behavioural transitions per minute for the period 10-25 minutes after 
placement in the open field was 20.6/min. in Long-Evans and 16.3/min. in Sprague-Dawley.
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Thus Long-Evans showed a higher transition rate (t (25)=-2.273, p<0.05). However, the 
difference in the transition rate during the first ten minutes was not significant.
Sprague-Dawley Long-Evans
Misc. Misc.
Figure 1 Percentage o f time spent on each behavioural category, for Sprague-Dawley (left, n=13) and Long-Evans 
(right, n=14) for a 25 minute period in the open field. ‘Voluntary m ovem ent’ [t (25)=-3.460, p<0.05] and ‘sniffing’ [t 
(25)=4.358, p<0.001] differed between strains. S.E. values are given in parenthesis.
Table 2 Significant strain differences in open field behaviour
Behaviour Time spent on behaviour (%) t-statistics (n=27)
Sprague-Dawley Long-Evans
Walking 9.0 (1.2) 14.3 (1.4) t(25)= - 0 o -v
l
p A 0 O
Squatting 0.6 (0.2) 4.6 (1.3) t(14)= 71.92.- p A 0 cn
Rearing 3.5 (0.7) 14.1 (1.9) t(17)= 63.35.- p A 0 o
Rearing supported 3.5 (0.4) 7.9 (0.9) t(18)= 02.54.- p A 0 1
Sniffing up 21.0 (1.5) 13.7 (1.5) t(25)=
CO2.53. .010.
V
p
Sniffing down 8.2 (0.7) 6.5 (0.4) t(25)=-2.111, 5.00.
V
p
Body grooming 1.2 (0.4) 0.3 (0.1) t(13)= 3 00 , p<0.05
S.E. values are given in parenthesis
2.3.2 Hippocampal EEG  correlates of open field behaviour 
Influence of behaviour on spectral power
For the eight EEG frequency bands, only the alpha-1 band (9-10 Hz) showed a significant effect 
of behaviour on absolute spectral power [F (23, 534)=1.939, p<0.01]. With regards to relative 
spectral power, behaviour had a significant effect on the theta [F (23, 534)=2.046, p<0.01], 
alpha-1 [F (23, 534)=3.341, p<0.001], and alpha-2 [F (23, 534)=1.861, p<0.01] band. In 
Sprague-Dawley rats, spectral power in the theta and alpha-1 band decreased in the order
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voluntary movement - sniffing and automatic movement - immobility. The alpha-2 band 
showed the inverse relationship of the theta band with behaviour; spectral power decreased in 
the order immobility - automatic movement - sniffing - voluntary movement. For Long-Evans 
rats spectral power for the theta and alpha-1 bands was high for voluntary movement and 
sniffing, and low for immobility and automatic movement. For the alpha-2 band an inverse 
relationship with behaviour was found; spectral power decreased in the order immobility - 
automatic movement - sniffing and voluntary movement.
Influence of strain on spectral power
Table 3 Significant strain differences in EEG power
Behaviour Frequency EEG power
band (Hz) Sprague-Dawley Long-Evans
Absolute power (arbitrary units) 
Voluntary movement 9-10 612.5 (77.8) 1236.1 (123.3)
18-20 90.5 (8.4) 168.1 (12.4)
Sniffing 9-10 565.1 (77.9) 1074.0 (128.2)
18-20 97.7 (9.0) 185.1 (16.8)
Exploratory walking 9-10 584.1 (141.7) 1299.7 (264.9)
Rearing 9-10 369.9 (106.8) 1293.6 (305.5)
Rearing object 9-10 300.4 (60.5) 974.2 (249.3)
Sniffing down 9-10 445.0 (95.0) 944.4 (207.7)
Relative power (%) 
Voluntary movement 6-8 24.6 (1.8) 18.1 (1.1)
9-10 10.6 (0.9) 17.0 (1.0)
18-20 1.8 (0.1) 2.7 (0.1)
Sniffing 9-10 10.4 (0.9) 16.7 (1.1)
18-20 2.1 (0.1) 3.5 (0.3)
Only values are given for significant differences and main effects (figures 2 & 3). S.E. values are given in parenthesis.
Absolute spectral power
Long-Evans rats showed an overall higher absolute power in the EEG than Sprague-Dawley. 
This strain effect on absolute power was most prominent in the alpha-1 frequency band (9-10Hz) 
and the beta-2 band (18-20 Hz) during voluntary movement and sniffing (Figure 2, table 3). 
Specifically for behavioural elements, exploratory walking [t (28)=-2.382, p<0.05], rearing [t 
(23)=-2.854, p<0.01], rearing object [t (20)=-2.627, p<0.05], and sniffing down [t (26)=-2.187, 
p<0.05] showed higher absolute power in the frequency band of 9-10 Hz for Long-Evans
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compared to Sprague-Dawley (table 3). For fast wave activity (31-100Hz) absolute power over 
all behavioural categories was higher in Long-Evans compared to Sprague-Dawley rats.
2) EEG Absolute Power 
, in-/decrease (%)
Q
-30-1
Q
-30-1
Awake immobility
Sniffing
delta theta alpha-1 alpha-2 beta-1 beta-2 beta-3 gamma 
1-5 6-8 9-1Q 11-12 13-17 1B-2Q 21-30 31-1QQ 
Frequency band (Hz)
90
60­
30­
0
-30
90
60­
30­
0
-30
90
60
30
0
-30
90
60
30
0
-30
3) EEG Relative Power 
in-/decrase (%>)
★ ★ ★ ★
Voluntary movement
★ ★
Automatic movement
Sniffing
delta theta alpha-1 alpha-2 beta-1 beta-2 beta-3 gamma 
1-5 6-8 9-1Q 11-12 13-17 1B-2Q 21-30 31-1QQ 
Frequency band (Hz)
Figure 2 & 3 Strain differences in EEG absolute (2) and relative (3) spectral power for each behavioural
category. The x-axis represents frequency band. The y-axis represents strain differences as percentage increase or 
decrease in absolute (2) or relative (3) spectral power o f  Long-Evans (n=20) rats compared to Sprague-Dawley (n=13) 
rats. Positive values signify higher power in Long-Evans rats, and negative values higher power in Sprague-Dawley rats. 
Division into bands from 1-30 Hz after Herrmann (1980), adjusted to integer frequencies. *p<0.01, **p<0.001
6 0 -
Relative spectral power
Figure 3 depicts strain differences in the relative distribution of power over frequency bands. 
Sprague-Dawley rats showed higher relative power in the 6-8 Hz band for voluntary movement, 
and lower relative power in frequency bands from 9-100 Hz compared to Long-Evans, most 
prominently for the alpha-1 and beta-2 frequency bands for voluntary movement and sniffing 
(table 3).
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2.4 Discussion
In the open field, Sprague-Dawley and Long-Evans rats differed in the level of activity and the 
organisation of exploratory behaviour; Long-Evans rats explored the environment actively 
(walking-rearing), whereas Sprague-Dawley rats behaved more passively (sitting-sniffing up). 
These results were consistent with findings of Andrews et al. (1995) and the general higher 
activity levels of pigmented rats compared to albino rats (Aulakh et al. 1989, Onaivi et al. 1992).
Behavioural state mainly influenced high RSA frequencies (9-10 Hz) in the 
hippocampal EEG. The relationship between RSA and behaviour was consistent with many 
studies, showing the correlation between RSA and type-1 motor movements (Coenen 1975, 
Vanderwolf 1969).
Results showed that not only behaviour, but also rat strain, mainly influenced RSA 
frequencies in the hippocampal EEG. Sprague-Dawley and Long-Evans differed in spectral 
power most prominently in the alpha-1 (9-10Hz) and beta-2 (18-20 Hz) frequency bands. The 
beta-2 frequencies (18-10 Hz) were likely to contain the second harmonics of the alpha-1 band 
(9-10 Hz) [cf. (Coenen 1975, Leung et al. 1982)], therefore reflecting power differences in the 
alpha-1 band. The human alpha-1 band corresponds with type-1 theta in the rat (Bennet 1981). 
Thus, results confirmed that RSA provides most information in the hippocampal EEG and 
indicated that strain differences in power in the hippocampal EEG and behavioural differences 
are likely to be related.
Although the relation between EEG and behaviour within each strain was similar, 
differences between the two strains were demonstrated. These differences were behaviour- 
dependent. Both for voluntary movement and sniffing behaviour, Long-Evans rats showed 
higher absolute and relative power in the alpha-1 band. These differences can be interpreted in 
the light of the differences found in exploratory behaviour.
It is probable that at least differences in vigour of motor movement have contributed to 
the strain differences demonstrated in the EEG. RSA not only correlates with motor behaviour, 
but also seems to code for aspects of the motor behaviour (Oddie & Bland 1998) in that the 
amplitude of RSA increases as the magnitude of movements increases (Whishaw & Vanderwolf 
1973), while the frequency of RSA increases as the velocity of the motor behaviour increases 
(Whishaw 1982). It was observed during behavioural scoring, but not quantified, that for 
example during rearing Long-Evans stretched the body further than Sprague-Dawley, making 
the movement more vigorous. Thus, increased absolute alpha-1 power amplitude for voluntary 
movements in the more actively exploring Long-Evans rats compared to Sprague-Dawley could 
reflect higher vigour of exploratory behaviour in Long-Evans. Additionally supporting the 
relation with higher vigour of behaviour is the relative shift to lower RSA frequencies in 
Sprague-Dawley, shown in the relative distribution of power over frequency bands.
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However, exploration includes both motor and sensory components and it is hard to 
separate the two in an open field situation. Therefore, it cannot be excluded that not only aspects 
of motor behaviour, but also sensory aspects have contributed to the behaviour-dependent strain 
differences in RSA power. This assumption is supported by the data on sniffing behaviour. In 
the more actively exploring strain, higher alpha-1 power was demonstrated not only for 
voluntary movement, but also for sniffing. This can be interpreted as more active sensory 
perception of the environment and more active behaviour directed towards this environment. In 
this way, the overall behavioural background in which a specific behaviour occurs can influence 
its behavioural RSA correlates; high or low exploratory activity was reflected in RSA correlates 
of voluntary movement and sniffing behaviours.
Thus, our results of combined open field behaviour and hippocampal EEG registration 
demonstrated behaviour-specific strain differences in RSA power, although the relation between 
EEG and behaviour within each strain was similar. The differences found in this study could be 
attributed to both motor and sensory components integrated in exploratory behaviour, as strain 
differences in EEG related to strain differences in exploratory behaviour. The relation between 
RSA and behaviour within each strain reveals the motor component of this relation. Comparison 
between strains suggests a main motor component in the relation between behaviour and 
hippocampal RSA, but possibly a smaller sensory component in addition. Contribution of 
sensory processes is in accordance with theories on the sensory-motor integration function of the 
hippocampus and hippocampal theta (Oddie & Bland, 1998; Sainsbury, 1998; Vanderwolf,
2001).
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Abstract
A pharmacological dissociation of the relation between electroencephalographic (EEG) activity 
and behaviour has been described for the benzodiazepines. While a decrease in high frequency 
EEG activity is associated with a decrease in arousal in drug-free conditions, sedative 
benzodiazepines increase beta activity. Non-benzodiazepine GABAa modulators can increase 
beta activity as well. To further study the relationship between rat behaviour and EEG under 
GABAa receptor modulation, EEG effects of diazepam (2.5 mg/kg) and zolpidem (2.5 mg/kg) 
were studied during different behaviours. Both drugs modulate the GABAA receptor, albeit that 
zolpidem shows ai-subunit selectivity while diazepam is non-selective. A detailed analysis of rat 
open field behaviour was made with a distinction of 25 behavioural elements. The EEG was 
segmented according to each behavioural element and a corresponding power spectrum 
calculated. Both diazepam and zolpidem increased EEG beta frequencies, characteristic for the 
benzodiazepines. However, the beta and gamma increase was specific for active behaviour and 
not for inactivity. Interestingly, diazepam and zolpidem seemed to amplify, rather than 
dissociate, the relation between behaviour and the EEG. It is hypothesised that the large increase 
in beta-3/gamma activity caused by diazepam and zolpidem is a compensatory mechanism that 
allows for behavioural activation, despite pharmacologically induced sedation.
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3.1 Introduction
A consistent relationship exists between electroencephalographic (EEG) activity and behaviour. 
EEG activity is intrinsically linked to spontaneous alterations in behavioural activity. 
Hippocampal rhythmical slow activity (RSA/theta, i.e. 6-10 Hz) and cortical low voltage fast 
activity (LVFA) dominate the EEG during the so called 'type 1 behaviours' or 'voluntary 
movements', but not during the 'type 2 behaviours' or 'automatic movements' or during awake 
immobility (Vanderwolf 1969, 1992, Coenen 1975). Psychoactive drugs can influence both EEG 
and behavioural activity. As a consequence many studies, aimed at describing the effects of 
psychoactive drugs on the EEG per se, measure during artificially controlled behavioural 
activity, for example by placing animals on a rotating drum (Krijzer et al. 1993, Visser et al. 
2003a). Benzodiazepines exert a unique effect regarding the relation between behaviour and 
EEG. In drug-free conditions an increase in attention and arousal is generally associated with an 
increase in power of higher (beta and gamma) EEG frequencies (Coull 1998, Egner & Gruzelier 
2004, Foster & Harrison 2002, Mann et al. 1993, Vazquez Marrufo et al. 2001). However, 
although benzodiazepines are sedative, they increase beta activity (Coenen & Van Luijtelaar 
1991, Krijzer et al. 1993, Van Rijn & Jongsma 1995). This has been termed a pharmacological 
dissociation of the normal relationship between EEG and behaviour by benzodiazepines 
(Coenen & Van Luijtelaar 1991). A number of non-benzodiazepine compounds that also act at 
the GABAa receptor complex were shown to increase beta activity as well (Visser et al. 2003a, 
2003b). However, barbiturates (like thiopental), propofol, and muscimol that also enhance 
GABA inhibition typically do not induce this beta increase (Bagetta et al. 1987, MacIver et al. 
1996, Yang et al. 1995).
In this paper, we want to address two questions related to the paradoxical relationship 
between EEG and behaviour under the influence of GABAa receptor modulation at the 
benzodiazepine site in rats. Firstly, can this pharmacological dissociation also be demonstrated 
under non-forced vigilance conditions? Secondly, can a more detailed analysis of behaviour with 
concurrent EEG recording provide more information concerning the nature of this dissociation? 
Often, the sedative effect and EEG effects are assessed in separate tests. By concurrently 
recording rat open field behaviour and EEG activity, EEG effects of psychoactive drugs can be 
studied under non-forced vigilance conditions during detailed behavioural analysis. In the novel 
environment of the open field, bouts of exploratory activity spontaneously alternate with bouts 
of inactivity and grooming behaviours. In this way, the relation and dissociation between 
behaviour and EEG under influence of GABAa modulation in rats can be studied in more detail.
Two drugs were selected for the study. Diazepam was chosen, because it can be 
regarded as the golden standard reference benzodiazepine. It is a non-subtype-selective GABAa 
receptor-allosteric modulator that (dose dependently) shows sedative effects (Coenen & Van 
Luijtelaar 1989). This sedative effect in combination with an EEG pattern typical of behavioural 
activation is the essence of the pharmacological dissociation. The sedative effect of the
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benzodiazapines is thought to be mediated by the a1 subunit of the GABAa receptor complex 
(Crestani et al. 2000). To further address the influence of this a1 GABAa receptor subunit on 
EEG activity, zolpidem was tested in addition to diazepam. The imidazopyridine zolpidem is a 
non-benzodiazepine that binds to the benzodiazepine site and is a1 subtype selective (Depoortere 
et al. 1986, Langer et al. 1992).
Due to the labour-intensive nature of the analysis, drug doses were chosen at a single 
level high enough (2.5 mg/kg) to induce some sedation (assumed to be essential for the 
pharmacological dissociation), but without complete loss of active behaviour (Schmitt & 
Hiemke 1998a; Rex et al. 1996; Elliot & White 2001). Wake open field behaviour was 
continuously scored and divided into 25 elements of behaviour according to definitions as found 
in Van Lier et al. (2003a). The EEG was segmented according to this behavioural scoring and 
for each behavioural element a power spectrum was calculated. The high frequency end of the 
EEG spectrum was divided into three beta sub-bands and an additional gamma band covering 
frequencies over 30 Hz (up to 100Hz). This was done, because in the literature high frequency 
ranges are found to be variably defined and EEG is often not measured over 30 Hz. This 
approach of detailed analysis of behaviour and concomitant EEG had previously been shown to 
be sensitive to strain differences (Van Lier et al. 2003a). To take into account localization- 
specific influences, the EEG was recorded bilaterally in three different cortical areas. In addition 
to the cortex, electrodes were placed in the hippocampus, because of the known strong relation 
between behaviour and the hippocampal theta rhythm.
3.2 Materials and methods
Animals
Experiments were conducted at the University of Nijmegen under Dutch animal legislation. 
Thirty-one male Long-Evans rats were obtained from Harlan (Bicester, UK). Animals were 
housed individually in macrolon cages with ad-libitum access to water and food and maintained 
on a reversed light/dark cycle (12/12 h).
Surgical procedure
Surgery was performed under isoflurane anaesthesia. The rat was placed in a stereotaxic 
apparatus (Kopf instruments) with bregma and lambda in the same horizontal plane. Local 
analgesic (Lidocaine) was applied to the exposed tissue of the head. Rats were instrumented 
with bipolar recording electrode sets bilaterally in three cortical areas epidurally and in the 
dorsal hippocampus. The two wires of the bipolar electrode sets were separated 1 mm 
horizontally for cortical electrodes, and 1 mm vertically for hippocampal electrodes. Coordinates 
are based on Paxinos & Watson (1986) and are given for the cortex for the most frontal 
electrode in the right hemisphere (anterior/posterior to bregma; lateral to midline in mm.):
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frontal (+4.2; +1.0), parietal (-1.2; +4.5), occipital (-4.3; +3.0). Coordinates for the hippocampus 
are given for the deepest electrode in the right hemisphere (anterior/posterior to bregma, lateral 
to midline, ventrally from skull surface, in mm.): (-4.0; +2.0; -3.0). An epidural screw served as 
ground electrode. Electrodes (stainless steel annealed / triple ML insulation wire, diameter 0.004 
mm (California Fine Wire Company) connected to a pin (ITT Cannon; 031-9540-000) with a 
small insert (track pins; Display Elektronica NL; 04.11.T1559) (Typical resistance 7.5 (SE 0.1) 
kQ), were inserted and fixated with superglue (Cyanolit) and dental cement. All electrode pins 
were fitted into an 18-hole connector (ITT Cannon; CTA3-IS-53). The electrodes and connector 
were embedded in dental cement, and the tissue was sutured.
Drug groups
Zolpidem was dissolved in saline, diazepam needed to be dissolved in 15% Intralipid. In order to 
be able to separate possible effects of the intralipid vehicle from diazepam per se, an additional 
vehicle control group was added that received an equal volume of intralipid only (n=6). Rats 
were injected intraperitoneally 30 minutes before testing with zolpidem (2.5 mg/kg) (n=8), 
diazepam (2.5 mg/kg) (n=8) or solvent (saline (0.9% NaCl) (n=9) or intralipid (n=6)). Zolpidem 
was obtained from Tocris Cookson Ltd, Bristol UK; diazepam was obtained from Dumex, 
Baarn, The Netherlands, and intralipid from Fresenius Kabi, 's-Hertogenbosch, The Netherlands. 
For each vehicle and each drug a different group of naive rats was used. Drug and vehicle could 
not be tested within the same rat, because repeated exposure to the open field would have caused 
marked differences in behaviour due to decreased novelty.
Behavioural testing
Rats recovered for at least 2 weeks after surgery before behavioural testing and EEG recording 
at the age of 14-16 weeks. Recording took place individually in an enriched open field, which 
was cleaned with ethanol (80 %) between sessions to prevent rats using olfactory cues left 
during the previous session. The observations lasted 25 minutes per animal and were carried out 
under red light conditions between the 2nd and the 5th hour of the dark period to minimize the 
influence of circadian fluctuations in behavioural activity.
Open field
The open field (black plastic, 1 m x 1 m x 0.4 m) had clear acrylic glass on one side to allow 
camera side view. The open field was enriched with a fixed amount of food, access to the spout 
of a drinking bottle and an object that could freely be explored, but not displaced by the animal 
(pyramidal shaped, glass object, 6 x 6 x 11.5 cm).
Behavioural Scoring
Behavioural epochs were recorded on two cameras placed at side and top view of the animal and 
scored off-line using the Observer Video-Pro (Noldus Information Technology, Wageningen,
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The Netherlands) (Noldus et al. 2000) with a time resolution of 0.04s. Twenty-five behavioural 
elements were scored (Van Lier et al. 2003a). Each behavioural element was placed in one of 
five categories. Type 1 behaviour included walking, running, hopping, exploratory walking, 
climbing, rearing, rearing supported (wall), rearing object, and manipulating food. Type 2 
behaviour included face washing, body grooming, genital grooming, scratching, wet dog shake, 
eating, and drinking. Immobility was scored as sitting. Sniffing included sniffing object, sniffing 
up, sniffing down, sniffing wall, and sniffing food. A miscellaneous category included squatting, 
freezing and orienting. For a detailed description of the behaviours see Van Lier et al. (2003a).
Analysis behavioural data
Using the Observer package, elementary analyses (e.g. frequencies, percentages, and duration of 
specific behaviours) were obtained. For all treatments, an overall multivariate test of variance 
was used to test for behaviour and treatment interactions for all variables. Each treatment was 
tested against its own control (i.e. vehicle) group. For significant interaction effects, post-hoc 
Student's t-tests for independent samples were performed (SPSS 10). T-values with degrees of 
freedom (in brackets) are given as well as the level of significance. Data present means averaged 
over rats.
EEG data acquisition and processing
Bipolar EEG recordings were obtained. The recording cable was connected to a swivel to allow 
free movement of the animal. Signals were amplified (x 5000, in-house built amplifier) and 
filtered high pass 1 Hz (1st order filter) and low pass 100 Hz (7th order elliptic filter). 
Digitisation (sampling rate 1024 Hz) and data recording were done using a Windaq (Dataq 
Instruments) acquisition system. EEG records were inspected visually and artefact-containing 
EEG was discarded before analysis.
Analysis EEG data
The EEG and behavioural files were synchronized with a resolution of 0.04 sec. A computer 
program segmented the EEG according to the files with behavioural scoring. EEG of 
behavioural epochs <1 sec. was discarded and epochs >1 sec. were divided into the largest 
number of integer consecutive 1 sec. segments. For each 1 sec. segment a power spectrum was 
calculated. These power spectra were averaged for each behaviour and for each rat. The EEG 
power spectrum was calculated for eight frequency bands in the range between 1 and 100 Hz. 
Seven frequency bands in the 1-30 Hz range, as distinguished for human EEG according to 
Herrmann et al. (1980, adapted to integer frequencies), were applied to these animal studies as in 
accordance with International Pharmaco EEG Group (IPEG) guidelines (IPEG, 1989) as agreed 
upon at the IPEG meeting 2000, Vienna (delta (1-5 Hz), theta (6-8 Hz), alpha-1 (9-10 Hz), 
alpha-2 (11-12 Hz), beta-1 (13-17 Hz), beta-2 (18-20 Hz), and beta-3 (21-30 Hz)). An additional 
eighth band covered the higher end of the EEG spectrum (31-100 Hz) and was termed gamma.
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On total absolute power, a univariate analysis of variance was used to test for position, 
behaviour, and treatment effects and interactions. On relative power, a multivariate (each 
frequency band) analysis of variance was performed to test for position, behaviour, and 
treatment effects and interactions. In case of interaction effects with position, a new multivariate 
analysis of variance, split per position, was performed to test for treatment-behaviour 
interactions and treatment effects. In case of treatment-behaviour interactions Student's t-tests 
for independent samples were performed for treatment effects per behaviour (SPSS 10). F- 
values with degrees of freedom (in brackets) are given and the level of significance. For the T- 
test the significance level was <.05. Each treatment was tested against its own control group.
For histological verification of hippocampal electrode placement, the rats were perfused and 
brains fixated with a 4% paraformaldehyde, 0.1 M phosphate buffer. Brain slices of 100 ^m 
were cut using a vibratome and stained with Cresyl violet.
3.3 Results
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Figure 1 Open field behaviour
Effects are shown for diazepam (a) and zolpidem (b) on open field behaviour for control groups (white bars) and drug 
treated groups (black bars). Bars represent the percentage o f time spent on the behaviour during the 25-minute period in 
the open field (y-axis). The behaviour is given on the x-axis. Only behaviours with a significant effect (*p<.05) in 
diazepam, zolpidem or both are presented. Percentage o f time o f  sitting is shown on the right y-axis and o f  all other 
behaviours on the left y-axis. Differences (p<.05) between the two control groups [intralipid in a), and saline in b)] are 
marked by an arrow.
The baseline activity for diazepam was different from the zolpidem baseline because of the 
effect caused by the intralipid vehicle. These effects are presented and discussed in section 3.5.
0 0 0
37
Chapter 3
Diazepam decreased the total number of behavioural transitions in 25 minutes from 659.3 (SE
63.4) in the control group to 340.4 (SE 36.4) [t(12)=4.6, p<.001]. Zolpidem decreased this 
number from 1006.9 (SE 41.2) in the control group to 334.8 (SE 40.8) [t(15)=11.5, p<.001]. 
Diazepam (Figure 1a) increased the total time spent on sitting [t(12)=4.2, p<.001]. Time spent 
on exploratory walking [t(12)=7.4, p<.001], rearing [t(6)=4.1, p<.01], rearing supported 
[t(6)=3.3, p<. 05] rearing object [t(12)=2.7, p<.05] and face washing [t(12)=6.9, p<.001] was 
decreased .
Zolpidem (Figure 1b) increased time spent sitting [t(15)=11.8, p<.001]. It decreased the time 
spent on walking [t(15)=6.5, p<. 001], running [t(9)=8.5, p<.01], squatting [t(8)=2.6, p<.05], 
rearing [t(8)=5.2, p<.001], rearing supported [t(8)=5.0, p<.001], rearing object [t(15)=2.6, 
p<.05], sniffing wall [t(15)=5.5, p<.001], and face washing [t(15)=3.5, p<.01].
Both diazepam and zolpidem largely increased inactivity in the open field and decreased other 
elements of behaviour.
3.3.2 EEG effects 
Absolute power
Diazepam or zolpidem did not significantly alter absolute power.
Relative power
No systematic differences were found between cortical areas or hemispheres in either diazepam 
or zolpidem. Therefore data for cortical electrodes were grouped for further analysis and 
presentation.
For relative power (Figure 2a), diazepam showed an interaction effect between 
treatment and electrode position [F(8,837)=18.3, p<. 001]. In the cortex, delta [F(1,684)=40.8, 
p<.001] and alpha-1 [F(1,684)=77.4, p<.001] activity were decreased, while beta-1 
[F(1,684)=12.3, p<.001], beta-2 [F(1,684)=74.5, p<.001], beta-3 [F(1,684)=160.4, p<.001] and 
gamma activity [F(1.684)=8.0, p<.01] were increased. In the hippocampus, theta [F(1,160)=5.6, 
p<.05] and alpha-1 [F(1,160)=161.2, p<.001] activity were decreased, while beta-2 
[F(1,160)=13.2, p<.001] and beta-3 [F(1,160)=80.8, p<.001] activity were increased.
Zolpidem (Figure 2b) showed an interaction effect between treatment and electrode position 
[F(8,1008)=26.8, p<.001] for relative power. In the cortex, delta [F(1,772)=86.5, p<. 001] and 
alpha-1 [F(1,772)=26.7, p<.001] were decreased, while alpha-2 [F(1,772)=7.1, p<.01], beta-1 
[F(1,772)=23.6, p<.001], beta-2 [F(1,772)=64.8, p<.001], beta-3 [F(1,772)=107.3, p<.001], and 
gamma activity [F(1,772)=25.7, p<.001] were increased. In the hippocampus delta 
[F(1,243)=16.2, p<.001] activity was increased, while alpha-1 [F(1,2430=143.3, p<.001] and 
gamma activity [F(1,243)=9.8, p<.01] were decreased.
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Frequency band (Hz) Frequency band (Hz)
H  Cortex 252 Hippocampus
Figure 2 EEG frequency bands
Percentage changes compared to control in relative EEG power per frequency band are given for each drug treatment, 
for the cortex (filled bars) (all cortical electrodes were grouped) and hippocampus (hatched bars) (both hemispheres were 
grouped). * significant change, p<.05.
Both zolpidem and diazepam showed a pattern of increased high frequencies and decreased delta 
and alpha-1 band activity in the cortical EEG. In the hippocampal EEG effects differed.
It has to be noted that the behavioural effect (Figure 1) and the EEG effect (Figure 2) of 
each drug have been de-coupled. An EEG spectrum was calculated for each behavioural 
element. The drug effect on the EEG, as given in figure 2, is an average effect over these 
averaged EEG spectra per behavioural element. Each behavioural element has an equal weight 
in the averaging. Thus, changes in the distribution of behavioural elements induced by the drug 
do not influence its EEG effects.
3.3.3 Behaviour-dependent EEG effects
Randomly selected examples of raw EEG for each drug and control for walking and sitting 
behaviour are given in tables 1 and 2.
Diazepam showed an interaction of treatment effects with behaviour [F(96,6752)=4.1, 
p<.001]. In the cortex, this was found in the alpha-1 [F(12,684)=8.9, p<.001], alpha-2 
[F(12,684)=15.1, p<.001], beta-1 [F(12,684)=4.9, p<.001], beta-3 [F(12,684)=2.4, p<.01] and 
gamma activity band [F(12,684)=2.0, p<.05]. The EEG effects during sitting differed from the 
rest of the behaviours. 9-17 Hz activity was increased in sitting, while other behaviours showed 
a decrease in this frequency range. In the 21-30 Hz band the increase in EEG activity was much 
lower in sitting than in other behaviours and where other behaviours showed an increase in 31­
100 Hz activity, sitting behaviour showed a decrease (Figure 3a). In the hippocampus similar
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effects were found, but only significantly for the alpha-1, alpha-2 and beta-3 activity band (data 
not shown).
Table 1 Raw EEG for walking and sitting behaviour for diazepam and intralipid
Intralipid Diazepam
Cortex (parietal) Walking
Sitting
Hippocampus Walking
Sitting
/ x / ' v ^ / v V V V A  f ^ A 1/ x / v' W V
500 pV
2000 pV
1 sec.
Table 2 Raw EEG for walking and sitting behaviour for zolpidem and saline
Saline Zolpidem
Cortex (parietal) Walking
Sitting
Hippocampus Walking
Sitting
v v v v v s v y v v v
|V v/\ w ^vv\ /y
500 pV
2000 pV
1 sec.
EEG effects of zolpidem showed an interaction with behaviour and electrode position 
[F(64,8120)=2.3, p<. 001]. In the cortex, all frequency bands showed an interaction between 
treatment and behaviour, except the theta and beta-1 band. (delta [F(8,772)=3.8, p<. 001], alpha
1 [F(8,772)=5.6, p<.05], alpha 2 [F(8,772)=4.2, p<.01]; beta2 [F(8,772)=3.4, p<.01], beta3 
[F(8,772)=7.2, p<.001], and gamma activity [F(8,772)=5.7, p<.001]). 21-30 Hz activity was
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increased in all behaviours except sitting and face washing. 31-100 Hz activity was decreased in 
sitting and increased or not changed in all other behaviours (Figure 3b). In the hippocampus, an 
interaction for treatment with behaviour was found only in the alpha-1 [F(8,243)=6.0, p<.001] 
and beta-3 F(8,243)=2.8, p<.01] bands (data not shown).
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Figure 3a & b Behaviour-dependent EEG changes
Behaviour-dependent changes in EEG relative power (y-axis) are given for each behaviour (x-axis) per frequency band 
for diazepam (a) and zolpidem (b). Percentage changes are depicted o f  the drug group compared to the control group. A 
# signifies a significant interaction between treatment and behaviour, * a significant treatment effect for the behaviour, 
p<.05. To emphasize the different effect during sitting behaviour, bars are hatched. For zolpidem for some behaviours, 
'no data' has been entered in the figure. These behaviours did not occur often enough for EEG collection and analysis.
Thus, effects of diazepam and zolpidem on the EEG differed between active and 
inactive behaviour. The increase in beta-3 and gamma activity was most specific for active 
behaviour. The decrease in alpha-1 activity specific for active behaviour presumably reflects the 
decrease in theta frequency, as the alpha-1 band includes the high frequencies of the theta 
rhythm (see Figures 4 and 5).
Basis of the EEG analysis were the behavioural observations. Inactivity was scored as 
sitting, because sleep postures (Coenen et al. 1983) were never observed. However, in the dark 
period during apparent inactivity, sleep patterns can occur in the EEG without rats assuming a 
typical sleep posture (Coenen et al. 1983). In addition, diazepam and zolpidem elicit typical 7-12
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Hz spindle bursts (Longo et al. 1988). Neither for saline nor for intralipid as vehicle, sleep or 
sleep-like EEG was recorded. Of the EEG recording diazepam contained 30.5% (SE 6.3%) and 
zolpidem 10.8% (SE 3.0%) sleep (-like) EEG. Sleep (-like) EEG was defined broadly by a large 
increase in amplitude of the EEG compared to amplitude during active wakefulness and by high 
amplitude slow waves with bursts of sleep spindles (Depoortere et al. 1995). Thus one finding 
would be that diazepam and zolpidem induce sleep or sleep-like EEG, though this is not a new 
finding (Longo et al. 1988, Depoortere et al. 1995). However, to exclude the possibility that 
occurrence of these sleep patterns influenced our other findings on the relative power of the beta 
and gamma bands, sleep pattern free-EEG was re-analysed. Increases in the alpha-1 and alpha-2 
bands during sitting were no longer found in either drug, thus these increases were probably 
caused by spindle activity. However, the described effects on the beta-3 and gamma band 
remained (data not shown).
3.3.4 Relation between EEG and behaviour
Walking - sitting
-■n-Intralipid 
— Diazepam
Frequency (Hz) 
b) Differential band spectrum
Intralipid
n
Diazepam
I___u
4) Diazepam
Walking - sitting
—n—Saline 
-Zolpidem
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b) Differential band spectrum
Saline Zolpidem
I
'ljljuu i  | | i>
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Figure 4 and 5 Relation between EEG and behavior (4) Diazepam, (5) Zolpidem
A differential frequency (a) and band (b) spectrum are given for the EEG during walking compared to the EEG o f sitting 
for diazepam and its vehicle (intralipid) (4) and zolpidem and its vehicle (saline) (5). Percentual changes in relative EEG 
power are depicted o f walking compared to sitting (y-axis). Frequency and frequency bands are given on the x-axis. In 
the frequency spectrum, a log x-axis is used for a more equal distribution o f frequency bands.
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To exemplify the relation between the EEG and behaviour, a differential frequency (a) and band 
(b) spectrum was calculated for walking behaviour compared to sitting behaviour (Figure 4 & 
5). Walking is characterized by increased theta and gamma activity as compared to sitting, for 
both control groups (saline and intralipid). Increases and decreases are amplified by diazepam 
and zolpidem, except the beta-3 band, which is now increased. Note that in the differential 
frequency spectrum diazepam and zolpidem shift several parameters to lower frequencies: theta 
peak, the second harmonic of theta, and the intercept with y=0 in the beta/gamma range.
3.3.5 Different drug solvents
Intralipid had an effect on behaviour as compared to saline (Figure 1). It decreased behavioural 
activity (total number of behavioural transitions in 25 minutes) from 1006.9 (SE 41.2) in saline 
to 659.3 (SE 63.4) in intralipid [t(13)=4.8, p<.001]. Time spent on sitting was increased from 
9.5% (SE 2.5) to 32.7% (SE 6.7) [t(13=3.7, p<.01], and decreased on walking from 16.3% (SE
1.4) to 8.9% (SE 1.7) [t(13)=3.4, p<.01] and on sniffing up from 10.5% (SE 1.9) to 5.0% (SE
0.9) [t(11)=2.6, p<.05].
Intralipid showed an interaction of treatment with electrode position for both absolute 
[F(1,1131)=85.1, p<.001] and relative EEG power [F(1,1124)=5.0, p<.001]. In the hippocampus, 
intralipid decreased absolute power from 38181.1 (SE 3428.6) to 13185.2 (SE 900.7) (^V)2 
[F(1,267)=28.8, p<.001]. This decrease of power in the hippocampus could be related to a 
relative decrease of theta activity in the hippocampus (theta from 34.9% (SE 0.9%) to 30.1% 
(SE 1.1%) [F(1,267)=10.7, p<.01] and alpha-1 from 9.8% (SE 0.3%) to 7.9% (SE 0.3%) 
[F(1,267)=15.7, p<.001]). Relative power in the delta and gamma activity band was increased. 
In the cortex, relative power of the gamma band was increased and activity in the alpha-1, beta-
1, beta-2, and beta-3 band decreased (data not shown). Intralipid did not show an interaction of 
behaviour with treatment effects.
Thus, the vehicle of diazepam, intralipid, showed effects on behaviour and on the EEG. 
The poor solubility of diazepam is a classic problem, and vehicle effects are hard to exclude for 
diazepam. These findings implicate that direct comparisons between the effects of diazepam and 
zolpidem are not warranted unless the confounding effect of intralipid is taken into account. The 
here reported effects of diazepam concurred with many previous reports. Our main new findings 
concern EEG effects specified for each behaviour. Because the relation between EEG and 
behaviour was not altered by intralipid compared to control, it is ensured that the results shown 
are truly diazepam effects and that using intralipid as vehicle did not cause qualitative effects on 
the diazepam results.
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3.4 Discussion
The dose of 2.5 mg/kg chosen for both diazepam and zolpidem induced sedation, while some 
active behaviour remained as measured by open field behaviour. In the cortical EEG, both drugs 
decreased delta (1-5 Hz) and alpha-1 (9-10 Hz) activity and increased higher frequencies, 
especially the beta-3 (21-30 Hz) band irrespective of vehicle effects. This pattern for diazepam 
is consistent with findings of previous studies (Nickel & Szelenyi 1989). The increase in the beta 
bands is consistent with many studies on the EEG effects of GABAA receptor modulators at the 
benzodiazepine site (Coenen & Van Luijtelaar 1991, Krijzer et al. 1993, Van Rijn & Jongsma 
1995, Visser et al. 2003a, Visser et al. 2003b). These results on the behavioural effects and EEG 
effects of the two GABAA receptor modulators diazepam and zolpidem are in agreement with 
earlier research. Furthermore, the beta-3 increase was consistent over different cortical 
localizations.
However, the EEG effects of diazepam and zolpidem are reported here to be 
conditional upon behaviour. The effect on high frequency EEG (beta-3 and gamma) activity was 
shown to differentiate between activity and inactivity. For both diazepam and zolpidem, gamma 
(31-100 Hz) activity was increased during activity but decreased during sitting. For sitting 
behaviour, beta-3 (21-30 Hz) activity was not changed in zolpidem and increased to a lesser 
extend compared to active behaviour in diazepam. Thus, the typical increase of beta-3 band EEG 
activity induced by benzodiazepines was shown to be predominant for behavioural activity but 
not inactivity.
In several studies that use the beta-3 band increase as a marker for GABAA agonism, 
EEG is registered during artificially induced behavioural activity by placing rats on rotating 
drums to control the level of vigilance (Krijzer et al. 1993, Visser et al. 2003a). This study 
replicates this increase in beta-3 activity for diazepam and zolpidem under non-forced vigilance 
conditions, and showed that the increase of beta-3 (and gamma) activity is most specific for 
active behaviour. Beta increase specific for behavioural activity has been reported before 
(Valerio & Massotti 1988). This dependency of the beta increase on behavioural activity could 
be suggested to explain why GABA agonists that induce general anaesthesia, such as thiopental 
and propofol, do not typically increase beta frequencies. These compounds have only been 
reported to increase beta frequencies during an initial phase of behavioural stimulation (Bagetta 
et al. 1987, MacIver et al. 1996, Yang et al. 1995).
Qualitatively, both the non-subtype-selective GABAa modulator diazepam and the a1 
selective zolpidem seemed to show similar effects. Thus, the existence of the effect does not 
seem to depend critically on the differential sensitivity of non-a1-containing receptors to 
diazepam versus zolpidem. However, drug solvent effects and the use of a single dose 
complicate a simple quantitative comparison between diazepam and zolpidem effects. Future 
studies aimed at more quantitative analysis could take into account PK/PD processes and 
incorporate alternative benzodiazepines. Nonetheless, the behaviour-specificity of the increase
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in EEG beta-3 band activity by both GABAa modulators tested already provides new 
information to unravel the intricate drug-behaviour-EEG relationship.
A pharmacological dissociation between behaviour and EEG has been described for the 
benzodiazepines (Coenen & Van Luijtelaar 1991). Although sedative, these drugs increase beta 
activity. High frequency activity, including both beta and gamma frequencies, have been 
implicated to mark arousal (Coull 1998, Trachsel et al. 1988, Uchida et al. 1992, Vanderwolf 
1992). However, analysis of the relation between behaviour and the EEG under control 
conditions revealed that in this study behavioural activity is characterized by increased theta and 
gamma activity, but not beta activity. Beta activity was actually higher in sitting behaviour than 
in walking behaviour. This is in accordance with rat EEG studies, which report that across sleep- 
wake states gamma, and not beta, activity varies reciprocally with delta activity (Maloney et al. 
1997). The attentive and active waking state is associated with activity >30 Hz (gamma) 
(Campbell & Feinberg 1993, Maloney et al. 1997). Thus, it can be hypothesised that gamma 
(frequencies > 30 Hz) rather than beta activity is a reliable indicator of arousal level.
The beta and gamma frequencies form a continuum of frequencies and there is no 
rationale for distinguishing between beta and gamma frequency bands (Steriade 2000). GABA is 
known to modulate the amplitude and frequency of gamma oscillations (Whittington et al. 
2000a). The frequency of gamma oscillations is controlled by the duration of individual 
inhibitory synaptic events and its power is additionally affected by the amplitude of the GABAa 
synaptic response. Drugs that affect these parameters of inhibition include many 
sedative/hypnotic or general anaesthetic drugs (Whittington et al. 2000a). Diazepam has been 
shown to predominantly increase the amplitude of gamma oscillations and additionally decrease 
their frequency (for review see Whittington et al. 2000b), but not to disrupt the synchrony or 
rhythmicity of gamma oscillations (Faulkner et al. 1998). A frequency reduction is also seen for 
the hippocampal theta rhythm. Thus, GABA-modulators, as the drugs used in this study, can 
increase gamma power and shift the frequency of gamma oscillations to lower frequencies in the 
beta range. Rather than 'de novo' activity in the beta-3 band, this could actually represent 
modified gamma activity (Whittington et al. 2000a, Faulkner et al. 1999). GABAa receptor 
modulators would increase gamma activity and by decreasing at the same time gamma 
frequencies would also cause an increase in beta activity. In earlier studies (Krijzer et al. 1993, 
Visser et al. 2003a), EEG frequencies are measured up to the beta-3 band and/or only under 
forced activity. Under these conditions, beta-3 frequencies would be largely increased and seen 
as 'de novo' and pharmacologically dissociated from behaviour.
The implications of our findings for the hypothesised pharmacological dissociation of 
the relation between the EEG and behaviour by GABAa modulation should be considered 
against the background of three observations. Firstly, under drug free conditions, gamma band 
activity represents arousal rather than beta band activity. Secondly, diazepam is known to 
decrease gamma frequencies to within the beta band range (Whittington et al. 2000a). Thirdly, 
the beta-3/gamma band increase by diazepam and zolpidem is specific for active behaviour.
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Thus, it seems that the relation between behaviour and EEG was maintained within the 
diazepam and zolpidem conditions. Gamma, extended into beta, activity was high during active 
behaviours. During inactive behaviour, a gamma decrease caused by GABAa receptor 
modulation is consistent with sedation and lower arousal levels. The drugs amplified the existing 
relation, with a large increase in beta-3 and gamma activity during activity. Consequently it 
should be concluded that diazepam and zolpidem amplify, rather than dissociate, the relation 
between behaviour and the EEG.
The function of this rather exaggerated increase in beta-3 and gamma activity specific 
for behavioural activity deserves some speculation. Supported by two findings in the literature, 
we would like to suggest that this increased beta-3/gamma activity is a prerequisite for 
behaviour to occur under sedation. Firstly, diazepam induces hyperlocomotion in a novel 
environment if the GABAa a1 subunit is not functional (Reynolds et al. 2001). This indicates 
that GABAa agonists activate motor systems, but that this effect is likely to be normally veiled 
by sedation mediated by the a1 subunit and by, in the case of diazepam, muscle relaxation. The 
increased beta-3/gamma activity can be seen as the reflection of increased activation of the 
systems driving motor behaviour. Secondly, it has been found that hippocampal theta levels are 
elevated before and after the occurrence of active behaviour compared to inactive behaviour 
(Van Lier et al. 2003b). Thus, active behaviour will occur at elevated levels of hippocampal 
theta. Similarly, active behaviour will occur at elevated levels of cortical beta/gamma activity. 
For active behaviour to occur when GABAa a1 receptor activity is increased, the level of 
cortical beta activity might need to be raised higher to reach an elevated threshold.
To summarize, psychoactive drug effects on the EEG are not the same during all types 
of behaviour. For two drugs acting as modulators at the GABAa receptor complex, diazepam 
and zolpidem, the increase in beta-3 and gamma activity was most specific for active behaviour, 
but not inactivity. Diazepam and zolpidem amplify, rather than dissociate, the relation between 
behaviour and the EEG. It is hypothesised that the large increase in beta-3/gamma activity by 
diazepam and zolpidem is a mechanism that allows for behavioural activity, despite sedation.
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Abstract
Psychoactive drugs can influence both the electroencephalographic (EEG) activity and 
behaviour, while a strong relation exists between the two. Among psychoactive drugs, the group 
of antidepressants seems to show diverging effects on behaviour and pharmaco-EEG in rats, 
possibly related to their diverse mechanisms of action. In order to be able to differentiate 
between the behavioural and EEG effects, it is not sufficient to describe changes in EEG 
irrespective of the subject's ongoing behaviour. Therefore, it was studied whether EEG activity 
is affected differentially with regard to the type of behaviour, and also with regard to the drug's 
mechanism of action in four antidepressants; mirtazapine (at 2.5 mg/kg), citalopram, fluoxetine, 
and imipramine (each at 10 mg/kg). A detailed analysis was made of open field behaviour, 
which was continuously scored and divided into 25 different elements of behaviour. The EEG 
was segmented according to this behavioural scoring and for each behavioural element a power 
spectrum was calculated. Not only behaviour was studied in detail, but also the spatial 
distribution of pharmaco-effects on its concurrent EEG across the brain. Citalopram, fluoxetine 
and mirtazapine decreased 9-10 Hz activity specific for behaviours such as walking, rearing, and 
sniffing, typically associated with hippocampal theta activity (6-10 Hz). The decrease is 
suggested to be related to a reduction of the frequency of hippocampal RSA. Thus, psychoactive 
drug effects on the EEG are not the same during all types of behaviour, as shown for several 
antidepressants.
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4.1 Introduction
Drugs with similar psychoactive actions show largely similar profiles in electroencephalographic 
(EEG) based sleep/wake organisation tests in rats (Ruigt et al. 1993). Despite consistent effects 
on sleep architecture, the group of presently clinically active antidepressants seems to show the 
most diverging pharmaco-EEG effects among the psychoactive drugs (Krijzer et al. 1993). Also, 
in a number of animal behavioural tests effects of different antidepressants on behaviour diverge 
(West & Weiss 1998). At the same time, antidepressant drugs have diverse mechanisms of 
action. Thus the antidepressants, while sharing mood-elevating properties in humans, are 
considered a non-homogeneous group of drugs with regard to effects on animal behaviour, 
pharmaco-EEG, and their mechanism of action.
While clear correlations have been demonstrated for behaviour and EEG activity, drugs 
can influence both. In order to be able to differentiate between the behavioural and EEG effects, 
it is not sufficient to describe changes in EEG irrespective of the subject's ongoing behaviour. 
Hippocampal rhythmical slow activity (RSA/theta, i.e. 6-10 Hz) and cortical low voltage fast 
activity (LVFA) dominate the EEG during the so-called 'type 1 behaviours' or 'voluntary 
movements' and exploratory sniffing, but not during 'automatic movements' or awake 
immobility (Vanderwolf 1969, 1992, Coenen 1975). Based on this relationship between the EEG 
and behaviour, this study aimed to explore the effects of different antidepressants on 
concurrently monitored EEG and behaviour. In this way, it was studied whether EEG is affected 
differentially with regard to the type of behaviour, and also with regard to the mechanism of 
action of the antidepressant. Moreover, it was assessed whether studying in detail the effects of a 
selection of antidepressants on rat behaviour and its EEG correlates can differentiate 
mechanisms of action.
A series of antidepressants were selected that form a spectrum with regard to their 
ability to affect 5-HT neurotransmission and other brain monoamines. These included 
citalopram, fluoxetine, imipramine, and mirtazapine. Citalopram, fluoxetine and imipramine are 
all reuptake inhibitors, with citalopram being most selective for serotonin (Hyttel 1982). 
Fluoxetine is a 'classic' selective serotonin reuptake inhibitor (SSRI) that mainly increases levels 
of 5-HT, but also to a lesser extent levels of noradrenaline and dopamine (Gobert et al. 1997). 
Imipramine is a classic tricyclic antidepressant that non-specifically inhibits the reuptake of both 
serotonin and norepinephrine, thus increasing levels of both serotonin and noradrenaline. 
Mirtazapine is a noradrenergic and specific serotonergic antidepressant (NaSSA) that has a dual 
action by increasing noradrenergic and serotonergic neurotransmission by binding directly at 
receptors. The acute increase in serotonergic transmission is thought to be specifically mediated 
by 5-HTi receptors because mirtazapine blocks 5-HT2 and 5-HT3 receptors. Additionally, 
mirtazapine is an antagonist of the adrenergic a2-auto- and a2-heteroreceptor (De Boer 1996). 
Mirtazapine also has histaminergic (H1) antagonist properties (De Boer et al. 1988) and 
increases dopamine levels in the frontal cortex (Millan et al. 2000).
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Drug doses were chosen from the literature at the minimally effective dose that induces 
changes in overall rat behaviour. For mirtazapine a dose of 2.5 mg/kg was chosen (Nowakowska 
et al. 1999) and 10 mg/kg for citalopram (Matto & Allikmets 1999, Kameda et al. 2001), 
fluoxetine (Pahkla et al. 2000, Cousins & Seiden 2000, Silva & Brandao 2000), and imipramine 
(West & Weiss 1998, Teixeira et al. 2000). A microanalysis of behaviour was made. Open field 
behaviour was continuously scored and divided into 25 elements of behaviour. The EEG was 
segmented according to this behavioural scoring and for each behavioural element the power 
spectrum was calculated. This protocol for detailed study of behaviour and concomitant EEG 
had previously been shown to be sensitive to strain differences (Van Lier et al. 2003a). Not only 
behaviour was studied in detail, but also the spatial distribution of antidepressant effects on its 
concurrent EEG across parts of the brain. To this end, EEG was recorded bilaterally in the dorsal 
hippocampus as well as in the frontal, parietal, and occipital cortices.
Thus, it was studied whether antidepressant drugs affect the EEG in the same way 
during different types of behaviour. Drugs were chosen from the antidepressant class of 
psychoactive drugs, because they can be considered a non-homogeneous class with regard to 
known effects on behaviour, pharmaco-EEG, and mechanism of action. The present study wants 
to further delineate possible systematics underlying the intricate interplay between the drug 
effects on these three parameters.
4.2 Methods
Animals
Experiments were conducted in accordance with United Kingdom Home Office Animals 
Scientific Procedures Act 1986 and Dutch animal legislation. 52 male Long-Evans rats were 
obtained from Harlan (UK, Ltd.). Animals were housed individually in macrolon cages with ad- 
libitum access to water and food and maintained were maintained on a reversed light/dark cycle 
(12/12 h).
Surgical procedure
Surgery was performed under isoflurane anaesthesia. The rat was placed in a stereotaxic 
apparatus (Kopf instruments) with bregma and lambda in the same horizontal plane. Local 
analgesic (Lidocaine) was applied to the exposed tissue of the head. Rats were instrumented 
with bipolar recording electrode sets bilaterally in three cortical areas and bilaterally in the 
dorsal hippocampus. The two wires of the bipolar electrode sets were separated 1 mm vertically 
for hippocampal electrodes, and 1 mm horizontally for cortical electrodes. Coordinates are based 
on Paxinos & Watson (1986) and are given for the cortex for the most frontal electrode in the 
right hemisphere (anterior/posterior to bregma; lateral to midline in mm.): frontal (+4.2; +1.0), 
parietal (-1.2; +4.5), and occipital (-4.3; +3.0). Coordinates for the hippocampus are given for
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the deepest electrode in the right hemisphere (anterior/posterior to bregma, lateral to midline, 
ventrally from skull surface, in mm.): (-4.0; +2.0; -3.0). An epidural screw served as ground 
electrode. Electrodes (stainless steel annealed / triple ML insulation wire, diameter 0.004 mm 
(California Fine Wire Company) connected to a pin (ITT Cannon; 031-9540-000) with a small 
insert (track pins; Display Elektronica NL; 04.11.T1559) (Typical resistance 7.5 (SE 0.1) kQ), 
were inserted and fixated with superglue (Cyanolit) and dental cement. All electrode pins were 
fitted into an 18-hole connector (ITT Cannon; CTA3-IS-53). The electrodes and connector were 
embedded in dental cement, and the tissue was sutured.
Drugs
Rats were assigned to either a drug or control group and used once. Rats were injected 
intraperitoneously 30 minutes before testing with citalopram (10 mg/kg) (n=7), fluoxetine (10 
mg/kg) (n=10), imipramine (10 mg/kg) (n=8), mirtazapine (2.5 mg/kg) (n=9) or its vehicle, 
which consisted of saline (0.9% NaCl) with 5% mulgofen (two groups; n=8 (corresponding to 
citalopram and imipramine) and n=9 (corresponding to fluoxetine and mirtazapine), total n=17). 
Fluoxetine (Fluoxetine hydrochloride) was obtained from Tocris Cookson Ltd., Bristol UK, and 
Imipramine (Imipramine hydrochloride) from Sigma-Aldrich, Zwijndrecht, the Netherlands. 
Mirtazapine was supplied by Organon Laboratories, Newhouse, UK, and Citalopram 
(Citalopram hydrobromide) by Lundbeck, Copenhagen, Denmark.
Behavioural testing
Rats recovered for at least 2 weeks after surgery before behavioural testing and EEG recording 
at the age of 14-18 weeks. Recording took place individually in an enriched open field, which 
was cleaned with ethanol (80%) between sessions to prevent rats using olfactory cues left by 
previously tested rats. The observations lasted 25 minutes per animal and were carried out under 
red light conditions between the 2nd and the 5th hour of the dark period to minimize the 
influence of circadian fluctuations in behavioural activity.
Open field
The open field (black plastic, 1 m x 1 m x 0.4 m) had clear acrylic glass on one side to allow 
camera side view. The open field was enriched with a fixed amount of food, access to the spout 
of a drinking bottle and an object that could freely be explored, but not displaced by the animal 
(pyramidal shaped, glass object, 6 x 6 x 11.5 cm).
Behavioural Scoring
Behavioural epochs were recorded on two cameras placed at side and top view of the animal and 
scored off-line using the Observer Video-Pro (Noldus Information Technology, the Netherlands) 
(Noldus et al. 2000), with a time resolution of 0.04s. Twenty-five behavioural elements were 
scored (Van Lier et al. 2003a). Each behavioural element was placed in one of five categories.
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Type 1 behaviour included walking, running, hopping, exploratory walking, climbing, rearing, 
rearing supported (wall), rearing object, and manipulating food. Type 2 behaviour included face 
washing, body grooming, genital grooming, scratching, wet dog shake, eating, and drinking. 
Wake immobility was scored as sitting. Sniffing included sniffing object, sniffing up, sniffing 
down, sniffing wall, and sniffing food. A miscellaneous category included squatting, freezing 
and orienting. For a detailed description of the behaviours see Van Lier et al. (2003a).
Analysis behavioural data
Using the Observer, elementary analyses (e.g. frequencies, percentages and duration of specific 
behaviours) were obtained. For all treatments, an overall multivariate test of variance was used 
to test for behaviour and treatment interactions for all variables. For significant interaction 
effects, post-hoc Students' t-tests for independent samples were performed (SPSS 10). T-values 
with degrees of freedom (in brackets) are given as well as the level of significance. The two 
saline control groups were grouped, as there were no differences between the groups.
EEG data acquisition and processing
Bipolar EEG recordings were obtained. The recording cable was connected to a swivel to allow 
free movement of the animal. Signals were amplified (x 5000, in-house built amplifier) and 
filtered high pass 1 Hz (1st order filter) and low pass 100 Hz (7th order elliptic filter). 
Digitisation (sampling rate 1024 Hz) and data recording were done using a Windaq (Dataq 
Instruments) acquisition system. EEG records were inspected visually and artefact-containing 
EEG was discarded before analysis.
Analysis EEG data
The EEG and behavioural files were synchronised with a resolution of 0.04 sec. A computer 
program segmented the EEG according to the files with behavioural scoring. EEG of 
behavioural epochs <1 sec. was discarded and epochs >1 sec. were divided into the largest 
number of integer consecutive 1 sec. segments. For each 1 sec. segment spectral power density 
(V2) was calculated. These power spectra were averaged for each behaviour and for each rat. 
The EEG power spectrum was calculated for eight frequency bands in the range between 1 and 
100 Hz. Frequency bands in the 1-30 Hz range, as distinguished for human EEG according to 
Herrmann et al. (1980, adapted to integer frequencies), were applied to these animal studies as in 
accordance with International Pharmaco EEG Group (IPEG) guidelines as agreed upon in the 
IPEG meeting 2000, Vienna (delta (1-5 Hz), theta (6-8 Hz), alpha-1 (9-10 Hz), alpha-2 (11-12 
Hz), beta-1 (13-17 Hz), beta-2 (18-20 Hz), and beta-3 (21-30 Hz)). An additional band covered 
the higher end of the EEG spectrum (31-100 Hz). On total absolute power, a univariate analysis 
of variance was used to test for position, behaviour, treatment effects, and interactions. On 
relative power, a multivariate (each frequency band) analysis of variance was performed to test 
for position, behaviour, treatment effects, and interactions. The highest order interactions that
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were found significant are given in the results. Interaction effects were further analysed using 
GLM's (General Linear Model) (SPSS 10). F-values with degrees of freedom (in brackets) are 
given as well as the level of significance. The significance level was <.05. Each treatment was 
tested against its own control group, taking into account possible differences between vehicles. 
For histological verification of hippocampal electrode placement, the rats were perfused and 
brains fixated with a 4% paraformaldehyde, 0.1 M phosphate buffer. Brain slices of 100 ^m 
were cut using a vibratome and stained with Cresyl violet.
4.3 Results
4.3.1 Behavioural effects
The number of behavioural transitions in the 25-minute period gives a measure of the alternation 
rate of behavioural elements. Saline controls did not differ [t(15)=0.4, p=0.71] and were 
grouped. Imipramine increased the number of behavioural transitions in 25 minutes to 892.3 (SE 
51.1) from 693.2 (SE 39.0) in the control group [t(23)=3.0, p<.01]. Mirtazapine decreased this 
number to 493.7 (SE 45.2) [t(24)=3.2, p<.01]. Citalopram and fluoxetine did not affect the 
number of behavioural transitions.
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Figure 1 Open field behaviour
Effects are shown on open field behaviour for saline control groups (white bars) and drug treated groups (black bars) of 
citalopram (a), fluoxetine (b), imipramine (c), and mirtazapine (d). Bars represent percentage o f  time spent on the 
behaviour during the 25-minute period in the open field (y-axis). The behaviour is given on the x-axis. Only behaviours 
with a significant effect (*p<.05) in at least one o f the drug treatments are presented.
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Out of the 25 specified behaviours only those that were significantly affected will be discussed. 
Saline controls were grouped.
Citalopram (Figure 1a) increased the total time spent on sniffing up [t(22)=2.9, p<.01] and 
sniffing wall [t(22)=2.3, p<.05], and decreased the time spent on rearing [t(22)=4.4, p<.001] and 
rearing supported [t(22)=3.2, p<.01].
Fluoxetine (Figure 1b) increased the time spent on sniffing up [t(25)=2.6, p<.05] and decreased 
face washing [t(25)=2.2, p<.05].
Imipramine (Figure 1c) decreased the time spent on face washing [t(25)=2.2, p<.05]. 
Mirtazapine (Figure 1d) increased time spent on sitting [t(24)=4.1, p<.001] and decreased the 
time spent on the type-1 behaviours walking [t(24)=3.9, p<. 001], rearing [t(24)=3.9, p<.001], 
and rearing supported [t(24)=3.8, p<.001].
4.3.2 EEG  effects 
Total absolute power
Citalopram decreased absolute power in the hippocampus to 14.1 x103 (SE 4.6 x103) from 39.3 
x103 (SE 4.0 x103) (^V)2 in control, and increased power in the parietal cortex to 2.0 x103 (SE 
0.09 x103) from 1.7 x103 (SE 0.07 x103) (^V)2 in control (treatment*position interaction 
[F(3,801)=13.0, p<.001]). Fluoxetine decreased absolute power in the hippocampus to 16.9 x103 
(SE 1.1 x103) from 22.7 x103 (SE 1.7 x103) (^V)2 in control, and in the occipital cortex to 0.9 
x103 (SE 0.06 x103 ) from 1.8 x103 (SE 0.1 x103 ) (^V)2 in control (treatment*position interaction 
[F(3,1183)=3.1, p<.05]). Imipramine had no effect on absolute power. Mirtazapine increased 
absolute power in the frontal cortex to 0.9 x103 (SE 0.1 x103 ) from 0.7 x103 (SE 0.03) (^V)2 in 
control, and decreased power in the occipital cortex to 1.3 x103 (SE 0.06 x103 ) from 1.8 x103 
(SE 0.1) (^V)2 in control and hippocampus to 12.3 x103 (SE 0.7 x103 ) from 22.7 x103 (SE 1.7 
x103) (^V)2 in control (treatment*position interaction [F(3,1099)=14.4, p<.001]). The type of 
behaviour did not influence drug effects on absolute EEG power.
Relative power in frequency bands
For relative power (Figure 2a), citalopram increased 1-5 Hz activity and decreased faster activity 
in the frontal cortex and occipital cortex. It decreased 9-17 Hz activity in the parietal cortex. In 
the hippocampus 6-12 Hz activity were decreased, while fast activity (21-100 Hz) was increased 
(Treatment*position interaction [F(21,2361)=7.6, p<.001]).
For fluoxetine (Figure 2b), a similar pattern for all recording sites was found, with a 
decrease of 1-5Hz and 9-10 Hz activity, and an increase in 6-8 Hz and 13-100 Hz activity 
(Treatment*position interaction [F(24,3558)=6.0, p<.001]).
Imipramine (Figure 2c) increased 1-5 Hz and decreased 18-100 Hz activity in the 
frontal and parietal cortex. It had no effect on the relative power distribution in the occipital
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cortex. In the hippocampus, 1-5 Hz and 31-100Hz activity were decreased, while 6-8Hz and 11- 
20Hz activity were increased (Treatment*position interaction [F(21,2817)=4.3, p<.001]).
Mirtazapine (Figure 2d) showed similar patterns in the parietal and occipital cortex, 
with decreased 1-5 and 9-10 Hz activity and increased 21-100 Hz activity. The EEG in the 
frontal cortex was hardly affected. In the hippocampus, 1-5 Hz and 9-10 Hz activity were 
decreased and 6-8 Hz and 13-17 Hz activity increased (Treatment*position interaction 
[F(24,3330)=8.6, p<.001]).
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Figure 2 EEG frequency bands
Percentual changes compared to control in relative EEG power per frequency band are given for each drug treatment, for 
the three cortical areas and hippocampus. Citalopram (a), fluoxetine (b), imipramine (c), and mirtazapine (d). An asterisk 
(*) marks a significant change, p<.05.
It has to be noted that the behavioural effect (Figure 1) and the EEG effect (Figure 2) of 
each drug have been de-coupled. An EEG spectrum was calculated for each behavioural 
element. The drug effect on the EEG, as given in figure 2, is an average effect over these 
averaged EEG spectra per behavioural element. Each behavioural element has an equal weight 
in the averaging. Thus, changes in the distribution of behavioural elements induced by the drug 
do not influence its EEG effects.
Hippocampal RSA
Average RSA peak frequency in all control groups was 8 Hz (SE G.G). This was decreased by 
citalopram to 7.3 Hz (SE G.13) [t(11)=5.7, p<.GG1], by fluoxetine to 7.6 Hz (SE G.11) [t(19)=3.9,
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p<.GG1]and by mirtazapine to 7.5 Hz (SE G.12) [t(16)=3.8, p<.G1]. Imipramine (7.8 Hz SE G.1) 
did not affect average RSA peak frequency. None of the drugs affected RSA relative peak 
power.
4.S.S Behaviour-dependent EEG effects
a) Citalopram (*) b) Fluoxetine
c) Imipramine
Figure 3 Behaviour-dependent alpha-1 EEG changes
Changes in alpha-1 EEG relative power (y-axis) are given for each behavioural category (x-axis). Citalopram (a), 
fluoxetine (b), imipramine (c), and mirtazapine (d). Percentual changes are depicted o f the drug group compared to the 
control group. A (*) signifies a significant interaction between treatment and behaviour, an * a significant treatment 
effect for the behaviour, p<.05. Behaviour (x-axis) has been grouped into the categories type 1, type 2, sniffing, and 
sitting behaviour (Vanderwolf, 1969; Coenen, 1975; Van Lier et al., 2003a).
40-
20-
40
2020
The 9-10 Hz band was affected behaviour-dependently (behaviour*treatment interaction, Figure
3) by citalopram [F(10,791)=2.5, p<.01] and mirtazapine [F(14,1115)=2.8, p<.001]. There was a 
decrease in 9-10 Hz activity for type 1, sniffing and type 2 behaviours in citalopram (Figure 3a), 
more specifically for explorative walking, rearing, rearing object, sniffing up, sniffing wall and 
face washing. For mirtazapine 9-10 Hz activity was decreased for type 1 and sniffing behaviour 
(Figure 3d), more specifically for explorative walking, rearing supported, sniffing up, sniffing 
down, and sniffing wall. Imipramine did not affect the 9-10 Hz band during any behaviour 
(Figure 3c). Fluoxetine did not give a significant interaction between behaviour and treatment, 
but did decrease 9-10 Hz activity during type 1 and sniffing behaviour only (Figure 3b), 
specifically for explorative walking, rearing and sniffing up, down and wall.
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4.4 Discussion
Direct drug effects on the rat EEG were studied, rather than indirect effects via behavioural 
changes. The spectral content of the rat EEG was affected behaviour-dependently in the 9-10 Hz 
band by a number of drugs. The antidepressants citalopram, and mirtazapine decreased relative 
9-10 Hz power behaviour-specifically for behaviour such as walking, rearing, and sniffing, 
typically associated with hippocampal rhythmical slow activity (RSA/theta, i.e. 6-10 Hz). For 
fluoxetine a trend similar to citalopram and mirtazapine was found, but this did not reach 
statistical significance. Imipramine did not show the behaviour-dependent effect on the alpha-1 
band.
The reason why the 9-10 Hz band was affected specifically for RSA related behaviours, 
could be a simple relation to drug effects on RSA itself. The 9-10 Hz frequency band covers the 
high frequencies of rat hippocampal RSA. The drugs that behaviour-dependently decreased 9-10 
Hz activity (citalopram, fluoxetine and mirtazapine) also decreased RSA peak frequency. 
Imipramine affected neither 9-10 Hz activity nor RSA peak frequency. If caused by effects on 
RSA, the alpha-1 effects can only occur during the RSA-related behaviours, because there is less 
or no hippocampal RSA present during type 2 behaviour and wake immobility. Thus, the 
behaviour-dependent effects on alpha-1 band power could be due to drug effects on type-1 
behaviour related hippocampal RSA.
Type-1 behaviour related hippocampal RSA is hypothesized to depend on ascending 
serotonergic projections to the hippocampus (Vanderwolf & Robinson 1981). Activity of post- 
synaptic 5-HTiA receptors in the forebrain has been suggested to determine the amplitude and 
frequency of type-1 behaviour related RSA (Kasamo et al. 1994). 5-HTiA receptors have been 
implied to play a role in the treatment of depression (Blier & Ward 2003). Therefore, the 
question can be addressed whether the decrease in frequency of type-1 behaviour related RSA 
(reflected in 9-10 Hz band power) could be indicative for acute activation of post-synaptic 5- 
HT1A receptors. If so, the behaviour-dependent 9-10 Hz decrease could be an early marker of 
antidepressant properties. However, several issues need to be addressed.
Firstly, is the behaviour-dependent 9-10 Hz effect mediated by the 5-HT1A receptor? 
Kasamo et al. (1994) demonstrated that post-synaptic 5-HTiA receptors are involved in the 
determination of the amplitude and frequency of type-1 behaviour related RSA. It can be tested 
if the behaviour-dependent 9-10 Hz effect is indeed mediated by the 5-HT1A receptor with use of 
the 5-HTiA receptor agonist 8-OH-DPAT.
Secondly, are these antidepressant drugs indeed capable of activating post-synaptic 5- 
HT1A receptors? Mirtazapine is a postsynaptic drug with low affinity for 5-HT1A receptors but its 
5-HT effect is mediated by 5-HTiA receptors due to blockade of 5-HT2 and 5-HT3 receptors (De 
Boer 1996). Citalopram, fluoxetine and imipramine are all serotonin reuptake inhibitors and do 
not bind with high affinity to 5-HT receptors. However, they increase 5-HT levels leading to the 
indiscriminate activation of all serotonin receptors (see Blier & Ward 2003). So yes, in this way
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these drugs would be capable of activating the post-synaptic 5-HTiA receptor. This can be 
verified by testing these drugs on their 9-10 Hz effect in combination with the 5-HTiA receptor 
antagonist WAY 100635.
Thirdly, is the behaviour-dependent 9-10 Hz effect exclusive for post-synaptic 5-HTiA 
receptor activation (selectivity)? It is not. Systemic administration of GABA agonists also 
reduces hippocampal RSA frequency (Yoshimoto et al. 1999, Woodnorth & McNaughton 2002). 
Indeed a similar behaviour-specific decrease in the 9-10 Hz band was shown for diazepam and 
zolpidem (Van Lier et al. 2004). RSA frequency reduction has also been suggested to mark 
anxiolytic properties (McNaughton et al. 1986) and is quite pronounced in the benzodiazepines. 
Some antidepressants indeed have anxiolytic effects next to antidepressant (for review see Nutt
2000).
Lastly, do all antidepressants show the behaviour-dependent 9-10 Hz effect (predictive 
validity)? At 10 mg/kg imipramine did not decrease 9-10 Hz power in this experiment. 
However, reduction of RSA frequency by imipramine has been shown at 30 mg/kg and was 
attributed to effects on 5-HTiA receptors that are not autoreceptors (Zhu & McNaughton 1994).
At a functional level, RSA frequency is thought to be important for information 
processing (Buzsaki 1989, O'Keefe 1993). Similar to drug effects in this study, differences in the 
9-10 Hz frequency band specifically for theta-related behaviours were found in a study on strain 
differences (Van Lier et al. 2003a). This difference was attributed to aspects of sensory-motor 
information processing during rat exploratory behaviour, as RSA activity seems to include both 
motor and sensory aspects (van Lier et al. 2003b). Alpha-1 power effects in the rat strain study 
were also related to effects on rat exploratory behaviour. Similar behavioural effects were found 
for mirtazapine, citalopram and to a lesser extent fluoxetine. Thus in analogy to the study on 
strain differences, antidepressant treatment can be hypothesised to have an effect on sensory- 
motor information processing.
Citalopram, imipramine and mirtazapine had limited or no effects in one of the cortical 
areas, while the other cortical areas were affected in a similar way. Cortical effects differed from 
hippocampal effects. Hence, these drugs did not have a generalized effect on brain activity, but 
showed localization of effects. Regional EEG effects of chronic, but not acute citalopram have 
been reported (Neckelman et al. 1996). The reason for regional differences in effects is not clear. 
Possibly, there are regional differences in receptor populations or levels of other 
neurotransmitters. Or, in different parts of the neuro-axis re-uptake inhibition has different 
potencies. Although the basis is yet not well understood, regional differences in pharmaco-EEG 
effects are clearly demonstrable.
Also, all drug effects showed an effect of hemisphere. EEG activity not only varied 
with position and hemisphere in the drug treated groups, but also in control groups. Inter- 
hemispheric asymmetry has been shown in rats (Vorobyov & Ahmetova 1998, Vyazovskiy et al. 
2002, Juarez & Corsi-Carbrera 1995) and anterior EEG alpha asymmetry in humans has been 
implicated in depression (Debener et al. 2000). Although there were differences in drug effect
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between the two hemispheres, this difference seemed quantitative rather than qualitative; most 
drug effects were not opposite in the hemispheres, but the magnitude of the effects differed. 
Analysis of the inter-hemispheric asymmetry (data not shown) did not indicate any structural 
inter-hemispheric differences. Thus, there seems to be variation in spontaneous EEG activity 
measured at different recording sites and at both hemispheres.
To conclude, psychoactive drug effects on the EEG are not the same during all types of 
behaviour, as shown for several antidepressants. 9-10 Hz EEG activity was reduced during 
hippocampal RSA related behaviours, but not during sitting and type 2 behaviour by citalopram, 
fluoxetine and mirtazapine. This is suggested to be related to a reduction of the frequency of 
hippocampal RSA. The combined study of open field behaviour in detail and concomitant 
pharmaco-EEG effects could have a predictive value for mechanisms of action (i.e. 5-HT), but 
further research and comparative studies with different classes of psychoactive compounds is 
needed to help to disentangle these pharmaco-EEG-behaviour relationships.
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EEG correlates of open field behaviour in the rat;
support for a sensory-motor function of hippocampal RSA
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Abstract
A clear relationship exists between moment-to-moment behavioural elements and hippocampal 
Rhythmical Synchronous Activity (RSA, theta rhythm). However, behavioural elements are not 
isolated events, but are part of behavioural sequences in a context of behavioural activity. By 
concurrently monitoring open field behaviour and hippocampal EEG, EEG correlates of open 
field behaviour in relation to preceding and following behaviour were studied in Sprague- 
Dawley rats to determine whether the behavioural context influences EEG correlates of 
behaviour. Results show that preceding and subsequent behavioural patterns influenced the 
spectral power correlates of behaviour. RSA power was increased when a ‘type 1 behaviour’ 
(voluntary movement) preceded the behaviour compared to when a ‘type 2 behaviour’ 
(automatic movement, awake immobility) preceded it. The modulating effect of behavioural 
transitions was shown for several types of behaviours, and systematic modulation of 
hippocampal EEG correlates of behaviour was demonstrated. The present report shows that the 
strong and systematic relationship between hippocampal RSA and behaviour is modulated by 
the behavioural-sequential context. Thus, in addition to the well-established relationship 
between RSA and motor activity, a second non-motor process seems to contribute to 
hippocampal RSA. A likely candidate is a sensory process, which is in accordance with theories 
on the sensory-motor function of hippocampal RSA.
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5.1 Introduction
Hippocampal Rhythmical Synchronous Activity (RSA / theta rhythm (6-10 Hz)) has already 
been described in 1939 by Jung and Kornmuller. In the search of its behavioural correlates, RSA 
has been related to psychological concepts such as memory and learning (Elazar & Adey 1967, 
Buzsaki 1989), arousal and attention (Green & Arduini 1954, Kemp & Kaada 1975), the 
orienting response (Grastyan et al. 1959), ‘type I ’ motor movement (Vanderwolf 1969, Coenen 
1975), and sensory (-motor) activity (Komisaruk 1970, Sainsbury 1998). Based on movement 
correlates with theta activity, behaviour can be divided into ‘type 1 behaviour’ (or ‘voluntary 
movement’), and ‘type 2 behaviour’ (‘automatic movement’ and awake immobility) (Coenen 
1975, Vanderwolf 1969, 1992). Type 1 behaviour is correlated with theta and includes behaviour 
such as walking, running, rearing, swimming, and changes in body posture; type 2 behaviour is 
accompanied by LIA and includes behaviour such as body grooming, face washing, and awake 
immobility. For Type 1 behaviour, more vigorous movements are accompanied by higher 
amplitude RSA (Whishaw & Vanderwolf 1973). Active exploratory sniffing is also highly 
correlated with theta activity (Forbes & Macrides 1984, Komisaruk 1970, Chang 1992). 
Different types of sniffing (sniffing air or sniffing an object) show differences in their 
electroencephalographic (EEG) power spectra (Coenen 1975), indicating that sniffing includes a 
group of behaviours that are not homogenous with respect to amount of theta activity.
So far, the moment-to-moment relation between behaviour and EEG seems clear. 
However, behavioural elements are not isolated events, but are part of behavioural sequences in 
a context of behavioural activity. Previous experiments (Van Lier et al. 2003a) showed that a 
context of low or high exploratory activity could modulate hippocampal EEG correlates of 
behaviour. The data suggested that in addition to main motor components, sensory components 
contribute to hippocampal EEG correlates of exploratory behaviour. To further investigate the 
relation between behaviour and the hippocampal EEG in its behavioural context, the question 
was addressed whether behaviour such as sniffing is the same in terms of its physiological 
correlate in association with voluntary movements compared to automatic movements. In an 
open field, bouts of exploratory activity alternate with bouts of inactivity and grooming 
behaviours. In this environment, epochs of behavioural elements in association with either type 
1 or 2 behaviour can be collected when behaviour is continuously scored. By concurrently 
monitoring open field behaviour and EEG, RSA correlates of open field behaviour in relation to 
preceding and following behaviour were studied to determine if the behavioural context 
influences RSA correlates of behaviour. It was studied if the RSA correlate of a behavioural 
element differs contingent upon its association with either type 1 or a type 2 behaviour. 
Behavioural elements included sniffing behaviours as well as type 1 and type 2 behaviours.
63
Chapter 5
5.2 Methods
Animals
Thirteen male Sprague-Dawley rats were obtained from Harlan (UK, Ltd.). The animals were 
housed individually in macrolon cages with free access to water and food and maintained on a 
reversed light/dark cycle (12/12 h) with lights on at 19.00 h. The animals were handled once a 
day for five minutes starting one week before testing. Experiments were performed at Organon, 
Newhouse (UK). Permission for all procedures was granted from the UK Home Office (Animals 
Scientific Procedures Act, 1986, PIL 60/2626).
Surgical procedure
Surgery was performed under isoflurane anaesthesia. The rat was placed in a stereotactic 
apparatus (Kopf instruments) with bregma and lambda in the same horizontal plane. Local 
analgesic (Xylocaine spray (Lidocaine)) was applied to the exposed tissue of the head. Animals 
were injected pre-operatively with an antibiotic (Amfipen, 0.3 ml sc. (Anhydrous ampicillin Ph. 
Eur. 100mg/ml)) and post-operatively with an analgesic (Carprofen, 1ml/kg sc (Rimadyl, non­
opioid analgesic 1:10)). Rats were instrumented with bipolar recording electrode sets bilaterally 
in three cortical areas and the dorsal hippocampus (only hippocampal data used in this article). 
The two wires of the bipolar electrode sets were separated 1 mm vertically for hippocampal 
electrodes. Coordinates: -4.0 (AP); ±2.0(lateral) relative to Bregma; -3/-2 (depth from skull) 
(Paxinos & Watson 1986). A screw was used as ground electrode. Electrodes (stainless steel 
wire, diameter 0.004 mm (California Fine Wire Co, USA) connected to a pin (ITT Cannon; 031­
9540-000) with a small insert (track pins; Display Elektronica NL; 04.11.T1559) (Typical 
resistance 7.5 (SE 0.1) kQ), were inserted and fixated with superglue (Cyanolit) and dental 
cement. All electrode pins were fitted into an 18-hole connector (ITT Cannon; CTA3-IS-53). 
The electrodes and connector were embedded in dental cement, and the tissue was sutured.
Behavioural testing
Rats recovered for at least 2 weeks after surgery, before behavioural testing at the age of 16-22 
weeks. Animals were habituated to experimental conditions by connecting them to a dummy 
cable and swivel in their homecage the night before the experiment. Recording took place 
individually in an enriched open field, which was cleaned with ethanol (70 %) between sessions 
to prevent rats using olfactory cues left by previously tested rats. Observations lasted 25 minutes 
per animal and were carried out under dimmed red light conditions between the 2nd and the 5th 
hour of the dark period to minimize circadian influences.
Open field
The open field (black plastic, 1 m x 1 m x 0.4 m) had one side made of clear acrylic glass to 
allow camera side view. The open field was supplied with a fixed amount of food, access to the
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spout of a drinking bottle and enriched with an object that could not be displaced by the animal 
(pyramidal shaped, glass object, 6 x 6 x 11.5 cm).
Behavioural scoring
Behaviour was recorded simultaneously on two cameras placed at side and top view of the 
animal and behaviour scored off-line using the Observer Video-Pro (Noldus Information 
Technology, the Netherlands) with a time resolution of 0.04s. A detailed analysis of behaviour 
included 21 behavioural elements (Van Lier et al. 2003a), based on the work of Timmermans 
(1978) and Vossen (1966) and own observations. Each behavioural element was placed into one 
of the following categories: type 1 behaviour, type 2 behaviour (Coenen 1975, Vanderwolf & 
Robinson 1981), or sniffing behaviour. Type 1 behaviour included walking, running, hopping, 
exploratory walking, climbing, rearing, rearing supported, rearing object, and manipulating food. 
Type 2 behaviour included eating, drinking, face washing, body grooming, genital grooming, 
scratching and sitting. Sniffing behaviour included sniffing object, sniffing up, sniffing down, 
sniffing wall and sniffing food. To enable quantification of the intensity motor movements 
during sniffing behaviour, intensity scores were calculated on the basis of the distance (in 
centimetres) moved by the head and the paws of the animal for each 0.5-second epoch.
Analysis behavioural data
Using the Observer, a lag sequential analysis was obtained. Number of transitions between 
behaviours was calculated and statistical significances tested with One-way ANOVA (with Post­
hoc Scheffe) using SPSS. Because of structural zeros in the data, Pearson chi-square statistic and 
adjusted residuals were calculated according to procedures using log-linear approaches as 
recommended by Bakeman & Quera (1995). An Iterative Proportional Fitting procedure was 
used (Fienberg 1980); adjusted residuals were calculated using the Newton-Raphson algorithm 
(Haberman 1979). All rats were included in the analysis.
EEG data acquisition
Bipolar recordings were obtained. Signals were filtered High Pass at 1 Hz and Low Pass at 100 
Hz and amplification 300^V/V. Digitisation (sampling rate 1024 Hz) and data recording was 
done using Windaq (Dataq Instruments).
Analysis EEG data
A computer program segmented the EEG according to the files with behavioural scoring. EEG 
segments were not overlapped and averaged for each rat and behaviour. Spectral power density 
(V2) was calculated, reflecting energy and thus electrical activity rather than amplitude (V). For 
the data of figures 2 and 3, power spectral density was calculated for segments of 1s. For figure
2, EEG of behavioural epochs <1s was discarded and epochs >1s were divided into the largest 
number of integer 1s segments. For figure 3, epochs <1 s were discarded while only the first
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second of epochs >1s was used. For the data of figure 4, behavioural epochs of at least 2s were 
used and divided into four consecutive segments of 0.5s for power spectral density calculation. 
For analysis after transition, the beginning of the first segment of an EEG epoch was 
synchronous with the behavioural transition and EEG was analysed up to 2s after transition. For 
analysis before transition, the ending of the first segment was synchronous with the transition, 
the second segment ended at the beginning of the first segment and so leading back to 2s before 
transition. Only animals showing the characteristic pattern of hippocampal electrical activity 
were selected for the analyses. From previous experiments it was clear from histological 
verification that electrodes were then adequately placed in the hippocampus (Van Luijtelaar & 
Coenen 1984). Data from both the left and right brain hemisphere were used in the analysis. 
Student paired t-test statistics and One-way ANOVA (with Post-hoc Scheffe) were calculated 
where appropriate (SPSS 10). Regression analysis and Covariance analysis were performed on 
movement intensity and 8 Hz EEG power, including normalized data from 7 rats (SPSS).
5.3 Results
5.3.1 Sequential analysis of Open Field behaviour
In figure 1, results are given of sequential analysis of the Open Field behaviour. Association 
strength between behavioural elements is depicted as adjusted residuals for the different types of 
sniffing. Behaviour was not independent of the immediately preceding or following behaviour 
[X2 (539)=3356.54, p< 0.001]. A high adjusted residual shows a high association (a higher 
number of transitions than can be expected based on the occurrence of the behaviours) between 
behaviours. ‘Sniffing up’ showed a high association with type 2 behaviours: sitting, face 
washing and eating as well as with rearing. ‘Sniffing down’ was highly associated with 
‘exploratory walking’; ‘sniffing wall’ was associated with ‘rearing supported’ and ‘walking’. 
The mean (±SD) number of transitions with type 1 behaviour as a percentage of number of 
transitions with type 1 and 2 behaviour, was for sniffing up: 0.71 (±0.17), sniffing down: 0.86 
(±0.12) and sniffing wall 0.91 (±0.06) (n=13). ‘Sniffing up’ had more transitions with type 2 
behaviours compared to ‘sniffing down’ and ‘sniffing wall’ [F(2,36)=9.277, p<0.001], post-hoc 
p<0.05 and p<0.01 respectively).
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Figure 1 Behavioural transitions with sniffing behaviours.
The figure shows the association strength (as adjusted residuals) o f  sniffing up, sniffing down and sniffing wall with 
other types o f  behaviour. A positive adjusted residual reflects a higher number o f transitions between two behaviours 
than can be expected based on the occurrence o f  the two behaviours; a negative adjusted residual means a lower number 
o f transitions between two behaviours than can be expected based on the occurrence o f  the two behaviours. The larger 
the adjusted residual, the stronger the association between the two behaviours is. Adjusted residuals are shown for 
transitions with sniffing behaviours as first act with the behaviours on the x-axis representing following behaviours 
( ‘sniffing as antecedent’, left), and for transitions with sniffing behaviours as second act with the behaviours on the x- 
axis representing preceding behaviours ( ‘sniffing as consequent’, right). Wa: walking, Ru: running, Ho: hopping, Ew: 
exploratory walking, Cl: Climbing, Re: Rearing, Rs: Rearing supported, Ro: Rearing object, Mf: Manipulating food, Ea 
Eating, Dr: Drinking, Fw: Face washing, Bg: Body grooming, Gg: Genital grooming, Sc: Scratching, Si: Sitting, So 
Sniffing object, Su: Sniffing up, Sd: Sniffing down, Sw: Sniffing wall, Sf: Sniffing food
5.3.2 EEG power spectra of sniffing
The power spectra for visually distinguished types of sniffing fell in between those for walking 
and sitting (Figure 2). Sniffing up resembled most the spectrum for sitting; sniffing wall was 
most similar to the spectrum of walking, and sniffing down fell in between the spectra of sitting 
and walking. ‘Sniffing up’ showed significant lower RSA amplitude at 8 Hz compared to 
‘sniffing wall’ [F(2,36)=3.954, p<0.05, post-hoc p<0.05].
67
Chapter 5
5000-,
CM
>
3  4000­
%g 3000- o
CL
■2 2000- 
o
JS 1000- 
<
0
--W alking
— Sniffing up
— Sniffing down
— Sniffing wall 
Sitting
—i-------- 1-------- 1-------- r -
12 15 18 21
—i---1—
24 27
—i
30
Frequency(Hz)
Figure 2 Hippocampal power spectra for visually distinguished types o f  sniffing (sniffing up, down and wall). Also 
shown are power spectra for walking and sitting (n=8).
5.3.3 EEG effects of behavioural transitions
The power at theta frequencies of 8 Hz [t(7)=6.003, p<0.01] and 9Hz [t(7)=2.558, p<0.05] was 
increased during ‘sniffing up’ following after ‘walking’ compared to during ‘sniffing up’ 
following after ‘sitting’ (Figure 3).
Frequency (Hz)
Figure 3 Power density spectrum for sniffing up when following after walking or after sitting. The first second of each 
sniffing up segment is used. * = Absolute power differs at 8 Hz [t(7)=6.003, p<0.01] and 9 Hz [t(7)=2.558, p<0.05].
The effect of preceding behaviour on RSA power was not specific for ‘sniffing up’ behaviour 
but was present during other types of sniffing as well. Also, during other type 1 behaviours and 
during other type 2 behaviours RSA power was increased if a type 1 behaviour preceded the 
behaviour compared to if a type 2 behaviour preceded it. In figure 4, behavioural elements were
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grouped into the categories sniffing, type 1 behaviour, and type 2 behaviour. Individual 
behavioural elements systematically showed the effects as shown for the grouped categories. 
Figure 4 shows (above) the difference in spectral power during a behaviour between following 
after a type 1 compared to after a type 2 behaviour. A marked difference occurred specifically 
for 8 Hz. In time, the effect of preceding behaviour on 8 Hz power during sniffing was most 
prominent in the first half-second after transition [t(7)=3.500, p<0.05], and still present 0.5-1.0s 
[t(7)=2.990, p<0.05], 1.0-1.5s [t(7)=3.134, p<0.05] , and 1.5-2.0s [t(7)=2.412, p<0.05] after the 
behavioural transition. During type 1 behaviour the effect was demonstrated for the first two 
half-second segments (0-1.0s) ([t(7)=3.662, p<0.01] and [t(7)=2.418, p<0.05] respectively); 
during type 2 behaviour the effect was shown for the second half second after transition (0.5­
1.5s) [t(7)=3.093, p<0.05]. Not only did preceding behaviour have an effect on 8 Hz power, but 
following behaviour had an effect as well (Figure 4, below). This effect of following behaviour, 
however, was smaller than the effect of preceding behaviour. It could only be demonstrated 
during sniffing, not during type 1 or type 2 behaviour. It was present in all four half-second 
segments 0-2.0s before behavioural transition ([t(7)=2.663, p<0.05], [t(7)=2.800, p<0.05], 
[t(7)=3.250, p<0.05], and [t(7)=3.344, p<0.05], respectively).
Type 1 behaviour 
After transition
Type 2 behaviour Sniffing behaviour
8 12 16 20 24 28 32
Time after/before transition
------0-0.5s
..... -0.5-1.0s
- 1 . 0 - 1 . 5 s  
------1.5-2.0s
8 12 16 20 24 28 32
Frequency (Hz) Frequency (Hz)
Figure 4 Transition effect
The transitions effect is shown for type 1, type 2 and sniffing behaviour, each line specifying one o f four consecutive 
time segments o f 0.5s. On the left, each line represents the difference in absolute power between following after type 1 
and following after type 2 behaviour ( ‘After transition’). On the right, each line represents the difference in absolute 
power between preceding before type 1 and before type 2 behaviour ( ‘Before transition’). * = significant difference in 
absolute power at 8 Hz between transitions with type 1 and type 2 behaviour (p<0.05). Note: the difference between the 
two spectra is shown.
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5.3.4 Intensity of head and paw movements during sniffing at behavioural transitions
Intensity of motor movements of the head and limbs during sniffing behaviour in the first 2s 
preceding or following transition differed between transitions with a type 1 or type 2 behaviour 
(Table 1). For all four time segments for both after and before transition, intensity of head and 
limb movements during sniffing behaviour was higher for transitions with a type 1 behaviour 
than for transitions with a type 2 behaviour.
Table 1 Intensity o f motor movements o f  head and limbs during sniffing behaviour.
Time segment Intensity of movements (centimetres 
moved by head and/or limbs)
Paired t-test
After transition
Type 1 Type 2 t-value p-value
0-0.5s 4.17 (0.35) 2.75 (0.31) 5.463 <.01 *
0.5-1.0s 2.82 (0.35) 1.96 (0.28) 3.687 <.01 *
1.0-1.5s 2.74 (0.32) 2.01 (0.17) 3.283 <.05 *
1.5-2.0s
Before transition
2.79 (0.20) 2.07 (0.21) 8.449 <.001 *
0-0.5s 5.23 (0.62) 2.26 (0.39) 7.161 <.001 *
0.5-1.0s 3.03 (0.30) 1.73 (0.29) 3.965 <.007 *
1.0-1.5s 2.77 (0.30) 1.58 (0.16) 2.984 <.05 *
1.5-2.0s 2.84 (0.28) 1.88 (0.16) 2.633 <.05 *
Data from the movement intensity and 8 Hz EEG power were combined and further analysed. 8 
Hz EEG power was higher for type 1 transitions compared to type 2 transitions 
[F(1,110)=103.227, p<0.001], as well as intensity of movement [F(1,110)=40.357, p<0.001]. 
Data of both 8 Hz EEG power and intensity of head and limb movements during sniffing 
behaviour were fitted in a regression analysis (Figure 5). Intensity of movement and 8 Hz EEG 
power correlated significantly [p<0.001] with R=0.453, explaining only 20.5% of the total 
variance. On the basis of the correlation between intensity of movement and 8 Hz EEG power, a 
covariance analysis was performed to establish whether the difference in 8 Hz EEG power could 
be attributed to differences in intensity of movement. The analysis of covariance with intensity 
of movement as covariate showed that the difference in 8 Hz EEG power during sniffing 
remained significant between transitions with a type 1 and type 2 behaviour [F(1, 109)=62.866, 
p<0.001]. Unstandardized residuals of the regression differed between type 1 and type 2 
transitions [F(1,110)=40.192; p<0.0001], showing that data points of type 1 transitions lay on 
average above the regression line (0.1, SEM 0.02) and data points of type 2 transitions on 
average under the line (-0.1, SEM 0.02).
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Intensity of movements
■ Type 1 transition □ Type 2 transition
Figure 5 Regression analysis o f intensity o f movements and 8 Hz power o f  sniffing.
For each rat, each time segment, and for both after and before transition, data points o f intensity o f  movements were 
plotted against 8 Hz EEG power o f sniffing. Transitions between sniffing and type 1 behaviour are represented by filled 
markers; transitions with type 2 behaviour are represented by open markers. Intensity o f  movements and 8 Hz EEG 
power were positively correlated; R=0.453. Data points o f type 1 transitions are on average above the regression line and 
data points o f  type 2 transitions on average under the regression line.
5.4 Discussion
The type of behaviour preceding and following a behavioural element influenced its spectral 
power. Transitions with either a type 1 or a type 2 behaviour modulated the RSA component. 
This modulating effect was shown during several types of behaviour. It was prominently present 
during sniffing and type 1 behaviour, and was less clearly found during type 2 behaviours. The 
duration of the effect made it evident that the effect could not solely be attributed to blurred 
starting or end points of behaviours. It has been reported that EEG appears to precede the EMG 
by 0.5s in the case of a spontaneous transition from standing to walking in dogs (Arnolds et al. 
1979). Our results showed a prolonged effect on RSA power, demonstrating a systematic 
modulation of hippocampal EEG correlates of behaviour by behavioural transitions.
This modulating effect on RSA power could contribute to the differences in EEG 
patterns between types of sniffing behaviour. The power spectrum of sniffing up resembled 
spectra of type 2 behaviour with regard to RSA peak power. In contrast, sniffing down and 
sniffing wall more closely resembled spectra of type 1 behaviour. This corresponds with 
observations made by Coenen (1975). Sequential analysis of behaviour showed that more 
transitions with type 2 behaviours relative to type 1 behaviours occurred in sniffing up compared 
to the other types of sniffing. Furthermore, a behavioural transition with a type 2 behaviour 
resulted in a lower RSA peak power than a transition with a type 1 behaviour. The combination 
of these two results would lead to the lower RSA power in the spectrum of sniffing up. It
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remains yet to be quantified to what extent the EEG effect of behavioural transitions could 
contribute to the differences in power spectra between types of sniffing relative to other putative 
influences. Such influences include differences in the level of automation or stereotypy between 
the sniffing behaviours (Coenen 1975), differences in motor patterns, and differences in the 
vigour of execution of head or paw movements that can occur concurrent with the sniffing 
(Vanderwolf & Robinson 1981).
A clear relationship between behaviour and hippocampal RSA has been amply 
demonstrated over the last decades. Our results indicate that in this relation, previous and 
following behaviour systematically modulate the RSA contents of the hippocampal EEG 
correlates of behaviour. The strong and systematic relation between hippocampal RSA and 
behaviour appears to be further modulated systematically by the behavioural-sequential context. 
Studies on hippocampal lesions have demonstrated the role of the hippocampus in sequential 
behaviour (Terlecki & Sainsbury 1978, Cannon et al. 1992). The modulating effect of 
behavioural transitions could indicate that the link between behavioural output and RSA is not as 
direct. Our results show different hippocampal EEG patterns (namely RSA) for the same 
visually scored behaviour in terms of movement patterns.
However, sniffing behaviour was not the same in terms of the intensity of movements 
of the head and paws. Concurrent with increased RSA power during sniffing for transitions with 
type 1 behaviour, increased intensity of head and paw movements during sniffing behaviour was 
demonstrated. It has been described that more vigorous movements are accompanied by higher 
amplitude RSA (Whishaw & Vanderwolf 1973). Our data confirm a positive correlation 
between EEG power at 8 Hz and the intensity of head and paw movements during sniffing. 
Therefore, differences in intensity of movement will have contributed to the transition effect. 
However, the percentage of variance explained by differences in movement intensity was low 
and covariance analysis showed that even when corrected for intensity of movements, transitions 
with type 1 behaviour still had a higher 8 Hz power. Thus, the higher 8 Hz power for transitions 
with type 1 behaviour can not be solely explained by the intensity of movements of head and 
paws during sniffing. A second factor seems to be involved, which is not dependent on the 
intensity of movements.
The estimate of only 20.5% of variance explained by intensity of motor movements is 
based on a linear association and assumes accurate measurement of actual intensity of motor 
movements. Movements were quantified by determining distances moved by the head and paws 
on a two-dimensional video screen, although movements are three-dimensional. Thus, distance 
moved could be underestimated, increasingly so for larger movements. At equal two­
dimensional movement scores, however, this underestimation should be equal. For the data 
points in the area of intensity scores between 0.47 and 0.60 (Figure 5), intensity scores are equal 
for type 1 and type 2 transitions. In this area, 8 Hz power still differs between the two groups. 
Thus, the higher 8 Hz EEG power for type 1 transitions will still hold, even if actual movements 
were underestimated. Video analysis of motor intensity, however, could not measure muscle
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tension that did not result in movement. With regard to the assumption of linearity, several non­
linear curves have been fitted on the data. Non-linear fits decreased R2, or only marginally 
increased R2 For example, an exponential relation rendered a R2 of 0.26 (0.20 for a linear 
association). The highest R2 was 0.30 for a 3rd order polynomial fit. However, this kind of 
association between 8 Hz power and movement intensity is hard to interpret. Thus, non-linear 
associations between 8 Hz EEG power and movement did not greatly influence the amount of 
variance explained by the association. Consequently, the suggested presence of a second factor 
that is independent of movement does not critically depend on the assumption of a linear 
association between 8 Hz EEG power and intensity of motor movements.
A likely possibility for a process that additionally contributes to the relationship 
between hippocampal theta and behaviour is a sensory process, in accordance with recent 
theories that relate hippocampal theta to sensory-motor mechanisms (Oddie & Bland 1998, 
Sainsbury 1998, Vanderwolf 2001). Bland and Oddie (2001) formulated a model that involves 
the hippocampal theta rhythm in mechanisms underlying sensory-motor integration. In this 
model, type 1 theta gives a direct indication of the level of activation of the motor systems 
involved in type 1 behaviour, whilst type 2 theta indicates the processing of sensory information. 
This type 2 theta is always coincidental with type 1 theta and provides the motor systems with 
continually updated feedback information on changing sensory conditions (Bland & Oddie
2001). The modulation of the hippocampal EEG correlates of behaviour by the sequential 
context, reported here, can be fitted to this sensory-motor integration model. Higher RSA power 
after or before a transition with a voluntary movement could indicate the contribution of sensory 
information processing in the form of type-2 theta. This is on the assumption that in the open 
field situation in these experiments more sensory information processing takes place in a 
sequence of voluntary movements (exploration) than in a sequence of type-2 behaviours.
The contribution of sensory processes to hippocampal theta in addition to motor 
activity could not only explain our data, but seems the more reasonable since complications with 
a simple motor movement hypothesis have repeatedly been reported. Many other species show 
obvious hippocampal theta during motionless vigilance states as well as during movement. 
Rabbits for example display trains of theta during immobility (Klemm 1971). Theta can be 
recorded from animals anaesthetized with ether (MacLean 1959) and theta appears in immobile 
rats just prior to a jump avoidance response (Vanderwolf 1969). Thus, our data confirm 
problems with a simple motor movement hypothesis and offer experimental support for the 
recent theories on a sensory-motor function of hippocampal theta.
Nevertheless, other processes could explain the data, for example a process that slowly 
changes the rat's brain state to increase both the probability of type-1 behaviour activity and the 
tendency for the production of theta rhythm. Our data cannot distinguish between the two 
possibilities, but these possibilities could well be one and the same process. Such a process as 
slowly changing brain states could operate by modulating the processing of sensory information. 
Thus, at behavioural transitions a second component of theta is revealed, reflecting the
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processing of sensory stimuli that are relevant to the initiation and maintenance of voluntary 
motor behaviours.
Another alternative is that higher order functions could, in addition to motor activity, 
contribute to the relationship between RSA and behaviour. However, it is not yet clear if these 
functions could contribute to RSA and through which specific mechanism. Higher order 
functions include attention (Wall & Messier 2001), memory (Redish 2001), spatial navigation 
and learning (Whishaw et al. 2001; Jarrard 1995), and anxiety (File et al. 2000).
To conclude, a systematic modulating effect of behavioural transitions on hippocampal 
EEG correlates of open field behaviour was shown. This indicates that the behavioural- 
sequential context modulates the relation between behaviour and hippocampal RSA. Results of 
the present studies suggest the presence of (at least) two superimposed processes in the 
relationship between hippocampal RSA and behaviour. In addition to the well-established 
relationship between RSA and motor activity, a second non-motor process appears to contribute 
to hippocampal RSA. A likely candidate is a sensory process, which is in accordance with 
theories on the sensory-motor function of the hippocampus and hippocampal EEG.
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Abstract
A relation between overt motor behaviour and hippocampal rhythmical synchronous activity 
(RSA, theta) has been amply demonstrated. Recently, experimental indications were found that a 
sensory process also contributes to hippocampal RSA by using a paradigm of behavioural 
transitions (Van Lier et al. 2003b). Modulation of the processing of sensory information could 
be relevant for the initiation and maintenance of motor behaviours. It was proposed that a similar 
transition effect could exist for cortical beta/gamma activity. Psychoactive drugs are known to 
interfere with behaviour, reactivity to the environment, and arousal levels amongst others. 
Therefore, it was studied whether psychoactive drugs influence the hippocampal theta transition 
effect and a hypothesised cortical beta/gamma effect. The study included a selection of 
antidepressant drugs with different mechanisms of action: citalopram (10 mg/kg), fluoxetine (10 
mg/kg), imipramine (10 mg/kg), and mirtazapine (2.5 mg/kg) as well as the anxiolytic diazepam 
(2.5 mg/kg) and the hypnotic zolpidem (2.5 mg/kg). A detailed behavioural and EEG study was 
performed, making use of the paradigm of behavioural transitions. Low doses of psychoactive 
drugs differentially modulated the hippocampal RSA transition effect. In drug-free conditions a 
transition effect for cortical beta/gamma activity could not be demonstrated, but it was 
consistently present under influence of diazepam. It is hypothesised, on the basis of our findings, 
that drugs that influence the transition effect (imipramine, zolpidem, diazepam) alter (sensory) 
information processing and thereby the reactivity to the environment. Furthermore, it is 
suggested that diazepam and zolpidem use the transition effect as an operandum to facilitate 
initiation of behavioural activity despite sedation.
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6.1 Introduction
The relation between hippocampal rhythmical synchronous activity (RSA, theta rhythm, 6-10 
Hz) in the EEG (Electroencephalogram) and moment-to-moment behaviour has been extensively 
studied in rats. These studies showed a clear relation between RSA and movement. Behaviour 
was classified accordingly as RSA related ‘type 1 behaviour’ (or ‘voluntary movement’), and 
‘type 2 behaviour’ (‘automatic movement’) and awake immobility that are not related to RSA 
(Coenen 1975, Vanderwolf 1969, 1992). However, in a recent study (Van Lier et al. 2003b), 
moment-to-moment behaviour was studied not as isolated events but as part of behavioural 
sequences. By using a paradigm of behavioural transitions indications were found for the 
existence of a sensory process, which also contributes to hippocampal RSA. This is in 
accordance with theories and data that claim that the hippocampus is involved in more than mere 
motor execution. Rather, hippocampal RSA is thought to be involved in the integration of 
sensory and motor information (Bland & Oddie 2001), which could serve as basis for 
hippocampal functions such as spatial navigation and memory (for reviews see Jarrard 1995, 
Redish 2001, Whishaw et al. 2001).
The study of behavioural transitions (Van Lier et al. 2003b) showed a modulating effect 
of previous and subsequent behaviour on the RSA correlates of behaviour. Previous or following 
behaviour influenced the RSA content of a specific behaviour; RSA power during a behavioural 
element was increased before or after a transition with a type 1 behaviour compared to the RSA 
power during the same behavioural element before or after a transition with a type 2 behaviour. 
This modulating effect was demonstrated even when compensated for overt motor activity. 
Thus, it was suggested that an additional, putative sensory process contributes to hippocampal 
RSA. Modulation of the processing of sensory information could be relevant for the initiation 
and maintenance of motor behaviours (Van Lier et al. 2003b).
Diazepam and zolpidem show a remarkable increase in cortical beta/gamma activity 
(Coenen & Van Luijtelaar 1991, Krijzer et al. 1993, Van Rijn & Jongsma 1995, Visser et al. 
2003a), which has been suggested to be necessary for the initiation and maintenance of active 
behaviour (Van Lier et al. 2004). Cortical beta/gamma activity is seen as an index for 
behavioural activity, similar to hippocampal theta activity (Vanderwolf 1992). Furthermore, 
theta activity is often associated with superimposed high frequency oscillations, which is 
thought to be involved in information processing (Bragin et al. 1995, Chrobak & Buzsaki 1998, 
Orban et al. 2001). Thus, the question arose if a transition effect, similar to hippocampal theta, 
can be found for cortical beta/gamma activity.
To further investigate the 'transition effect', the influence on this effect of a number of 
psychoactive drugs was studied in rats. Psychoactive drugs are known to influence behaviour, 
reactivity to the environment, and arousal levels amongst others. Thus, they can be hypothesised 
to influence the transition effect. The drugs in this study included the antidepressants citalopram 
(10 mg/kg), fluoxetine (10 mg/kg), imipramine (10 mg/kg), mirtazapine (2.5 mg/kg), and the
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anxiolytics diazepam (2.5 mg/kg) and zolpidem (2.5 mg/kg). Drug doses were chosen at the 
minimal dose that induces changes in rat behaviour. These drugs show diverging mechanisms of 
actions and influences on behaviour and EEG, which had been studied previously (Van Lier et 
al. 2004). Furthermore, some of these drugs are known to reduce RSA frequency. Thus, if the 
transition effect is really linked to RSA, reduction of RSA frequency by drugs should be 
concomitant with a reduction in the frequency at which the transition effect can be found. 
Because these drugs and their effects are largely known, possible influences on the transition 
effect could provide more information on the prerequisites for occurrence of this phenomenon as 
well as its underlying neuro-pharmacological mechanisms.
In our original study the transition effect was shown for all types of behaviour in rats 
but most consistently for sniffing behaviour, further supporting the idea of sensory processing. 
Therefore, we limited analysis of the transition effect in this study to sniffing behaviour. 
Differences between EEG spectra during sniffing behaviour before or after a transition with 
either a type 1 or a type 2 behaviour were studied. Three questions were addressed. Firstly, is the 
transition effect a real RSA effect? If so, drugs that influence RSA frequency should 
correspondingly influence the frequency at which the transition effect can be found. Secondly, is 
there a similar transition effect for cortical beta/gamma activity? And lastly, do psychoactive 
drugs influence the hippocampal theta transition effect and a hypothesised cortical beta/gamma 
effect? If so, do they do this differentially for their mechanism of action? This could provide 
more information to reflect on the role and interplay of hippocampal theta and cortical 
beta/gamma activity in information processing and behavioural activation and the underlying 
neuro-pharmacological mechanisms.
6.2 Methods
Animals
Experiments were conducted in accordance with animal legislation. Male Long-Evans rats were 
obtained from Harlan (Bicester, UK). Animals were housed individually in macrolon cages with 
ad-libitum access to water and food and maintained on a reversed light/dark cycle (12/12 h).
Surgical procedure
Surgery was performed under isoflurane anaesthesia. The rat was placed in a stereotaxic 
apparatus (Kopf instruments) with bregma and lambda in the same horizontal plane. Local 
analgesic (Lidocaine) was applied to the exposed tissue of the head. Rats were instrumented 
with bipolar recording electrode sets bilaterally in three cortical areas and bilaterally in the 
dorsal hippocampus. The two wires of the bipolar electrode sets were separated 1 mm 
horizontally for cortical electrodes, and 1 mm vertically for hippocampal electrodes. Coordinates 
are based on Paxinos & Watson (1986) and are given for the cortex for the most frontal
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electrode in the right hemisphere (anterior/posterior to bregma; lateral to midline in mm.): 
frontal (+4.2; +1.0), parietal (-1.2; +4.5), occipital (-4.3; +3.0). Coordinates for the hippocampus 
are given for the deepest electrode in the right hemisphere (anterior/posterior to bregma, lateral 
to midline, ventrally from skull surface, in mm.): (-4.0; +2.0; -3.0). An epidural screw served as 
ground electrode. Electrodes (stainless steel annealed / triple ML insulation wire, diameter 0.004 
mm (California Fine Wire Company) connected to a pin (ITT Cannon; 031-9540-000) with a 
small insert (track pins; Display Elektronica NL; 04.11.T1559) (Typical resistance 7.5 (SE 0.1) 
kQ), were inserted and fixated with superglue (Cyanolit) and dental cement. All electrode pins 
were fitted into an 18-hole connector (ITT Cannon; CTA3-IS-53). The electrodes and connector 
were embedded in dental cement, and the tissue was sutured.
Histological verification
For histological verification of electrode placement, the rats were perfused and brains fixated 
with a 4% paraformaldehyde, 0.1 M phosphate buffer. Brain slices of 100 ^m were cut using a 
vibratome and stained with Cresyl violet. Data from both the left and right brain hemisphere 
were used in the analysis.
Drugs
Rats were injected intraperitoneously 30 minutes before testing with fluoxetine (10 mg/kg, 
n=10), mirtazapine (2.5 mg/kg, n=9), citalopram (10 mg/kg, n=7), imipramine (10 mg/kg, n=8), 
zolpidem (2.5 mg/kg, n=8), or diazepam (2.5 mg/kg, n=8). All drugs were dissolved in saline 
(0.9% NaCl) with 5% mulgofen, except for zolpidem (no mulgofen added) and diazepam 
(needed to be dissolved in Intralipid (15%)). Control groups were added that received an equal 
volume of each solvent, in order to separate possible effects of the solvent from drug effects 
(saline with 5% mulgofen (n=17), saline (n=8), Intralipid (n=6)). For each vehicle and each 
drug a different group of rats was used. Drug and vehicle could not be tested within the same rat, 
because repeated exposure to the open field would have caused marked differences in behaviour 
due to decreased novelty. Fluoxetine (fluoxetine hydrochloride) and zolpidem were obtained 
from Tocris Cookson Ltd, Bristol UK. Imipramine (imipramine hydrochloride) was obtained 
from Sigma-Aldrich, Zwijndrecht the Netherlands, diazepam from Dumex BV, Baarn the 
Netherlands and intralipid from Fresenius Kabi the Netherlands BV, 's-Hertogenbosch. 
Mirtazapine was supplied by Organon Laboratories Ltd, Newhouse UK, and citalopram 
(citalopram hydrobromide) by Lundbeck, Copenhagen Denmark.
Behavioural data acquisition
Rats recovered for at least 2 weeks after surgery before behavioural data collection and EEG 
recording at the age of 14-18 weeks. Behavioural data were acquired individually in an enriched 
open field, which was cleaned with ethanol (80 %) between sessions to prevent rats using 
olfactory cues left during the previous session. The observations lasted 25 minutes per animal
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and were carried out under red light conditions between the 2nd and the 5th hour of the dark 
period to minimize the influence of circadian fluctuations in behavioural activity.
Open field
The open field (black plastic, 1 m x 1 m x 0.4 m) had clear acrylic glass on one side to allow 
camera side view. The open field was enriched with a fixed amount of food, access to the spout 
of a drinking bottle and an object that could freely be explored, but not displaced by the animal 
(pyramidal shaped, glass object, 6 x 6 x 11.5 cm).
Behavioural Scoring
Behavioural epochs were recorded on two cameras placed at side and top view of the animal and 
scored off-line using the Observer Video-Pro (Noldus Information Technology, the Netherlands) 
(Noldus et al. 2000) with a time resolution of 0.04s. Twenty-five behavioural elements were 
scored (Van Lier et al. 2003a). Behavioural elements were placed into one of the following 
categories: type 1 behaviour, type 2 behaviour, or sniffing behaviour. Type 1 behaviour included 
walking, running, hopping, exploratory walking, climbing, rearing, rearing supported, rearing 
object, and manipulating food. Type 2 behaviour included eating, drinking, face washing, body 
grooming, genital grooming, scratching and sitting. Sniffing behaviour included sniffing object, 
sniffing up, sniffing down, sniffing wall and sniffing food. The three remaining behavioural 
elements that were not placed into one of these three categories were not relevant for further 
analysis.
EEG data acquisition
Bipolar recordings were obtained. Signals were filtered High Pass 1 Hz and Low Pass 100 Hz. 
Digitisation (sampling rate 1024 Hz) and data recording were done using a Windaq (Dataq 
Instruments) acquisition system.
Analysis EEG data
The EEG and behavioural file were synchronized with a resolution of 0.04 sec. A computer 
program segmented the EEG according to the files with behavioural scoring. Corresponding 
EEG segments of sniffing epochs could be selected with specification of preceding or following 
behaviour. EEG segments of 1 sec. were not overlapped, generating a power spectrum with a 1 
Hz resolution. EEG of behavioural epochs <2 sec. was discarded and epochs >2 sec. were 
divided into two consecutive segments of 1 sec. For analysis after behavioural transition, the 
beginning of the first segment was synchronous with the behavioural transition and EEG was 
analysed up to 2 sec. after transition. For analysis before transition, the ending of the first 
segment was synchronous with the transition and the second segment ended at the beginning of 
the first segment. Due to limited numbers of behavioural segments longer than two seconds, the 
effect was not analysed longer than 2 seconds.
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For each rat and each hemisphere an average power spectrum was generated. For the analysis of 
the hippocampal transition effect, complete power spectra were used with a resolution of 1 Hz. 
Because of possible influences of drug treatment on absolute power, relative power spectra were 
used in the analysis. For the analysis of the cortical beta and gamma transition effect, spectral 
power was summed into bands. Band definitions were used as described in Van Lier et al 
(2003a) with beta-3: 21-30 Hz, and gamma (fast oscillations): 31-100 Hz.
Statistical analysis
The existence of a transition effect was, in our previous study, shown at peak RSA frequencies 
(Van Lier et al. 2003b). As some drugs used in this study are known to reduce RSA peak 
frequency, frequency of the peak power difference was determined for each treatment. The 
presence of the effect was tested at the frequency of peak power difference. Because of possible 
differences in peak RSA frequency between a transition with a type 1 behaviour and a type 2 
behaviour, it was additionally tested whether the transition effect was due to a difference in RSA 
peak power or to a difference in RSA peak frequency. Therefore, power differences between 
transition with type 1 and with type 2 behaviour were also tested at individual peak RSA power. 
The presence of the transition effect was tested with a General Linear Model (GLM), Repeated 
Measures, with time segment as between-subject factor. Possible differences between control 
groups (different solvents) were tested (GLM) and as no differences between control groups 
were demonstrated, controls were grouped for further analysis. Treatment effects on the 
transition effect were statistically tested for each treatment to the grouped control. Possible 
influences of time segment (0-1s or 1-2s before/after transition) were included in the analysis 
(GLM)(SPSS 10). Due to the large number of data, complete F-statistic tables are not given for 
each analysis, but only relevant outcomes.
6.3 Results
Hippocampal EEG
6.3.1 Transition effect (Figure 1)
An example of the transition effect in the hippocampal EEG for a control group is given in 
Figure 1. EEG power at 8 Hz during sniffing behaviour was increased at a transition with type 1 
behaviour compared to a transition with type 2 behaviour [t(11)=4.40, p<.01]. For each 
treatment, power spectra were compared at each frequency and the maximum in difference in 
power (Figure 2a) and its frequency (Figure 3) determined. All treatments showed a transition 
effect before and after transition over both time segments (main effect, no interaction with time 
segment) (F-statistics are given in Table 1). Controls were grouped, as there was no difference
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between groups (before transition: group*time segment interaction [F(3,64)=0.9, p=.42] group 
effect [F(3,64)=2.4, p=0.07]; after transition: group*time segment interaction [F(3,80)=0.3, 
p=.80] group effect [F(3,80)=0.9, p=0.44]).
Frequency (Hz)
Frequency of transition effect 
(Figure 3)
Figure 1 The transition effect under a control condition. Power at 8 Hz during sniffing behaviour was increased when 
a transition with a type 1 behaviour occurred compared to a transition with a type 2 behaviour. A * marks a significant 
difference (p<.05). In addition, the figure depicts the parameters that are shown in figures 2a, 2b and 3.
Table 1 F-statistics o f  the existence o f a transition effect in drug and control groups (*=significant effect).
Treatment Before transition 
(main effect)
After transition 
(main effect)
Control
Fluoxetine
Mirtazapine
Citalopram
Imipramine
Diazepam
Zolpidem
F(1,70)=236.4, p<.001 * 
F(1,18)=81.8, p<.001 * 
F(1,30)=88.6, p<.001 * 
F(1,12)=24.5, p<.001 * 
F(1,18)=76.1, p<.001 * 
F(1,18)=21.9, p<.001 * 
F(1,22)=99.1, p<.001 *
F(1,86)=93.6, p<.001 * 
F(1,23)=70.6, p<.001 * 
F(1,27)=41.4, p<.001 * 
F(1,16)=26.4, p<.001 * 
F(1,22)=71.8, p<.001 * 
F(1,18)=30.1, p<.001 * 
F(1,18)=128.9, p<.001 *
6.3.2 Drug effects on the transition effect 
Effects on magnitude of the transition effect (Figure 2a)
Before transition
Effects of the drugs on the magnitude of the transition effect (maximum power difference) did 
not depend on the time segment. Therefore, the data shown are combined for both time
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segments. Magnitude of the transition effect was reduced in citalopram [F(1,82)=13.6, p<.001], 
while mirtazapine [F(1,100)=22.0, p<.001], imipramine [F(1,88)=5.9, p<.05], and zolpidem 
[F(1,92)=42.4, p<.001] increased the magnitude of the transition effect. Magnitude of the 
transition effect was not influenced by fluoxetine and diazepam.
After transition
Zolpidem increased the magnitude of the transition effect at 0-1 sec., but not 1-2 sec. after 
transition (zolpidem: time segment interaction [F(1,104)=8.2, p<.01], post-hoc for 0-1 sec. 
[F(1,52)=22.0, p<.001]). The other drugs did not influence the magnitude of the after-transition 
effect.
Figure 2 a & b Effects o f  drugs on the magnitude o f the transition effect are depicted. The transition effect is 
depicted as the difference in power in EEG spectra during sniffing between a transition with a type 1 behaviour and a 
transition with a type 2 behaviour. In a) the two spectra were compared and the maximal difference and its frequency 
determined (for the frequency data see figure 3). In b) the two spectra were compared and the difference in power 
determined at peak RSA power (see also figure 1). The effect both before and after transition is depicted. Asterisks (*) 
above bars represent significant differences (p<.05) in power o f the transition effect between the treatment group and its 
corresponding control group. Filled bars represent effects on both time segments (0-1 and 1-2 sec. before/after 
transition). Hatched bars represent effects that were significant at the first time segment (0-1 sec.) only.
Effects on the EEG frequency of the transition effect (Figure 3)
The frequency in the EEG spectrum of sniffing, for which the maximum difference in power 
between type 1 and type 2 transitions was found, was termed frequency of transition effect. Data 
of before and after transitions were grouped. Controls were grouped, as there was no difference 
between control groups in the frequency of the transition effect [F(3,156)=0.9, p=0.45]. The 
EEG frequency of the transition effect was reduced by diazepam [F(1,198)=65.6, p<.001] and 
zolpidem [F(1,202)=27.5, p<.001] (Figure 3, x-axis). This reduction in frequency of the 
transition effect coincided with a reduction in peak RSA frequency during sniffing for both these 
drugs (Figure 3, y-axis). (Diazepam [F(1,198)=366.1, p<.001] and [F(1,198)=102.5, p<.001] at 
type 1 and type 2 transition respectively; zolpidem [F(1,202)=172.7, p<.001] and 
[F(1,202)=137.1, p<.001] at type 1 and type 2 transition respectively). The frequency at which
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the transition effect was maximal showed a close relationship with the peak RSA frequency. For 
each treatment, the frequency of maximum transition effect was plotted against peak RSA 
frequency and a linear regression performed (Figure 3). Data for before and after transition and 
for both time segments were averaged, but split for RSA frequency during sniffing at type 1 
(filled symbols) or type 2 (open symbols) transitions. The slope of the linear regression for the 
type 1 transitions did not differ from the type 2 transitions [F(1,10)=0.4, p=0.53]. Therefore 
linear curves were fitted with the same slope for both, giving R2=0.96 for type 1 transitions and 
R2=0.79 for type 2 transitions. The frequency of maximum transition effect varied with RSA 
frequency and the transition effect occurred approximately at peak RSA frequency. However, 
the intercepts of the fitted lines did differ between type 1 and type 2 transitions [F(1,11)=5.2, 
p<. 05]. Thus, peak RSA frequency was lower for type 2 transitions than type 1 transitions. 
Therefore, the hypothesis was subsequently tested if the transition effect was caused by a shift in 
peak RSA frequency between type 1 and type 2 transitions.
Control
Mirtazapine
Imipramine
Fluoxetine
Citalopram
Zolpidem
Diazepam
Frequency of transition effect (Hz)
Figure 3 Frequency o f  the transition effect and hippocampal RSA peak frequency are plotted against each other. For 
each treatment (given on the x-axis) the frequency at which the transition effect was maximal (x-axis) is plotted against 
hippocampal RSA peak frequency o f  sniffing (y-axis) at type 1 transitions (filled symbols) and at type 2 transitions 
(open symbols). A linear curve was fitted with R2=0.96 for type 1 transitions and R2=0.79 for type 2 transitions.
6.3.3 The transition effect: power difference versus peak shift (Figure 2b)
Power differences between type 1 and type 2 transitions were tested at peak RSA power of each 
transition type. Controls were grouped, as there was no difference between groups (before 
transition: group*time segment interaction [F(3,64)=1.4, p=.27] group effect [F(3,64)=2.0, 
p=0.13]; after transition: group*time segment interaction [F(3,80)=0.8, p=.52] group effect 
[F(3,80)=0.9, p=0.46]).
Before transition
When peak RSA power during sniffing is compared between before a transition with a type 1 
behaviour and a type 2 behaviour, the transition effect remained for the control group over both
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time segments, although power of the transition effect was reduced [F(1,71)=83.2, p<.001]. For 
all treatments except citalopram the transition effect was still demonstrated over both time 
segments (F-statistics given in table 2). Effects of the drugs on the magnitude of the transition 
effect did not depend on the time segment. Magnitude of the transition effect remained increased 
by imipramine [F(1,88)=5.8, p<. 05] and zolpidem [F(1,92)=37.5, p<.001]. Mirtazapine now 
increased power only during the first time segment (interaction with time segment 
[F(1,100)=4.5, p<.05], post hoc for first time segment [F(1,49)=7.3, p<.01]). Additionally, 
diazepam now did increase the magnitude of the transition effect [F(1,88)=17.9, p<.001].
After transition
When peak RSA power during sniffing was compared between after transition with a type 1 
behaviour and a type 2 behaviour, the transition effect was present only in the first time segment 
in control groups with reduced power [F(1,43)=33.6, p<.001]. For drug treated groups, the 
transition effect was still present in the first time segment for fluoxetine, imipramine, and 
zolpidem only (F-statistics given in table 2). Imipramine [F(1,54)=4.2, p<. 05] and zolpidem 
[F(1,52)=22.0, p<.001] increased the power of the transition effect at 0-1s after transition.
Table 2 F-statistics o f  the existence o f  a transition effect in drug and control groups at peak RSA power (*=significant 
effect).
T reatment Before transition After transition
(main effect)
(interaction effect with (main effect at 0-1 sec.)
time segment)
Control F(1,70)=24.3, p<.001 * F(1,86)=6.8, p<.05 * F(1,43)=11.7, p<.001 *
Fluoxetine F(1,18)=12.1, p<.01 * F(1,23)=6.2, p<.05 * F(1,12)=9.8, p<.01 *
Mirtazapine F(1,30)=11.1, p<.01 * F(1,27)=2.5, p=.12 not performed
Citalopram F(1,12)=1.1, f =.31 F(1,16)=0.3, p=.24 not performed
Imipramine F( 1, 18)=12.9, p<.01 * F(1,22)=14.8, p<.001 * F(1,11)=67.5, p<.001 *
Diazepam F(1,18)=18.4, p<.001 * F(1,18)=.05, p=.83 not performed
Zolpidem F( 2 ) = CO 3, p<.001 * F(1,18)=16.7, p<.001 * F(1,9)=27.7, p<.001 *
At the individual rat level, only few rats (20.6%) showed the same frequency for all three 
frequency parameters: peak RSA frequency at transitions with type 1 behaviour, with type 2 
behaviour, and frequency of the maximal transition effect. In 31.3% of the cases the frequency 
was the same for the maximum transition effect and peak RSA frequency at type 1 transitions, 
while both were higher than the frequency at type 2 transitions. In 21.9% of the cases, the 
frequency of the maximum transition effect was higher than the peak RSA frequency of both 
types of transitions.
Therefore the present findings indicate that the transition effect can be attributed to both a 
frequency shift and power difference.
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6.3.4 Specificity of RSA increase
For drugs that influenced the power of the transition effect at peak RSA, it was tested if this 
increase was due to a generally increased RSA power or a transition-type specific increase. For 
the before-transition effect, imipramine, diazepam and zolpidem selectively increased RSA 
power at type 1 transitions, but not type 2 transitions. Mirtazapine increased RSA power at both 
transitions. For the after transition effect, zolpidem increased RSA power selectively at type 1 
transitions. The influences on RSA power were not significant for imipramine. Data and 
statistics are given in table 3.
Table 3 Effects on RSA power (*=slgnlficantly different from control).
Treatment Transition Drug Control F-statistics
Before transition 
Mirtazapine (0-1s) Type 1 25% (0.03) 14% (0.01) F(1, 49)=20.8, p<.001 *
Type 2 19% (0.02) 12% (0.01) F(1,49)=17.2, p<.001 *
Imipramine Type 1 18% (0.01) 15% (0.01) F(1,90)=6.9, p<.01 *
Type 2 13% (0.01) 12% (0.01) F(1,90)=0.3, p=.58
Diazepam Type 1 20% (0.02) 15% (0.01) F(1,90)=9.6, p<.01 *
Type 2 13% (0.01) 12% (0.01) F(1,90)=.005, p=.941
Zolpidem Type 1 24% (0.02) 15% (0.01) F(1,94)=33.1, p<.001 *
Type 2 14% (0.01) 12% (0.01) F(1,94)=1.0, p=.31
After transition 
Imipramine (0-1s) Type 1 20% (0.02) 18% (0.01) F(1,54)=0.8, p=.39
Type 2 12% (0.01) 14% (0.01) F(1,54)=0.7, p=.41
Zolpidem (0-1s) Type 1 27% (0.02) 18% (0.01) F(1,52)=9.4, p<.01 *
Type 2 16% (0.01) 14% (0.01) F(1,52)=0.5, p=.50
Cortical EEG
6.3.5 Beta transition effect
In control groups, no consistent transition effect could be demonstrated for power in the 21-30 
Hz (beta-3) and 31-100 Hz (gamma) frequency bands for relative or absolute power. The only 
drug that showed a systematic transition effect, on both bands and both before and after 
transition, was diazepam (Figure 4) (beta-3: before [F(1,77)=7.9, p<.01], after [F(1,77)= 29.4, 
p<.001]; gamma: before [F(1,77)=16.0, p<.001], after [F(1,77)=19.7, p<.001]), most obviously 
for absolute power. The differences in power were larger than in the control group (beta-3: 
before [F(1,368)=26.8, p<.001], after [F(1,372)=89.1, p<.001]; gamma: before [F(1,368)=34.4, 
p<.001], after [F(1,)372=22.3, p<.001]). In addition, fluoxetine, mirtazapine and zolpidem 
induced an increased difference in power for some cases.
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It was tested whether the increase in the transition effect by diazepam was due to a general 
increase in power or to a selective increase. For gamma band activity, power was increased by 
diazepam compared to control for sniffing behaviour in association with type-1 behaviour only 
(Before: type 1 transition [F(1,370)=6.3, p<.05], type 2 transition [F(1,370)=0.4, p=.54]; after: 
type 1 transition [F(1,374)=5.3, p<.05], type 2 transition [F(1,374)=1.3, p=.25]). For beta band 
activity, power was increased for both type 1 and type 2 transitions. However, this increase was 
much larger before/after a type 1 transition (after transition 244% increase at type 1 transition 
compared to 168% at type 2 transition, before transition 225% versus 185%).
Figure 4 Cortical high frequency transition effect. The transition effect is depicted as the difference in power during 
sniffing between a transition with a type 1 behaviour and a transition with a type 2 behaviour, for the 21-30 Hz (beta-3) 
and 31-100 Hz (gamma) band. The effect both before and after transition is shown. Data are for 0-2 sec. before/after 
transition. Asterisks (*) in the bottom of bars represent significant transition effects. Asterisks (*) above bars represent 
significant differences (p<.05) in power o f the transition effect between the treatment group and the grouped control 
group.
6.4 Discussion
The hippocampal transition effect described in Sprague-Dawley rats (Van Lier et al. 2003b) was 
also demonstrated in the present experiments in Long-Evans rats. The EEG power spectra during 
one and the same behaviour differ upon previous and following behaviour. Thus, the 
behavioural sequential context modulates the EEG correlates of behaviour. The transition effect 
was demonstrated at hippocampal theta frequencies. Furthermore, drugs that reduce 
hippocampal theta frequencies also reduced the frequency at which the transition effect was 
maximal. Thus, one finding in this paper is the confirmation of the presence of a transition effect 
(Van Lier et al. 2003b) and moreover that this effect is maximal at theta frequencies in the 
hippocampal EEG.
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The hippocampal transition effect consisted of a difference in theta activity, partly in 
power and partly in frequency, between a type 1 and a type 2 transition. Shifts in theta peak 
frequency have been implied in the initiation of movements, and a 'triggering' frequency for 
movement has been suggested (Bland 1986, Vanderwolf 1969). Furthermore, frequency changes 
are considered as a critical index of the influence of synchronizing brain sites (brainstem, 
reticular formation) in modulating the excitability of hippocampal formation neurons involved in 
theta generation (Bland 1986, Vertes 1981).
The transition effect for hippocampal RSA was consistently present in control groups. 
Although there were indications for a transition effect for cortical high frequency EEG activity 
(in particular gamma activity), this could not be consistently demonstrated in all control groups. 
Thus under drug free conditions, prior to or after the occurrence of a specific behavioural 
element, beta/gamma activity is not modulated. The transition effect has been suggested to be 
indicative of changes in sensory processing, which can be involved in the initiation and 
maintenance of active behaviour (Van Lier et al. 2003b). If so, at least initiation of moment-to- 
moment behavioural activity seems to be regulated more through a hippocampal RSA 
mechanism than through beta/gamma cortical activation. Cortical beta/gamma activity could be 
more related to general arousal levels, rather than moment-to-moment behaviour (Vanderwolf 
1990).
A further notable finding of this study is that psychoactive drugs affect the transition 
effect. Diazepam induced a cortical beta/gamma transition effect. The hippocampal theta 
transition effect was preserved under psychoactive drug administration. Furthermore, these 
drugs differentially affected the power of the theta transition effect in a bimodal way. 
Citalopram and mirtazapine influenced the theta transition effect by affecting hippocampal RSA 
power for both a type 1 and type 2 transition. In contrast, imipramine and zolpidem selectively 
increased hippocampal RSA for a type 1 transition, but not a type 2 transition. Thus only for the 
latter two drugs, there seems to be a specific enhancement of the theta transition effect rather 
than a general effect on hippocampal RSA.
From the data inferences can be made on two fronts: firstly, how neuro- 
pharmacologically the transition effect can be modulated, and secondly the functional 
significance of the phenomenon. Hippocampal RSA has both a serotonergic and a cholinergic 
component (Kramis et al. 1975, Lopes da Silva et al. 1990). Furthermore, RSA is under GABA- 
ergic modulation (Smythe et al. 1992). Thus, both the serotonergic and GABA-ergic drugs could 
be expected to affect the hippocampal RSA and thereby the theta transition effect.
Of the drugs tested, citalopram increases extracellular 5-HT levels most specifically as 
it is considered the most selective serotonin reuptake inhibitor (SSRI) (Felton et al. 2003, Owens 
et al. 1997, Tatsumi et al. 1997). Serotonergic modulation seemed restricted to a general effect 
on RSA rather than a specific effect on the theta transition effect. Thus, regarding the transition 
effect, it seems that type 1 RSA is not modulated (serotonergic in origin). Then type 2 RSA, 
which is thought to be involved in information processing (Bland & Oddie 2001), should be
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modulated. If so, this would further support the idea that the transition effect shows the sensory 
information processing aspect of hippocampal RSA (Van Lier et al. 2003b). However, one 
would expect the SSRI fluoxetine to have shown similar effects.
Imipramine affects levels of both noradrenaline (Ordway et al. 1997) and 5-HT (Felton 
et al. 2003). Zolpidem influences GABAa receptor transmission (Langer et al. 1992). Therefore 
it is not likely that these two drugs use the same mechanism in influencing the theta transition 
effect, but they could differentially manipulate a common end pathway. By indirect modulation 
of hippocampal RSA through noradrenaline and GABA respectively, imipramine and zolpidem 
could exert their effect on the theta transition effect.
Like zolpidem, diazepam is an allosteric modulator of the GABAa receptor complex. 
However, diazepam did not show such a marked increased theta transition effect but did instead 
show a consistent and striking cortical beta/gamma transition effect. Sedative benzodiazepines 
increase cortical beta activity (Coenen & Van Luijtelaar 1991, Krijzer et al. 1993, Van Rijn & 
Jongsma 1995, Visser et al. 2003a) and GABA is known to modulate the amplitude of gamma 
oscillations (Whittington et al. 2000a). Zolpidem is selective at a1 subunit containing GABAa 
receptors (Langer et al. 1992), while diazepam is non-selective. Possible differences between 
diazepam and zolpidem in enhancing either the hippocampal theta or cortical beta/gamma 
transition effect could perhaps be related to this difference in receptor selectivity.
The functional significance of the transition effect and the drug effects hereon deserve 
some speculation, although available literature is yet limited. The transition effect demonstrates 
that theta and/or beta/gamma activity is elevated before a type 1 behaviour, compared to a type 2 
behaviour. Theta and beta/gamma oscillations are thought to form a system for information 
processing (Bragin et al. 1995, Chrobak & Buzsaki 1998, Orban et al. 2001). The processing of 
sensory stimuli is relevant for the initiation and maintenance of type 1 behaviours (Bland & 
Oddie 2001). Psychoactive drugs can cause alterations in information processing (Brioni & 
Arolfo 1992, Clifford & Buchman 2002, d'Ardhuy et al 1999, Jongsma et al. 1998). It can 
therefore be hypothesised that drug influences on a theta and/or beta/gamma transition effect are 
expressions of alterations in (sensory) information processing and that this information 
processing is relevant for the initiation of behaviour. Functional differences between the two 
transition effects and between the theta and beta/gamma oscillations can be supposed, as a theta 
transition effect could be demonstrated but not a beta/gamma transition effect under drug-free 
conditions. If so, the differences between psychoactive drugs in their influence on a theta or 
beta/gamma transition effect could indicate differences in altering information processing.
For diazepam and zolpidem altered information processing could be relevant for the 
initiation of active behaviour despite pharmacologically induced sedation. Both are sedative and 
showed a large increase in the transition effect. The increased theta or beta/gamma activity prior 
to or after a transition with a type 1 behaviour could make initiation and continuation of the 
behaviour possible despite this sedation. While a beta transition effect is not used in drug-free 
conditions, it could be an important mechanism while under influence of diazepam.
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In summary, the hippocampal RSA transition effect described by Van Lier et al. 
(2003b) was replicated and shown to be preserved and differentially modulated by psychoactive 
drugs. A transition effect for cortical beta/gamma activity could not be demonstrated in drug- 
free conditions, but was largely present under influence of diazepam. It is hypothesised that 
drugs that influenced the transition effect (imipramine, zolpidem, diazepam), alter the processing 
of (sensory) information. Furthermore, it is suggested that diazepam and zolpidem use the 
transition effect to facilitate initiation of behavioural activity despite pharmacologically induced 
sedation.
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The aim of this thesis was to describe how spontaneous and pharmacologically induced activity 
is represented in EEG activity and, vice versa, how behavioural activity is determined by 
spontaneous and pharmacologically induced EEG activity. This was introduced in chapter 1. 
Chapters 2 and 5 address the question whether spontaneous differences in the level of activity 
can influence the representation of behaviour in EEG activity. Chapters 3, 4 and 6 deal with the 
influence of pharmacological agents on the representation of behaviour in the EEG. A number of 
more specific questions were formulated and answered in the chapters 2 through 6 in this thesis, 
namely:
A) Are physiological differences in behavioural activity, as studied by means of different 
rat strains, reflected in the representation of behaviour in the EEG? (Chapter 2)
B) Is there an interaction between psychoactive drug effects on the EEG and behaviour? 
(Chapters 3 and 4)
C) What is the nature of the dissociation of the relationship between EEG and behaviour 
under GABAa receptor modulation? (Chapter 3)
D) Are spontaneous differences in behavioural activity, as studied by means of behavioural 
transitions, reflected in the representation of behaviour in the EEG? (Chapter 5)
E) Do psychoactive drugs influence the modulating effect of behavioural transitions on the 
relationship between EEG and behaviour? (Chapter 6)
7.1 Main findings
Whether naturally existing differences in activity levels are reflected in the representation of 
behaviour in the EEG was studied by means of rat strains in chapter 2. A strong relationship 
between behaviour and EEG activity has been demonstrated, especially for hippocampal EEG 
activity. This relation is known to be similar across species and strains, but to date no direct 
comparisons between rat strains within one study have been made. The study described in 
chapter 2 compared two rat strains (Sprague-Dawley and Long-Evans) with regard to open field 
behaviour and concurrent hippocampal EEG recordings. It was expected that these two strains 
would differ in exploratory activity in the open field. In this way, the question was addressed 
whether differences in levels of behavioural activity are reflected in the representation of 
behaviour in the EEG. The two strains differed in exploratory activity and in spectral power in 
the 9-10 Hz frequency band (high frequency RSA (Rhythmical Slow Activity 6-10 Hz)). Long- 
Evans rats showed higher levels and intensity of exploratory activity and higher 9-10 Hz spectral 
power specifically for voluntary movement and sniffing behaviours. Thus, these behaviour- 
specific strain differences in RSA power demonstrated that differences in activity levels are 
reflected in the representation of these behaviours in the EEG.
Whether manipulation of activity levels by pharmacological agents is reflected in the 
representation of behaviour in the EEG was studied by means of two classes of psychoactive
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drugs: anxiolytics / sedatives (chapter 3) and antidepressants (chapter 4). Chapter 3 focussed on 
the pharmacological dissociation of the relation between EEG activity and behaviour, described 
for the benzodiazepines. While a decrease in high frequency EEG activity is associated with a 
decrease in arousal in drug-free conditions, sedative benzodiazepines increase beta activity. 
Non-benzodiazepine GABAa modulators can increase beta activity as well. By employing the 
more detailed analysis of behaviour with concurrent EEG recording, a method central to this 
thesis, this study attempted to provide more information on the nature of the paradoxical 
relationship between rat behaviour and EEG under GABAa receptor modulation. Both a 
benzodiazepine (diazepam) and non-benzodiazepine (zolpidem) GABAa modulator increased 
EEG beta frequencies, characteristic for the benzodiazepines. However, the beta and gamma 
increase was specific for active behaviour and not for inactivity. Thus, an interaction with 
behaviour was demonstrated for the EEG effects of two anxiolytics. Based on this finding, it was 
argued that diazepam and zolpidem seem to amplify, rather than dissociate, the relation between 
behaviour and the EEG. The behaviour-specific EEG effect study seemed to indicate that the 
relationship between rat behaviour and EEG after administration of diazepam or zolpidem, two 
drugs acting as modulators at the benzodiazepine site of the GABAa receptor complex, is not so 
paradoxical after all.
Possible further behaviour-specific EEG effects of psychoactive drugs, like the beta- 
3/gamma effect in diazepam and zolpidem, were studied in chapter 4 for antidepressant drugs. 
Psychoactive drugs can influence both the electroencephalographic (EEG) activity and 
behaviour, while a strong relation exists between the two. In order to be able to understand these 
effects, it is not sufficient to describe changes in either separately. Rather, changes in EEG 
caused by psychoactive drugs should be described in direct concurrent relation with the subject's 
ongoing behaviour. It was studied if EEG activity is affected differentially with regard to the 
type of behaviour, and also with regard to the mechanism of action in four antidepressants; 
mirtazapine (2.5 mg/kg), citalopram, fluoxetine, and imipramine (all at 10 mg/kg). Among the 
psychoactive drugs, the group of antidepressants seems to show the most diverging effects on 
pharmaco-EEG, possibly related to their diverse mechanisms of action. Again, the detailed 
analysis of behaviour with concurrent EEG recording central to this thesis was employed. Again, 
behaviour-specific pharmaco-EEG effects were found. Citalopram, fluoxetine and mirtazapine 
decreased 9-10 Hz activity specific for behaviours such as walking, rearing, and sniffing, 
typically associated with hippocampal theta activity (6-10 Hz). Thus, EEG effects of 
antidepressants showed an interaction with behaviour. The possibility that the type-1 behaviour 
related EEG alpha-1 band decrease is a biomarker for 5-HTiA receptor activation was discussed 
and further experiments suggested.
Results of chapter 2 demonstrated that the level of behavioural activity is reflected in 
the EEG representation of behaviour. This was further elaborated in chapter 5. Again, focus was 
on the clear relationship between moment-to-moment behavioural elements and hippocampal 
RSA. However, behavioural elements are not isolated events, but are part of behavioural
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sequences in a context of behavioural activity. By concurrently monitoring open field behaviour 
and hippocampal EEG, EEG correlates of open field behaviour in relation to preceding and 
following behaviour were studied in Sprague-Dawley rats to determine whether the behavioural 
context influences EEG correlates of behaviour. Results show that preceding and subsequent 
behavioural patterns influenced the spectral power correlates of behaviour. RSA power was 
increased when a ‘type 1 behaviour’ (voluntary movement) preceded the behaviour compared to 
when a ‘type 2 behaviour’ (automatic movement, awake immobility) preceded it. Thus, the 
relationship between EEG and behaviour is not completely fixed for a given behaviour, but is 
modulated by behavioural transitions. The modulating effect of behavioural transitions was 
shown for several types of behaviours, and systematic modulation of hippocampal EEG 
correlates of behaviour was demonstrated. Thus, the strong and systematic relationship between 
hippocampal RSA and behaviour is modulated by the behavioural-sequential context. Activity 
levels influence the representation of behaviour in the EEG.
This modulating effect of behavioural transitions on EEG correlates of behaviour, was 
termed 'transition effect'. The transition effect was further studied under influence of the 
psychoactive drugs of the studies in chapters 3 and 4. The paradigm of behavioural transitions 
was suggested to demonstrate that a sensory process also contributes to hippocampal RSA. 
Modulation of the processing of sensory information could be relevant for the initiation and 
maintenance of motor behaviours. It was proposed that a similar transition effect could exist for 
cortical beta/gamma activity. Psychoactive drugs are known to interfere with behaviour, 
reactivity to the environment, and arousal levels amongst others. Therefore, it was studied if 
psychoactive drugs influence the hippocampal theta transition effect and a hypothesised cortical 
beta/gamma effect. A detailed behavioural and EEG study was performed, making use of the 
paradigm of behavioural transitions. Low doses of psychoactive drugs differentially modulated 
the hippocampal RSA transition effect. In drug-free conditions a transition effect for cortical 
beta/gamma activity could not be demonstrated, but it was consistently present under influence 
of diazepam. Thus, psychoactive drugs influence the modulating effect of behavioural 
transitions on the relationship between EEG and behaviour.
To summarize and integrate these five chapters (see Figure 1), hippocampal RSA 
shows the clearest relation with ongoing behaviour of all patterns in the EEG. This has not only 
been shown in the literature within an animal species or strain, but was also one of the findings 
of this thesis when rat strains were compared and in this way behavioural activity level was 
manipulated (Chapter 2). Additionally, findings of behaviour-dependent pharmaco-EEG effects 
were shown at RSA frequencies for the antidepressants and GABAa modulators (Chapter 3 &
4). The GABAa modulators also showed behaviour-specific effects at the beta-3/gamma band 
(Chapter 3). Beta/gamma activity has also been implicated to correlate with behaviour. 
However, it seemed that this type of activity shows a less direct relation with moment-to- 
moment behaviour (Chapter 6) but is associated with general arousal levels. Furthermore, 
gamma activity seems to be an indicator of arousal level, rather than beta activity (Chapter 3).
94
Discussion
Thus these two activities in the EEG, theta rhythm and beta/gamma activity, show the most 
prominent relation with behaviour under both control conditions and pharmacologically induced 
EEG conditions. One of the most innovative aspects of the studies was the use of behavioural 
sequences in the study on the relationship between behaviour and EEG. This provided new 
information on the functional significance of the hippocampal theta rhythm (Chapter 5). The so- 
called transition effect was further explored under influence of the drugs used throughout this 
thesis (Chapter 6).
Based on the collected findings in this thesis, suggestions can be made on how several 
aspects of behavioural activity are being expressed in, and perhaps regulated by, the EEG under 
normal and pharmacologically altered conditions.
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Figure 1 Simplified schematic representation o f the main findings (Chapter 7.1).
Behaviour and EEG are related to each other through hippocampal theta and cortical beta/gamma levels (All chapters).
A) Differences in behavioural activity levels, as studied by strain differences, are reflected in the representation 
of these behaviours in the EEG. (Chapter 2)
B) Pharmaco-EEG effects can be behaviour-dependent. A  number of antidepressants and GABAa modulators 
decrease 9-10 Hz activity specifically for type 1 behaviours. Additionally, the beta/gamma increase by diazepam and 
zolpidem is specific for active behaviour. (Chapters 3 & 4)
C) The relationship between EEG and behaviour after administration of diazepam or zolpidem is amplified 
rather than dissociated. (Chapter 3)
D) The strong and systematic relationship between hippocampal RSA and behaviour is modulated by the 
behavioural sequential context, “transition effect”. (Chapter 5)
E) Psychoactive drugs can influence the transition effect. (Chapter 6)
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7.2 Implications of the influence of spontaneous differences in 
behavioural activity on the representation of behaviour in the EEG
Both in the rat strain study (Chapter 2) and behavioural transitions study (Chapter 5) 
spontaneous activity levels were reflected in the representation of behaviour in the EEG. 
Different RSA levels were demonstrated for visually scored behaviour that was the same in 
terms of movement patterns. This implicates that behaviour as visually scored can differ in 
certain aspects of the behaviour, other than the movement pattern. In chapter 2, it was suggested 
that these aspects include motor components such as vigour of movement and sensory 
components. Thus, the major implication of the finding of differences in the representation of 
certain behaviour in the EEG effects depending on spontaneous behavioural activity is that there 
seems to be more information in the EEG signal concomitant with behaviour than purely the 
behaviour in terms of its movement patterns. This will be further elaborated in section 7.4.1 on 
the basis of results described in chapter 5.
7.3 Implications of interactions between psychoactive drug 
effects on the EEG and behaviour
In the interplay between EEG, behaviour and drug, it was shown that drug effects on the EEG 
can be behaviour selective (Chapter 3 and 4). Thus, drugs not only affect brain state and 
behaviour, but these drug effects also depend on the subjects ongoing behaviour. This implicates 
that in EEG studies it is necessary to take care when measuring EEG and interpreting the EEG 
with regard to behavioural effects.
7.3.1 Behaviour-dependent changes in beta/gamma activity
Biomarkers are important for the research and development of psychoactive drugs. EEG beta 
band activity increase has been implicated to be a biomarker for GABAa agonism (Visser et al. 
2003a). In most studies the EEG is measured under forced vigilance conditions. It was 
demonstrated (Chapter 3) that the EEG beta increase is also valid under non-forced vigilance 
conditions. However, our studies indicated that this effect could only be measured at behavioural 
activity for diazepam and zolpidem, and not during quiet waking. Thus, claims for beta band 
increase as a biomarker need to be carefully formulated for they are not valid in all 
circumstances. So perhaps yes, it can be used as a biomarker, but its validity should then be 
limited to a beta band increase during behavioural activity.
In addition, based on the behaviour-dependency of the changes in beta/gamma activity 
it was argued that there is no real pharmacological dissociation of the relationship between
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behaviour and the EEG after administration of diazepam and zolpidem. The increase in 
beta/gamma activity induced by diazepam and zolpidem is specific for active behaviour 
(Chapter 3). Two observations supported the argument. Firstly, under drug free conditions 
gamma activity represents arousal and not beta (Chapter 3 and Maloney et al. 1997). Secondly, 
there are two types of beta oscillations. The first type is physiological, but the second is induced 
by anaesthetics/sedatives (e.g. diazepam and zolpidem) and hypothesised to be modified gamma 
activity (Whittington et al. 2000a). Thus, it can be argued that there is no pharmacological 
dissociation, but rather an exaggeration of the relation between behaviour and the EEG, under 
influence of diazepam and zolpidem. But why would this relation be thus exaggerated?
In Chapter 3 it was argued that the beta/gamma increase specific for active behaviour 
facilitates the occurrence of this behaviour despite sedation. This is in close agreement with 
chapters 5 and 6, in which the transition effect demonstrates that theta levels are elevated for the 
occurrence of active behaviour, compared to inactive behaviour. In chapter 6, a beta/gamma 
transition effect was demonstrated for diazepam, which was similarly suggested to be important 
for initiation of active behaviour.
7.3.2 Behaviour-dependent changes in 9-10 Hz activity
Another pharmaco-EEG effect, the decrease in alpha-1 band frequencies, was also found to be 
behaviour dependent (Chapter 3 and 4). It was attributed to a decrease in RSA frequency, and its 
behaviour-dependency ascribed to the fact that during active behaviour there is more RSA to 
change. RSA frequency reduction has been implied to be a biomarker for anxiolysis 
(McNaughton et al. 1986) and is quite pronounced after administration of benzodiazepines. This 
RSA frequency reduction and an associated behaviour dependent decrease in alpha-1 EEG 
power were indeed demonstrated in diazepam and zolpidem (chapters 3 and 6). In addition, 
some antidepressants also decreased RSA frequency, though to a lesser extend (Chapter 4). 
Thus, the RSA frequency reducing effect is not exclusive to the GABA-ergic neurotransmitter 
system (McNaughton & Coop 1991). Some antidepressants have anxiolytic effects next to 
antidepressant actions (for review see Nutt 2000).
Indeed, fluoxetine (Chouinard et al. 1999, Gorman 1997), mirtazapine (Leinonen et al. 
1999, Bruijn et al. 1999, Goodnick et al. 1999) and citalopram (Leinonen et al. 1999) have been 
implicated to have anxiolytic properties in the clinic, and were shown to reduce RSA frequency 
(Chapter 4). Imipramine did not show the frequency reduction, in accordance with the fact that it 
seems to have less strong serotonergic and anxiolytic effects at the dose tested (Rickels & Rynn 
2002, Bruijn et al. 1999). However, a similar behaviour-dependent alpha-1 effect was found in 
the rat strain study. If RSA frequency reduction were a universal marker for anxiolysis, we 
would have to assume that Sprague-Dawley rats are less anxious than Long-Evans rats in 
analogy with anxiolytic drug action. However, experimental data rather suggest the opposite
97
Chapter 7
(Andrews et al. 1995). The predictive value for alpha-1 decrease for antidepressant properties 
remains to be evaluated.
Alpha-1 power differences between rat strains were related to differences in rat 
exploratory behaviour. Effects on exploratory behaviour were also found for the psychoactive 
drugs. The meaning of RSA frequency is not yet fully understood, but RSA frequency has been 
implicated to be important for information processing (Buzsaki 1989, O'Keefe 1993). As argued 
in chapter 5, RSA activity seems to include both motor and sensory aspects. Thus, the 
concomitant effects of psychoactive drug or strains on RSA (alpha-1) EEG activity and 
exploratory behaviour can be hypothesised to express alterations in sensorimotor information 
processing. This could have an association with anxiolytic properties (McNaughton 1997) or 
perhaps antidepressant effects, but this need not be the only property affected by altered 
sensorimotor processing. In addition, anxiolysis could be reached by other means.
7.3.3 Implications for research and development of psychoactive drugs
One aim of the studies was to see if a spectrum of action mechanisms would give a similar 
spectrum of effects. To this end the psychoactive drug selection was made. In particular the 
antidepressants form a spectrum from purely serotonergic action on the one end to action on 
multiple neurotransmitter systems on the other end. Additionally, there is an overlap of some 
antidepressant drugs with anxiolytic effects. So the drug selection created a spectrum of 
antidepressant to anxiolytic properties. However, such a spectrum in effects could not readily be 
seen reflected by the data. The closest approximation for such a spectrum has been described 
above for alterations in hippocampal RSA frequency. However, the drug with the clearest 
combination of both anxiolytic and antidepressant properties did not fall into this spectrum. With 
inclusion of three cortical areas and the hippocampus bilaterally, twenty-five behavioural 
elements, and eight frequency bands, large data sets were generated. For such complicated data 
sets, sophisticated extraction tools should be developed and more drugs should be included to 
find common effects and differences between psychoactive drugs, which then can be related to 
pharmacological properties.
The behaviour-dependent pharmaco-EEG and the (pharmaco-) transition effect 
rendered information for theories on how behaviour and the EEG are related and how 
psychoactive drugs might influence their interplay. But what use might they actually have in the 
research and development of drugs? Different drugs showed different effects on the behaviour- 
dependent pharmaco-EEG and pharmaco transition effect. This was evaluated in light of their 
pharmacological properties, but the predictive value for therapeutic effect remains to be 
evaluated. Whether the pharmaco-transition effect can be incorporated in pharmaco-models also 
remains to be seen. One current problem is that the analyses are very labour-intensive and thus 
not suitable for high throughput screening. However, developments in the technology of
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automated behavioural scoring are promising and progress will determine whether these 
analyses can be automated and thus speeded up to an acceptable throughput for industrial use. It 
was argued that the transition effect reflects information processing. If the paradigm of 
behavioural transitions is indeed sensitive to information processing and alterations therein, this 
could be of much interest for the further development of psychoactive drugs.
7.4 Implications of the transition effect
7.4.1 Implications for the relation between behaviour and hippocampal RSA
The old controversy dating back to the 1970's, whether hippocampal RSA was merely related to 
motor behaviour or to mental processes, had never really been settled by studying the correlation 
between behaviour and theta. Little information was added to this debate in ensuing years. In 
this thesis, use of a new paradigm in the relation between EEG and behaviour, namely that of 
behavioural transitions (Chapter 5) offered new information. The data suggested that an 
additional process next to the well-established motor-component does contribute to the RSA 
(Chapter 5). The nature of this second component cannot be directly derived from the study. 
However, our findings fit very well with recent models on a sensorimotor integration function of 
hippocampal RSA (Bland & Oddie 2001). The contribution of sensory processes was also 
suggested in our strain differences study (Chapter 2). Additionally, for sniffing behaviour the 
strongest so-termed transition effect was demonstrated, which is in line with the hypothesis of a 
sensory aspect contributing to hippocampal RSA.
Sensorimotor integration
Based on the two types of hippocampal theta activity (type 1 and type 2 RSA, see §1.2.1 of 
introduction), a sensorimotor integration model has been proposed for the function of 
hippocampal RSA. In this model, type 1 theta gives a direct indication of the level of activation 
of the motor systems involved in type 1 behaviour, whereas type 2 theta indicates the processing 
of sensory information. This type 2 theta is always coincidental with type 1 theta and provides 
the motor systems with continually updated feedback information on changing sensory 
conditions. It is the electrical sign of processing sensory stimuli that are critical to the initiation 
of a subsequent motor response or the maintenance of an on-going motor-activity (Oddie & 
Bland 1998). Thus, the hippocampus functions to integrate sensory and motor information 
(Bland & Oddie 2001). The transition effect could show modulation of the sensory (type 2 RSA) 
processes. Additional indications of modulation of type 2 RSA come from pharmacological 
manipulation of the transition effect (Chapter 6). Type 1 RSA is serotonergic in origin and the 
most serotonin selective drug citalopram did not specifically influence the transition effect.
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Thus, it seemed that type 1 RSA is not modulated by the transition effect. This would leave type
2 RSA to be modulated by the transition effect.
Going back again to the old controversy, the hippocampus has been implied to be relevant for 
functions of higher-order than sensory-motor integration. It would be a rather large step to 
assume that with the transition effect higher-order functions are demonstrated, such as attention 
(Wall & Messier 2001), memory (Redish 2001), spatial navigation and learning (Jarrard 1995, 
Whishaw et al. 2001). Rather, the integration of motor and sensory information in the form of 
the theta rhythm could form the basis of higher-order processes. If this integration of 
information is disturbed, higher order processes will also be affected without the need to 
presume that the theta rhythm itself is a representative of those higher order processes.
It is not without reason that the debate on hippocampal RSA function has never really 
been settled. A problem in the correlational studies on RSA and behaviour in freely moving 
animals has always been that motor activity is hard to decouple from other aspects such as 
spatial information processing and arousal levels. This was also shown in chapter 5: part of the 
transition effect could still be attributed to differences in concomitant motor activity. Although 
the paradigm of behavioural transitions gives us first indications, future research should seek 
further sophisticated paradigms that allow for better dissociation of the motor component and 
sensory component of the hippocampal theta rhythm.
7.4.2 Towards theoretical implications for theta and beta/gamma activity in 
behavioural control
The aim of this thesis was to provide detailed information about the relations between 
(pharmaco-) EEG and behaviour in rats. In the introduction the question was formulated: "How 
is spontaneous and pharmacologically induced activity represented in EEG activity and how is 
activity determined by spontaneous pharmaco-EEG activity?" This already implies some sort of 
chicken and egg problem. What comes first? Do certain patterns in the EEG control behaviour, 
or are these patterns a mere reflection of the behavioural activity? Results of the transition effect, 
described in this thesis, do not only have implications for the function of theta rhythm (Chapter
5) but also seem to offer indications towards this chicken and egg problem. The transition effect 
demonstrated that prior to the occurrence of active behaviour, levels of theta activity in the EEG 
are already elevated without being able to see this in the overt behaviour. One could quickly 
conclude from this that the brain obviously dictates what behaviour will come next, in 
accordance with the claim of Steriade (2000) that "Brain oscillations determine behavioural 
states". However, a strictly unidirectional way proofs to be too simple: theta levels were also 
elevated after the active behaviour. Thus, the transition effect could rather indicate that the theta 
EEG activity level fluctuates and that this level might determine some sort of probability level
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for active behaviour to occur. The theta transition effect was suggested to represent information 
processing as in accordance with models of Bland & Oddie (2001). Fluctuations of information 
processing as expressed by the theta level/ could be induced by external and internal input, 
which in their turn are connected to overt behaviour. For, in an explorative mode, the animal 
will receive more external input. The theta level, when comparing strains was higher in Long- 
Evans than Sprague-Dawley rats (Chapter 2). Long-Evans were more active than Sprague- 
Dawleys. Thus, when receiving more input Long-Evans rats show more active behaviour, but 
also when they show more active behaviour they receive more input.
Similar to this theta level, a beta/gamma level can be presumed. However, in drug free 
conditions, this beta/gamma level seemed less relevant for moment-to-moment initiation of 
behaviour but rather for general brain state (Chapter 6). The GABAa agonists diazepam and 
zolpidem, binding at the benzodiazepine site, were suggested to raise the beta/gamma threshold 
level for behavioural activity to occur, because of pharmacological induced sedation (Chapter 3). 
To conclude, a critical level of theta/beta/gamma activity can be hypothesised to determine 
probability of active behaviour to occur. This level reflects external and internal sensory 
information processing. Psychoactive drugs can influence these critical theta/beta/gamma levels, 
thus altering sensorimotor integration, reactivity to the environment, and behavioural activity.
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Figure 2 Simplified schematic representation of the main theoretical implications (Chapter 7).
Behaviour and EEG are related to each other through hippocampal theta and cortical beta/gamma levels (All chapters).
A) Information processing as expressed by theta levels reflects internal and external input, which influences
behavioural activity level. At the same time behavioural activity level influences the level o f input and information 
processing. (Chapters 2 and 5)
B)
C)
D)
E)
1) I f  EEG beta band increase is a biomarker for GABAA agonism, its validity is limited to during 
behavioural activity. (Chapter 3)
2) Is type-1 behaviour related EEG alpha-1 band decrease a biomarker for 5-HT1A receptor 
activation? Does it have predictive validity for anxiolytic or antidepressant properties? (Chapters 3 & 4) 
Diazepam and zolpidem elevate beta/gamma threshold levels for occurrence of behavioural activity (Chapter
3)
Theta levels represent, next to motor activity, (sensory-) information processing. (Chapter 5)
Psychoactive drugs can alter sensorimotor integration and reactivity to the environment and behavioural 
activity through alterations. (Chapter 6)
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Brain activity and behaviour are related to each other. Psychoactive drugs can influence both 
brain activity and behaviour. In order to be able to understand the interplay between brain 
activity as measured by the electroencephalogram (EEG), behaviour, and psychoactive drugs, it 
is not sufficient to describe changes in either behaviour or EEG separately. Rather, changes in 
EEG caused by psychoactive drugs should be described in direct concurrent relation with the 
subject's ongoing behaviour. Thus, this thesis was aimed at the description of how spontaneous 
and pharmacologically induced activity is represented in EEG activity and how behavioural 
activity is determined by spontaneous and pharmaco-EEG activity in rats.
In Chapter 1 firstly an introduction was given to these three subjects EEG, behaviour, 
and psychoactive drugs. Consequently, their interactions are introduced. The strongest 
relationship between spontaneous brain activity and the behaving animal has been demonstrated 
for rhythmical slow activity (RSA) that predominates the EEG of the rat hippocampus. Based on 
correlates with hippocampal RSA a distinction has been made between type 1 behaviour 
(voluntary movement) and type 2 behaviour (automatic movement and immobility). In contrast 
to the hippocampus, the cortex is dominated by an EEG pattern of low voltage high frequency 
activity during behavioural activity. Although this activity does not show the precise relation to 
concurrent motor behaviour as hippcampal RSA does, it has been associated with general levels 
of arousal. Behaviour, EEG and their relation were the focus of further studies on the effects of 
psychoactive drugs. For the study of psychoactive drugs, it is essential to consider their effects 
on the level of the intact brain. Therefore the EEG is a useful tool for the development and 
assessment of psychoactive drugs. Two major classes of psychoactive drugs were chosen: 
antidepressants and anxiolytics. Relevant information for the drugs used in the studies was 
given. Limited information is yet available on the interplay between drug effects on behaviour 
and drug effects on the EEG. Indications that some information may lie in this interplay are 
given by a phenomenon called 'pharmacological dissociation' of the normal relation between 
EEG and behaviour.
The aim of this thesis was to describe how spontaneous and pharmacologically induced 
activity is represented in EEG activity and how behavioural activity is determined by 
spontaneous and pharmaco-EEG activity. A number of more specific questions were formulated 
and answered in the chapters 2 through 6 in this thesis. Are spontaneous differences in 
behavioural activity, as studied by means of different rat strains, reflected in the representation 
of behaviour in the EEG? (Chapter 2) Is there an interaction between psychoactive drug effects 
on the EEG and behaviour? (Chapters 3 and 4) What is the nature of the dissociation of the 
relationship between EEG and behaviour under GABAa receptor modulation? (Chapter 3) Are 
spontaneous differences in behavioural activity, as studied by means of behavioural transitions,
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reflected in the representation of behaviour in the EEG? (Chapter 5) Do psychoactive drugs 
influence the modulating effect of behavioural transitions on the relationship between EEG and 
behaviour? (Chapter 6)
In Chapter 2 the question was addressed if spontaneous differences in behavioural 
activity, as studied by means of different rat strains, are reflected in the representation of 
behaviour in the hippocampal EEG. Two rat strains, the albino Sprague-Dawley and pigmented 
Long-Evans, differed in exploratory behaviour. They also differed in EEG spectral power in the 
9-10 Hz frequency band (high frequency RSA). Furthermore, this EEG effect was behaviour- 
specific for voluntary movement and sniffing behaviour. Thus, these behaviour-specific strain 
differences in RSA power demonstrated that differences in activity levels are reflected in the 
representation of these behaviours in the EEG. The strain differences were attributed to a main 
motor component but also to a sensory component integrated in exploratory behaviour. This is in 
accordance with theories on the sensorimotor function of the hippocampus and hippocampal 
RSA activity.
In Chapter 3 the effects of the GABAa modulators diazepam and zolpidem were 
addressed on the hippocampal and cortical EEG and behaviour and a possible interaction. More 
specifically, the nature of the dissociation of the relationship between EEG and behaviour under 
GABAA receptor modulation was further studied in Long-Evans rats. While a decrease in high- 
frequency EEG is associated with a decrease in arousal in drug-free conditions, sedative 
benzodiazepines increase beta activity. Both a benzodiazepine (diazepam) and non­
benzodiazepine (zolpidem) GABAa modulator increased EEG beta frequencies, characteristic 
for the benzodiazepines. However, the beta increase was specific for active behaviour and not 
inactivity. Thus an interaction with behaviour was demonstrated for the EEG effects of two 
GABAA modulators. Based on this finding it was argued that diazepam and zolpidem seem to 
amplify rather than dissociate the relationship between behaviour and the EEG. It is 
hypothesised that the large increase in beta-3/gamma activity caused by diazepam and zolpidem 
is a possible compensatory mechanism that allows for behavioural activation, despite 
pharmacologically induced sedation.
In Chapter 4 antidepressant (citalopram, fluoxetine, imipramine, mirtazapine) drug 
effects on the hippocampal and cortical EEG and behaviour and possible interactions were 
studied in Long-Evans rats. Among the psychoactive drugs, the group of the antidepressants 
seems to show the most diverging effects on behaviour and the pharmaco-EEG in rats, possibly 
related to their diverse mechanism of action. Citalopram, fluoxetine and mirtazapine decreased 
9-10 Hz activity, specific for behaviours such as walking, rearing and sniffing typically 
associated with hippocampal RSA activity. Thus an interaction with behaviour was 
demonstrated for the EEG effects of three antidepressants. At the dose tested, imipramine did 
not affect 9-10 Hz activity. The combined study of detailed open field behaviour and 
concomitant pharmaco-EEG effects seemed to have a predictive value for mechanisms of action.
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In Chapter 5 the question was addressed if spontaneous differences in behavioural 
activity, as studied by means of behavioural transitions, are reflected in the representation of 
behaviour in the hippocampal EEG. Behaviour does not consist of isolated behavioural 
elements; rather behavioural elements are part of behavioural sequences in a context of 
behavioural activity. Hippocampal EEG correlates of open field behaviour in relation to 
preceding and following behaviour were studied in Sprague-Dawley rats to determine whether 
the behavioural context influences EEG correlates of behaviour. Results showed that the 
preceding and subsequent behavioural pattern influenced the spectral power correlates of 
behaviour. RSA power was increased when a type 1 behaviour preceded the behavioural 
element, compared with when a type 2 behaviour preceded it. Thus, the relationship between 
EEG and behaviour was not fixed for a given behaviour, but could be modulated by previous or 
following behaviour at behavioural transitions. The modulating effect was shown for several 
types of behaviour, and systematic modulation of the relationship between hippocampal EEG 
correlates of behaviour was demonstrated. Thus, the strong and systematic relationship between 
hippocampal RSA and behaviour was modulated by the behavioural-sequential context. It is 
suggested that a second, non-motor process contributes to hippocampal RSA. A likely candidate 
is a sensory-process as in accordance with theories on the sensorimotor function of hippcampal 
RSA.
In Chapter 6 it was studied whether psychoactive drugs influence the modulating 
effect of behavioural transitions on the relationship between hippocampal EEG and behaviour. 
In addition, it was studied whether a similar effect could be demonstrated for cortical 
beta/gamma activity. This study in Long-Evans rats confirmed the existence of a transition 
effect. Furthermore, psychoactive drugs differentially modulated the hippocampal RSA 
transition effect. In drug-free conditions a transition effect for cortical beta/gamma activity could 
not be demonstrated, but it was consistently present under influence of diazepam. It was 
hypothesised that drugs that influence the transition effect (imipramine, zolpidem, diazepam) 
alter (sensory) information processing and thereby reactivity to the environment. Furthermore, it 
was suggested that diazepam and zolpidem use the transition effect as an operandum to facilitate 
initiation of behavioural activity despite sedation.
In Chapter 7, the general discussion, the most important findings of the experimental 
chapters were summarized and their implications were given. Some changes in the EEG induced 
by psychoactive drugs were found to be behaviour dependent. Therefore, EEG effects should be 
studied in direct relation with the subject's concurrent behaviour. In the research and 
development of psychoactive drugs, behaviour-specific pharmaco-EEG changes could play a 
future role. It was shown that if EEG beta band increase is indeed a biomarker for GABAa 
agonism, its validity is limited to periods of behavioural activity. Furthermore, the possibility 
that the type-1 behaviour related EEG alpha-1 band decrease is a biomarker for 5-HTiA receptor 
activation was discussed, while its predictive validity for anxiolytic or antidepressant properties 
remains to be evaluated. Future developments in automated behavioural analysis will determine
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if the paradigm of behaviour-specific EEG changes and the paradigm of behavioural transitions 
can be utilised for further development of psychoactive drugs.
One of the most innovative aspects of the studies was the use of behavioural sequences 
in the study on the relationship between behaviour and EEG. This provided new information on 
the functional significance of the hippocampal theta rhythm. The theta transition effect was 
suggested to represent (sensorimotor) information processing as in accordance with models of 
Bland & Oddie (2001). The transition effect was suggested to indicate that the theta EEG level 
fluctuates and that this level might determine some sort of probability level for active behaviour 
to occur. This level influences, and can be influenced by, internal and external input, which is 
connected to overt behaviour.
Similar to the theta levels a beta/gamma level can be presumed, although this seems 
less relevant for initiation of moment-to-moment behaviour in drug free conditions. A critical 
level of theta and/or beta/gamma activity can be hypothesised to determine the probability of 
active behaviour to occur. This level reflects external and internal sensorimotor information 
processing. Psychoactive drugs can alter these levels and consequently sensorimotor integration, 
reactivity to the environment, and behavioural activity. For example GABAa receptor 
modulation elevates beta/gamma threshold levels for occurrence of behavioural activity.
In short, there is a strong relationship between behaviour and EEG in rats. Spontaneous 
behavioural activity levels are reflected in the representation of behaviour in the EEG [strain 
differences (Chapter 2) and behavioural transitions (Chapter 5)]. Also, psychoactive drugs can 
influence the representation of behaviour in the EEG, as some pharmaco-EEG effects occur 
specifically during certain behavioural elements (Chapters 3 and 4). Thus, the relationship 
between EEG and behaviour is not completely fixed but can be modulated by spontaneous and 
pharmacological factors. Furthermore, these two factors interact, as psychoactive drugs 
influence the modulating effect of behavioural transitions on the relationship between EEG and 
behaviour (Chapter 6). Although modulation takes place, a dissociation of the relation between 
EEG and behaviour by the GABAa modulators diazepam and zolpidem, as suggested in the 
literature, was not found (Chapter 3). The modulation of the relationship between EEG and 
behaviour, spontaneously or pharmacologically, is hypothesised to determine fluctuating 
probability levels for behavioural activity to occur by influencing (sensorimotor) information 
processing (Chapter 7).
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Samenvatting
Hersenactiviteit en gedrag zijn aan elkaar gerelateerd. Psychoactieve geneesmiddelen kunnen 
zowel hersenactiviteit als gedrag beïnvloeden. Om de wisselwerking te begrijpen tussen 
hersenactiviteit, gedrag en psychoactieve geneesmiddelen is het apart beschrijven van 
veranderingen in ofwel hersenactiviteit, gemeten met het elektro-encefalogram (EEG), ofwel 
gedrag niet toereikend. De door psychoactieve stoffen veroorzaakte veranderingen in het EEG 
zouden in directe relatie met het gelijktijdige gedrag beschreven moeten worden. Dit proefschrift 
beschreef hoe spontaan en farmacologisch geïnduceerd gedrag tot uiting komt in EEG activiteit 
en hoe gedrag bepaald wordt door spontane en farmaco-EEG activiteit in ratten.
In Hoofdstuk 1 werd allereerst een inleiding gegeven op deze drie onderwerpen: EEG, 
gedrag, en psychoactieve geneesmiddelen; en vervolgens hun interacties. De sterkste relatie 
tussen spontane hersenactiviteit en diergedrag is aangetoond voor rhythmical slow activity 
(RSA) dat het EEG van de hippocampus van de rat domineert. Gebaseerd op correlaties met 
hippocampaal RSA is gedrag ingedeeld in type 1 gedrag (gewilde bewegingen) en type 2 gedrag 
(automatische bewegingen en immobiliteit). In tegenstelling tot de hippocampus wordt de cortex 
gedomineerd door een hoog frequent EEG patroon van laag voltage gedurende actief gedrag. 
Alhoewel deze EEG activiteit niet de precieze relatie vertoond met motorisch gedrag zoals 
hippocampaal RSA dat doet, wordt het geassocieerd met algehele niveaus van bewustzijn. 
Gedrag, EEG en hun onderlinge relatie waren het onderwerp van de verdere studies naar de 
effecten van psychoactieve stoffen. Bij het onderzoek naar psychoactieve geneesmiddelen is het 
essentieel om hun effecten te bekijken op het niveau van het intacte brein. Daarom is het EEG 
nuttig voor de ontwikkeling en toetsing van psychoactieve geneesmiddelen. Twee belangrijke 
klassen van psychoactieve geneesmiddelen werden gekozen: antidepressiva en anxiolytica. 
Vooralsnog is er beperkt informatie beschikbaar over de wisselwerking tussen drug effecten op 
gedrag en drug effecten op het EEG. Het fenomeen 'farmacologische dissociatie' van de normale 
relatie tussen EEG en gedrag geeft indicaties dat er iets aan de hand is in deze wisselwerking.
De doelstelling van dit proefschrift was te beschrijven hoe spontaan en farmacologisch 
geïnduceerd gedrag tot uiting komt in EEG activiteit en hoe gedrag bepaald wordt door spontane 
en farmaco-EEG activiteit. In hoofdstuk 2 tot en met 6 van dit proefschrift werden meer 
specifieke vraagstellingen geformuleerd en beantwoord. Komen spontane verschillen in actief 
gedrag, bestudeerd met behulp van verschillende ratten stammem, tot uiting in de representatie 
van gedrag in het EEG? (Hoofdstuk 2). Is er een interactie tussen de effecten van psychoactieve 
geneesmiddelen op het EEG en op gedrag? (Hoofdstukken 3 en 4). Wat is de aard van de 
dissociatie van de relatie tussen EEG en gedrag tijdens modulatie van de GABAA receptor? 
(Hoofdstuk 3). Komen spontane verschillen in gedragsmatige activiteit, bestudeerd met behulp 
van gedrags-overgangen, tot uiting in de representatie van gedrag in het EEG? (Hoofdstuk 5).
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Beïnvloeden psychoactieve stoffen het modulerende effect van gedrags-transities op de relatie 
tussen EEG en gedrag? (Hoofdstuk 6).
In Hoofdstuk 2 werd bestudeerd of spontane verschillen in actief gedrag, bestudeerd 
met behulp van verschillende ratten stammem, tot uiting komen in de representatie van gedrag in 
het EEG. Twee ratten stammen, de albino Sprague-Dawley en gepigmenteerde Long-Evans 
ratten, verschilden in exploratie gedrag. Ze verschilden ook in EEG spectrale power in de 9-10 
Hz frequentie band (hoog frequent RSA). Bovendien was dit EEG effect gedrags-specifiek voor 
‘gewilde bewegingen’ en snuffel gedrag. Deze gedrags-specifieke stamverschillen in RSA 
power toonden aan dat verschillen in het niveau van activiteit tot uiting komen in de 
representatie van deze gedragingen in het EEG. De stamverschillen werden toegeschreven aan 
een motorische en een sensorische component geïntegreerd in exploratie gedrag. Dit komt 
overeen met theorieën over de sensorisch-motorische functie van de hippocampus en 
hippocampale RSA activiteit.
In Hoofdstuk 3 werden de effecten bestudeerd van diazepam en zolpidem op het 
hippocampale en corticale EEG en gedrag en een veronderstelde interactie. Meer specifiek werd 
ingegaan op de aard van de dissociatie van de relatie tussen EEG en gedrag tijdens modulatie 
van de GABAa receptor in Long-Evans ratten. Terwijl een vermindering van hoogfrequente 
EEG activiteit geassocieerd wordt met een verlaging van bewustzijn in drug vrije condities, 
verhogen sedatieve benzodiazepines bèta activiteit. Zowel een benzodiazepine (diazepam) als 
een niet-benzodiazepine (zolpidem) GABAa modulator verhoogden EEG bèta frequenties, 
karakteristiek voor de benzodiazepines. Maar deze bèta verhoging was specifiek voor actief 
gedrag en niet voor inactiviteit. Hiermee werd een interactie met gedrag aangetoond voor de 
EEG effecten van twee GABAA modulatoren. Gebaseerd op deze bevinding werd 
beargumenteerd dat diazepam en zolpidem de relatie tussen gedrag en EEG eerder lijken te 
versterken dan te dissociëren. De hypothese werd gesteld dat de verhoging in bèta-3/gamma 
activiteit veroorzaakt door diazepam en zolpidem mogelijk een compensatie mechanisme is dat 
actief gedrag mogelijk maakt, ondanks farmacologisch geïnduceerde sedatie.
In Hoofdstuk 4 werden de effecten van antidepressiva (citalopram, fluoxetine, 
imipramine, mirtazapine) op het hippocampale en corticale EEG, op gedrag en veronderstelde 
interacties onderzocht in Long-Evans ratten. Onder de psychoactieve geneesmiddelen lijkt de 
groep van de antidepressiva de meest uiteenlopende effecten op gedrag en het farmaco-EEG te 
hebben in ratten, mogelijkerwijs gerelateerd aan de verschillende actiemechanismen. 
Citalopram, fluoxetine en mirtazapine verlaagden 9-10 Hz activiteit, specifiek voor gedragingen 
die gekenmerkt worden door hippocampale RSA activiteit zoals lopen, rearen en snuffelen. 
Hiermee werd een interactie met gedrag aangetoond voor de EEG effecten van drie 
antidepressiva. Bij de geteste dosis beïnvloedde imipramine de 9-10 Hz activiteit niet. De 
combinatie van gelijktijdig gedetailleerd open veld gedrag en farmaco-EEG effecten leek een 
voorspellende waarde te hebben voor actiemechanisme.
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In Hoofdstuk 5 werd de vraag gesteld of spontane verschillen in gedragsmatige 
activiteit, bestudeerd met behulp van gedragsovergangen, tot uiting komen in de representatie 
van gedrag in het hippocampale EEG. Gedrag bestaat niet uit losse gedragselementen, maar 
gedragselementen maken deel uit van gedragssequenties in een context van activiteit. Om te 
bepalen of de context van gedrag de EEG correlaten van gedrag beïnvloedt werden correlaten 
van open veld gedrag in het hippocampale EEG bestudeerd in relatie tot het voorafgaande en 
volgende gedrag in Sprague-Dawley ratten. De resultaten lieten zien dat het voorafgaande en 
volgende gedragspatroon de spectrale power correlaten van gedrag beïnvloedden. RSA power 
was hoger wanneer een type 1 gedrag voorafging aan het gedragselement, vergeleken met 
wanneer een type 2 gedrag eraan voorafging. Zo staat de relatie tussen EEG en gedrag niet vast 
voor een bepaald gedrag, maar kan deze gemoduleerd worden door voorafgaand of volgend 
gedrag bij gedragstransities. Het modulerende effect werd gevonden voor verschillende types 
gedrag en werd systematische modulatie van de relatie tussen hippocampale EEG correlaten van 
gedrag aangetoond. Hiermee moduleert de context van gedragssequenties de sterke en 
systematische relatie tussen hippocampaal RSA en gedrag. Dit suggereert dat een tweede, niet­
motorisch, proces bijdraagt aan hippocampaal RSA. Een waarschijnlijke kandidaat is een 
sensorisch proces, in overeenstemming met theorieën over de sensorimotorische functie van 
hippocampaal RSA.
In Hoofdstuk 6 werd onderzocht of psychoactieve geneesmiddelen het modulerende 
effect van gedragstransities op de relatie tussen hippocampaal EEG en gedrag beïnvloeden. 
Daarnaast werd onderzocht of een dergelijk effect ook aangetoond kan worden voor corticale 
bèta/gamma activiteit. Deze studie in Long-Evans ratten bevestigde het bestaan van een transitie 
effect. Bovendien beïnvloedde psychoactieve geneesmiddelen op verschillende wijze het 
hippocampale RSA transitie effect. In drug vrije condities kon een transitie effect voor corticale 
bèta/gamma activiteit niet aangetoond worden, maar het was wel consequent aanwezig onder 
invloed van diazepam. De hypothese werd gesteld dat drugs die het transitie effect moduleren 
(imipramine, zolpidem, diazepam) de verwerking van (sensorische) informatie beïnvloeden en 
hiermee de reactiviteit naar de omgeving. Bovendien werd gesuggereerd dat diazepam en 
zolpidem het transitie effect gebruiken om, ondanks sedatie, de initiatie van actief gedrag te 
vergemakkelijken.
In Hoofdstuk 7, de algemene discussie, werden de belangrijkste experimentele 
bevindingen van de voorgaande hoofdstukken samengevat en hun implicaties besproken. Een 
aantal door psychoactieve geneesmiddelen geïnduceerde veranderingen in het EEG waren 
afhankelijk van het gedrag. Daarom zouden EEG effecten in directe relatie tot het gelijktijdige 
gedrag onderzocht moeten worden. In het onderzoek en de ontwikkeling van psychoactieve 
stoffen zouden gedragsspecifieke farmaco-EEG veranderingen mogelijk in de toekomst een rol 
kunnen gaan spelen. Het werd aangetoond dat als de EEG bèta band verhoging inderdaad een 
biomarker is voor GABAA agonisme, de validiteit beperkt is tot periodes van actief gedrag. De 
mogelijkheid werd bediscussieerd dat een verlaging van de EEG alfa-1 band tijdens type-1
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gedrag een biomarker is voor 5-HT1A receptor aktivatie, terwijl de predictieve validiteit voor 
anxiolytische of antidepressieve eigenschappen nog geëvalueerd moet worden. Toekomstige 
ontwikkelingen in geautomatiseerde gedragsanalyse zullen bepalen of het paradigma van 
gedragsspecifieke EEG veranderingen en het paradigma van gedragstransities gebruikt kunnen 
gaan worden in de verdere ontwikkeling van psychoactieve geneesmiddelen.
Een van de meest vernieuwende aspecten was het gebruik van gedragstransities in de 
studie naar de relatie tussen gedrag en EEG. Dit leverde nieuwe informatie op over de 
functionele betekenis van het hippocampale theta ritme. Het theta transitie effect werd 
verondersteld een uiting te zijn van (sensorimotorische) informatie verwerking, in 
overeenstemming met modellen van Bland & Oddie (2001). Het transitie effect zou kunnen 
aangeven dat het niveau van EEG theta activiteit fluctueert en dat dit niveau een 
waarschijnlijkheids-niveau bepaalt voor het optreden van actief gedrag. Dit niveau beïnvloedt, 
en wordt beïnvloed door, interne en externe input, dat verbonden is met vertoond gedrag.
Vergelijkbaar met het theta niveau kan een bèta/gamma niveau verondersteld worden, 
alhoewel dit minder relevant lijkt voor de initiatie van moment-tot-moment gedrag in drug vrije 
condities. De hypothese kan gesteld worden dat een kritiek niveau van theta en/of bèta/gamma 
activiteit de waarschijnlijkheid bepaald dat actief gedrag op zal treden. Dit niveau weerspiegelt 
externe en interne sensorimotorsiche informatie verwerking. Psychoactieve stoffen kunnen deze 
niveaus veranderen en dientengevolge sensorimotorsiche integratie, reactiviteit naar de 
omgeving en gedrag. GABAa receptor modulatie verhoogt bijvoorbeeld de bèta/gamma drempel 
niveaus voor het optreden van actief gedrag.
Samenvattend bestaat er een sterke relatie tussen gedrag en EEG in ratten. Spontane 
activiteitsniveaus van gedrag worden weerspiegeld in de representatie van gedrag in het EEG 
[stamverschillen (Hoofdstuk 2) en gedragstransities (Hoofdstuk 5)]. Ook kunnen psychoactieve 
geneesmiddelen de representatie van gedrag in het EEG beïnvloeden, aangezien sommige 
farmaco-EEG effecten specifiek tijdens bepaalde gedragselementen optreden (Hoofdstukken 3 
en 4). Aldus ligt de relatie tussen EEG en gedrag niet kompleet vast maar kan deze gemoduleerd 
worden door spontane en farmacologische factoren. Bovendien is er een interactie tussen deze 
twee factoren, daar psychoactieve stoffen het modulerende effect van gedragstransities op de 
relatie tussen EEG en gedrag beïnvloeden (Hoofdstuk 6). Alhoewel er sprake is van modulatie, 
werd een dissociatie van de relatie tussen EEG en gedrag, zoals gesuggereerd in de literatuur 
voor de GABAA modulatoren diazepam en zolpidem, niet gevonden (Hoofdstuk 3). De 
hypothese werd gesteld dat de modulatie van de relatie tussen EEG en gedrag, spontaan of 
farmacologisch, fluctuerende waarschijnlijkheids-niveaus bepaald voor het optreden van actief 
gedrag door (sensorimotorsiche) informatie verwerking te beïnvloeden (Hoofdstuk 7).
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